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ABSTRACT 
 
A proteomic screen to identify novel SUMO (small ubiquitin-related modifier) 
substrates in budding yeast Saccharomyces cerevisiae revealed the TATA-binding 
protein (TBP) as a candidate. TBP is a ubiquitous transcription factor required for 
transcription by the three eukaryotic RNA polymerases. TBP was confirmed to be 
SUMOylated in vivo using affinity purification techniques. Lysine (K) residues in the 
N terminus were confirmed to be the SUMO-accepting sites, suggesting the existence 
of a ―SUMO region‖ in the N-terminal domain of TBP. Among the six lysine residues 
identified, K47 was a strong SUMOylation site. I generated TBP SUMO-deficient 
mutants to interrogate the functional role of TBP SUMOylation. The mutants showed 
much higher protein stability. Additionally, chromatin immunoprecipitation (ChIP) 
analysis revealed that the occupancy of TBP SUMO mutants at promoters of both 
constitutive and inducible genes were much lower than TBP wildtype, with a lower 
recruitment efficiency. Cross-linking kinetic (CLK) analysis further proved that the 
lower promoter occupancy of the SUMO mutants was caused by lower promoter 
dynamics. This was supported by fluorescence recovery after photobleaching (FRAP) 
assays, which showed a larger immobile population for the TBP SUMO-deficient 
mutants. The lower promoter dynamics is expected to lead to lower transcription 
plasticity and/or aberrant transcriptional output. Consistent with this, cells expressing 
either type of TBP mutant exhibit significant defects during sporulation, which is a 
cellular process involving genome-wide transcription reprogramming.  
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1. Introduction 
 
 
 
CHAPTER 1 
 
 
introduction 
 
 
 
BUDDING YEAST Saccharomyces cerevisiae 
 
There are approximately 700 hundred known yeast species in 100 genera (de 
Spencer, 2003), and the budding yeast Saccharomyces cerevisiae is commonly used 
for research in the labs. Yeast is a unicellular eukaryote that exhibits both haploid and 
diploid states, and reproducing by dividing asymmetrically into a larger mother cell 
and a ―bud‖ of a smaller size. A haploid yeast cell contains 16 compact chromosomes, 
of which genes constitute around 70% (Stansfield, 2007).  
Yeast offer several advantages as an experimental model for basic biological 
research, including a short life cycle (normally around 90-120 min of a doubling time), 
a small genome which has been completely sequenced and mapped, simple growth 
requirements, ease of genetic manipulation, and many orthologs in human (Dan Burke, 
2000). It is also very simple to transform DNA into yeast, as any sequence carried by 
plasmids or even a synthetic oligonucleotide can be integrated into a targeted location 
in the genome via homologous recombination (Shernan, 1991). 
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SUMOYLATION 
 
 
1.1.  SUMO isoforms 
 
SUMO (small ubiquitin-related modifier) is a roughly 10-kDa protein modifier 
which covalently and reversibly conjugates to numerous protein substrates. It was 
initially identified in Saccharomyces cerevisiae and afterwards found to be conserved 
in all eukaryotes. There is only one gene encoding SUMO in yeast (known as smt3), 
whereas vertebrates contain four isoforms SUMO-1, SUMO-2, SUMO-3 and 
SUMO-4. Among these, the difference between SUMO-2 and -3 is only three 
N-terminal residues, and both of them show 50% homology with SUMO-1 (Johnson, 
2004; Wilkinson and Henley, 2010). Most substrates can be modified by both 
SUMO-1 and SUMO-2/3, although some targets are specific for one SUMO isoform. 
At all times, there are high levels of free, unconjugated SUMO-2/3 in cells, whereas 
most SUMO-1 molecules are conjugated to their substrates. A variety of 
environmental stresses such as heat shock, osmotic stress, and oxidative stress were 
reported to induce a global change of SUMOylation levels (Tempe et al., 2008). In 
these circumstances, the change in SUMOylation is primarily changes in SUMO-2/3 
conjugation, suggesting the free SUMO-2/3 might provide a reservoir of SUMO to 
deal with sudden cellular stress (Wilkinson and Henley, 2010).  
 
 
1.2.  SUMO conjugation pathway 
 
The name ‗SUMO‘ reflects its resemblance to ubiquitin, both with regard to its 
three-dimensional structure, and its conjugation pathway (Geiss-Friedlander and 
Melchior, 2007). SUMO is transcribed as an inactive precursor carrying a C-terminal 
stretch of amino acids which needs to be cleaved by the SUMO protease (Ulp1 in 
yeast and SENP in mammals) to expose an invariant Gly-Gly motif (Fig. 1-1). This 
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mature SUMO protein then enters the SUMO conjugation pathway which happens in 
three steps (Anckar and Sistonen, 2007). Initially, this mature SUMO is activated by 
formation of a thioester bond with an E1 activating enzyme, the heterodimer Aos1–
Uba2, in an ATP-dependent reaction. The activated SUMO is subsequently 
transferred to the E2 conjugating enzyme Ubc9 (ubiquitin-conjugating enzyme 9). In 
the final step, aided by an E3 ligase, Ubc9 catalyses the formation of an isopeptide 
bond between SUMO and the Lys residue of a target protein (Anckar and Sistonen, 
2007). The SUMO binding sites on the substrate usually contain a consensus 
sequence ΨKXE, where Ψ is a large hydrophobic amino acid; K is the lysine residue 
that is modified; X is any residue; and E is a glutamic acid (Johnson, 2004). This 
consensus motif provides a direct binding site for Ubc9. Nevertheless, not all SUMO 
targets that have been identified contain this sequence. In S. cerevisiae, the proteases 
Ulp1 and Ulp2 release SUMO from substrates as an intact protein, ready to undergo 
the next round of conjugation to other targets. The Ulps are essential for cell cycle 
progression and maintaining chromosome stability (Yeh, 2009). Components of the 
SUMO machinery in S. cerevisiae and mammals are listed in Table 1-1.  
 
 
1.3.  PolySUMOylation 
 
As is true for its relative ubiquitin, SUMO can form polymeric chains by 
addition of SUMO moieties to a Lys residue of the previous SUMO (Tatham et al., 
2001). SUMO-2 and SUMO-3 but not SUMO-1 contain consensus SUMO motifs and 
appear to be subject to polySUMOylation formation via Lys 11. In yeast, the only 
SUMO protein, Smt3, is also able to form chains, and Lys 11, 15, and 19 are 
identified as potential sites of SUMO attachment (Bylebyl et al., 2003). In contrast to 
the essential role of Smt3 in yeast, SUMO chains are dispensable for viability 
(Bylebyl et al., 2003).  
1. INTRODUCTION 
- 4 - 
 
 
 
Figure 1-1. SUMO conjugation pathway. (Adapted from (Wilkinson and Henley, 2010)) 
 
 
 
Table 1-1. SUMO Machinery in Mammals and Yeast * 
Protein Family Yeast (S. cerevisiae) Mammals 
SUMO Smt3 SUMO-1 
  SUMO-2 
  SUMO-3 
E1 (activating enzyme) Aos1 SAE1 
 Uba2 SAE2 
E2 (conjugating enzyme) Ubc9 Ubc9 
E3 (ligase) Siz1 PIAS1 
 Siz2 PIAS3 
  PIASxα 
  PIASxβ 
  PIASy 
  RanBP2 
  Pc2 
 Mms21 Mms21 
  HDAC4 
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  HDAC7 
  MUL1 
  Rhes 
  TOPORS 
  TLS 
  TRAF7 
SUMO proteases & isopeptidases Ulp1 SENP-1 
 Ulp2 SENP-2 
  SENP-3 
  SENP-5 
  SENP-6 
  SENP-7 
* Adapted from (Wilkinson and Henley, 2010) 
 
 
1.4.  Molecular consequences of SUMOylation 
 
Modification by SUMO may influence localisation, stability, activity or 
interaction of substrate proteins with other molecules. At the molecular level, there 
are three possible consequences of SUMOylation (Geiss-Friedlander and Melchior, 
2007; Wilkinson and Henley, 2010). First, the attachment of SUMO could mask 
binding sites of other interacting proteins. Secondly, SUMO could provide a new 
binding interface or novel non-covalent interactions with other interacting molecules. 
Finally, SUMOylation could cause a conformational change in the modified target. 
This may lead to exposure or disruption of a binding site or alteration of the activity 
of a target directly. SUMO-conjugation is a covalent reaction, but numerous proteins 
have been shown to interact non-covalently with SUMO via a short motif named the 
SUMO-interacting motif (SIM) (Kerscher, 2007). A SIM contains a hydrophobic core 
domain flanked by acidic or phosphorylatable serine residues, and the stability of 
SIM-SUMO interactions are supported by electrostatic interactions or negative charge 
(Kerscher, 2007).  
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1.5.  A small number of SUMOylated proteins can cause significant 
outcomes 
 
An interesting feature of SUMO is that for most of its substrates, only a small 
proportion of proteins are SUMOylated at any given time. However, this low level of 
SUMOylation is enough to induce a large effect, and disruption of this process can 
cause dramatic changes in cellular functions such as transcriptional activity 
(Geiss-Friedlander and Melchior, 2007; Wilkinson and Henley, 2010). Although how 
such a small proportion of SUMOylated proteins are able to achieve intense effects 
remains to be further explored, some explanations have been provided. SUMO 
proteases act very rapidly and so the low level of SUMOylated forms detected may 
reflect the rapid cycling between SUMOylated and deSUMOylated forms of the 
protein despite the entire population being targeted for SUMOylation. Moreover, 
attachment of SUMO might result in a prolonged effect, such as the recruitment of 
downstream factors or further protein modifications in response to SUMOylation, 
which persists after deSUMOylation (Geiss-Friedlander and Melchior, 2007; 
Wilkinson and Henley, 2010). For instance, it is reported that SUMOylation of 
transcription factor Elk-1 facilitates recruitment of histone deacetylase which creates a 
repressive environment on chromatin, and this repressive state derived from 
deacetylation of histones remains after deSUMOylation of Elk-1 (Yang and Sharrocks, 
2004).  
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1.6.  Interaction between SUMOylation and other post-translational 
modifications 
 
1.6.1. Ubiquitylation 
 
SUMOylation and other post-translational modifications can mutually affect 
each other. SUMO and ubiquitin could antagonise each other since they have many 
common substrates and often target the same Lys residues. These two closely related 
modifiers also have crosstalk, modifying components of each other‘s enzymatic 
pathways (Denuc and Marfany, 2010; Mullen and Brill, 2008; Mullen et al., 2010; 
Wilkinson and Henley, 2010). For example, Sentrin/SUMO-specific proteases 
(SENPs), responsible for removing SUMO in mammals, are constitutively under 
ubiquitin-dependent degradation (Huang et al., 2009). By contrast, USP25 is a 
ubiquitin-specific protease with both ubiquitin-interacting motifs (UIMs) and SIMs. 
K99 of USP25 is able to be modified by either ubiquitin or SUMO, which have 
opposite effects on USP25 activity (Praefcke et al., 2012). DNA repair is an 
extensively studied nuclear event involving ubiquitylation and SUMOylation on 
multiple related factors. The structural maintenance of chromosomes (SMC5-6) 
complex, which acts in DNA repair as well as chromatin condensation and cohesion 
during DNA replication, acts as both a ubiquitin and SUMO ligase. In this complex, 
the components Nse1 and Mms21 are respectively responsible for ubiquitylation and 
SUMOylation (Doyle et al., 2010; Praefcke et al., 2012; Stephan et al., 2011). 
SUMOylation has also been reported to enhance ubiquitylation of certain substrates. 
A number of ubiquitin ligases capable of recognising SUMOylated proteins by their 
SIMs, named SUMO-targeted ubiquitin ligases (STUbLs), serve as the bridge 
between these two modifications. SUMO-dependent ubiquitylation of these proteins 
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promote deSUMOylation or proteasome-mediated degradation (Praefcke et al., 2012; 
Prudden et al., 2007).  
 
1.6.2. Acetylation and Phosphorylation 
 
Apart from ubiquitylation, SUMOylation is also known to be associated with 
other post-translational modifications. In some cases, acetyl groups compete with 
SUMO for the same Lys residue. Histone deacetylases can promote SUMO 
modification, and some of them are even SUMO targets themselves (Wilkinson and 
Henley, 2010). Phosphorylation plays an important role in SUMOylation. There is a 
consensus domain, PDSM (phosphorylation-dependent SUMOylation motif), present 
on SUMO targets. PDSM includes a proline-directed phosphorylatable serine residue 
at position +3 downstream of a consensus SUMO binding site (Anckar and Sistonen, 
2007). The negative charge provided by phosphate groups enhances the binding of 
SUMO to substrates. Besides, as is true for ubiquitin and SUMO, phosphorylation and 
SUMOylation can mutually modify each other‘s machinery as well (Wilkinson and 
Henley, 2010).  
 
 
1.7.  Biological functions of SUMOylation 
 
Deletion of SUMOs contributes to loss of viability for most eukaryotic cells 
including S. cerevisiae. Hundreds of SUMO targets have now been identified, and the 
number continues to expand. Reversible SUMO modification is involved in a variety 
of cellular processes, including transcriptional regulation, genome stability and 
genome integrity, nucleocytoplasmic transport and signal transduction (Gill, 2004; 
Johnson, 2004).  
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1.7.1. Genome stability and integrity 
 
SUMO has been shown to widely participate in DNA damage repair. For 
example, thymine DNA glycosylase (TDG), a DNA-repair enzyme, binds to 
mismatch bases and removes them. However, to target the next incorrect base, 
tightly-bound TDG needs to be released from DNA by a SUMOylation-induced TDG 
conformational change (Geiss-Friedlander and Melchior, 2007). Another example is 
that SUMOylation of the recombinase complex Rad51/Rad52 is critical for their 
recruitment to DNA damage sites to promote homologous chromosome 
recombination (Muller et al., 2004). Additionally, the SUMO ligase Nse2/Mms21, a 
component of Smc5/6 complex, is required for chromosome segregation, resolution of 
DNA damage-induced recombination intermediates, and recruitment of cohesin to 
double-strand breaks during DNA repair (Cubeñas-Potts and Matunis, 2013; Stephan 
et al., 2011; Zhao, 2007). Moreover, SUMO is also involved in maintenance of 
repetitive DNA regions such as rDNA and telomeres. It is found that telomeres are 
abnormally elongated in SUMO- or SUMO ligase-deficient yeast cells (Cubeñas-Potts 
and Matunis, 2013). Finally, during DNA replication, establishment of sister 
chromatid cohesion is also highly dependent on SUMOylation of cohesin (Almedawar 
et al., 2012).  
 
1.7.2. Nucleocytoplasmic transport 
 
SUMO is also involved in the regulation of nucleocytoplasmic transport. The 
first SUMO substrate identified was mammalian guanosine triphosphate (GTP)ase- 
activating protein RanGAP1, and SUMOylation of RanGAP1 is required to relocalise 
cytoplasmic RanGAP1 to the nucleus and to tightly bind on the nuclear pore complex 
(Girdwood et al., 2004; Mahajan et al., 1997; Matunis et al., 1996). Furthermore, the 
study in S. cerevisiae revealed that an impaired SUMO conjugating pathway causes a 
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defect in the nuclear import of proteins carrying a classical nuclear localisation signal 
(cNLS) (Stade et al., 2002).  
 
 
1.8.  SUMO and Transcription 
 
1.8.1. Transcription repression 
 
A role for SUMOylation in gene expression regulation is one of the most 
well-recognised. A large pool of transcription factors are SUMO targets, including 
promoter-specific transcription factors, co-factors and chromatin-modifying proteins 
(Cubeñas-Potts and Matunis, 2013; Makhnevych et al., 2009; Zhao, 2007; Zhao et al., 
2004). SUMOylation of the majority of these SUMO substrates leads to transcription 
repression (Chupreta et al., 2005; Gill, 2005). Other studies also elucidate an intrinsic 
inhibitory function of SUMO in transcription (Gill, 2005; Lyst and Stancheva, 2007). 
Fusing GAL4, a transcriptional activator, with SUMO ligase Ubc9 leads to 
SUMOylation of chromatin surrounding the GAL4 binding site and significantly 
represses transcription of the GAL4 reporter gene (Shiio and Eisenman, 2003). 
Additionally, recruiting SUMO moieties to transcriptional regulatory DNA motifs by 
conjugating SUMO with GAL4 DNA-binding domain also leads to lower 
transcription activities (Holmstrom et al., 2003; Yang and Sharrocks, 2004). 
Disturbing SUMOylation of a number of transcription factors by either mutating 
SUMO-accepting sites or overexpression of a SUMO protease increases their 
transcriptional activities (Gill, 2005). Moreover, all core histones in S. cerevisiae are 
SUMO targets, and their SUMOylation contributes to transcriptional repression via 
interrupting other activating histone modifications such as acetylation (Nathan et al., 
2006).  
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1.8.2. Transcription activation 
 
Despite the generally inhibitory influence of SUMO in transcription, growing 
evidence has revealed a role for SUMO in transcription activation (Cubeñas-Potts and 
Matunis, 2013; Guo and Sharrocks, 2009; Lyst and Stancheva, 2007). For example, 
SUMO not only facilitates DNA methylation but also DNA demethylation, keeping 
chromosomes in an active state (Cubeñas-Potts and Matunis, 2013). Moreover, 
SUMOylation of certain transcription factors results in higher transcription activities 
(see below).  
 
1.8.3. Combination of positive and negative effects 
 
Instead of having a discrete function on activation or repression, SUMO 
elegantly modulates transcription by taking part in both sides at the same time. A 
recent study shows that SUMOylated proteins accumulate at promoter regions of 
constitutive and ―activated‖ inducible genes (Rosonina et al., 2010). Here, SUMO 
functions by recruiting Pol II to constitutive promoters, but the disruption of 
SUMOylation has no obvious effect on the transcriptional levels of these genes. On 
the other hand, Ubc9 (SUMO-conjugating enzyme) is also recruited to activate 
inducible genes and in its absence, the transcription of these genes are increased. The 
increase in expression is derived from prolonged transcription due to failure of 
promoter clearance after activating signals are removed. This has been further 
demonstrated by the transcriptional activator Gcn4, which has been found to be one of 
the SUMO targets appearing on promoter regions. SUMO is required for its 
proteolysis, and its removal might be important for shut down of Gcn4-dependent 
genes (Rosonina et al., 2012).  
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1.8.4. Transcriptional regulatory mechanisms of SUMO 
 
Both positive and negative effects of SUMO can act through several mechanisms 
(Girdwood et al., 2004; Lyst and Stancheva, 2007). Firstly, the binding of 
transcription factors to DNA can be affected by SUMO. Despite a negative charge 
carried by SUMO which may interfere with the binding between transcription factors 
and DNA (Lyst and Stancheva, 2007), a structure-function analysis of SUMO-1 and 
SUMO-2 has showed that a number of positively charged basic residues in a highly 
conserved surface on SUMO are responsible for its inhibitory property (Chupreta et 
al., 2005). Alternatively, binding of SUMO can alter the conformation of the 
transcription factor to enhance DNA binding. For instance, heat shock transcription 
factor 1 (HSF1) is subject to stress-induced SUMOylation, which converts inactive 
HSF1 to a DNA-binding form, thereby activating heat shock genes (Hong et al., 
2001).  
In addition to protein-DNA interaction, SUMO could influence transcription via 
altering protein stability of transcription factors. p53 is constitutively ubiquitylated 
under normal conditions. Upon activation, SUMOylation of p53 is required for its 
nuclear localisation and results in an increase in its protein stability (Gostissa et al., 
1999; Liu et al., 2013; Rodriguez et al., 1999). A similar effect was observed on IκBα, 
which inhibits transcription factor NFκB activity by retaining it in the cytoplasm. 
Once IκBα is ubiquitylated for proteasome-dependent degradation, NFκB is able to be 
released to the nucleus. It is found that IκBα is a SUMO-1 target, and the 
SUMOylated form is resistant to degradation, thereby decreasing NFκB transcription 
activity (Desterro et al., 1998; Girdwood et al., 2004; Hay et al., 1999).  
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1.8.5. SUMO and HDAC 
 
Substantial evidence has indicated a close relationship between HDACs and 
SUMO in transcription regulation (Gill, 2005; Lyst and Stancheva, 2007). It has been 
shown that SUMOylation of transcription factor Elk1 facilitates recruitment of 
HDACs which then repress Elk1-mediated genes (Yang and Sharrocks, 2004). 
Additionally, SUMOylation of DNA methyltransferase 3a (Dnmt3a) disrupts its 
interaction with HDACs and this reduces its ability to repress transcription (Ling et al., 
2004; Lyst and Stancheva, 2007). Another example is Ikaros, which is involved in 
gene regulation during lymphocyte development and homeostasis. The interaction of 
Ikaros with HDACs is also disrupted by SUMO modification on two lysine residues 
of Ikaros, resulting in a loss of its repressive function (Gómez-del Arco et al., 2005). 
Apart from being an effector, HDACs themselves are also the target of SUMO, and 
their SUMOylated forms have reduced deacetylase activity and thus lower 
transcriptionally repressive activities (Cheng et al., 2004; David et al., 2002; Kirsh et 
al., 2002). 
 
1.8.6. Cytoplasmic SUMO substrates 
 
Although most of SUMO substrates are nuclear proteins, SUMOylation also 
occurs in the cytoplasm and participates in the function and activities of cytoplasmic 
compartments including mitochondria, the endoplasmic reticulum (ER) membrane 
and the plasma membrane (Geiss-Friedlander and Melchior, 2007; Muller et al., 
2001).  
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1.9.  SUMO and stress 
 
1.9.1. General increase of SUMOylation under stresses 
 
Growing evidence supports the connection between SUMO and stress response 
(Tempe et al., 2008; Wilkinson and Henley, 2010). Global protein SUMOylation is 
up-regulated by various cellular stresses such as heat shock, osmotic stress, ethanol 
treatment, and oxidative stress in vertebrates as well as in S. cerevisiae (Saitoh and 
Hinchey, 2000; Zhou et al., 2004). It has been shown that the SUMOylation of Drp1 
(a GTPase) is up-regulated during oxygen and glucose deprivation due to degradation 
of the mammalian SUMO protease SENP3. The resultant increase in SUMOylated 
form of Drp1 triggers a stress protective response to promote cell survival (Guo et al., 
2013).  
Stress-related SUMO substrates are involved in a wide range of cellular 
processes including transcription, translation, DNA replication, chromosome 
segregation, metabolic processes, and stress responses (Zhou et al., 2004), revealing 
the important role of SUMO in triggering the cell adaptation mechanisms 
systemically in response to any stress. The response in SUMOylation may be 
regulated at the level of target itself, where the effect from phosphorylation on PDSM 
or other sites of the same substrate are often observed. Alternatively, it can be 
regulated via the SUMO machinery such as SUMO-conjugating enzymes or SUMO 
proteases (Tempe et al., 2008).  
 
1.9.2. Reduction of SUMOylation on certain targets 
 
However, despite most cellular stresses facilitating degradation of SENP3 
described above, it has been shown that mild reactive oxygen species (ROS) can also 
inhibit degradation of SENP3 and promote its relocalisation to the nucleus (Huang et 
al., 2009). It is also reported that the change in SUMOylation or possibly 
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deSUMOylation may depend largely on the intensity of the stress (Tempe et al., 2008). 
Furthermore, although many proteins are SUMOylated after heat shock, 
SUMOylation of other substrates such as topoisomerase 1 and PML (promyelocytic 
leukaemia) are found to be significantly abolished (Mo et al., 2002; Nefkens et al., 
2003), suggesting that, despite the general increase in SUMOylation, stress-induced 
alteration of SUMO modification is still specific for each target.  
 
 
 
TRANSCRIPTION  
 
 
1.10. Transcription overview 
 
    There are around 5000 open reading frames (ORFs) in Saccharomyces cerevisiae 
(http://www.yeastgenome.org/cache/genomeSnapshot.html Saccharomyces Genome 
Database). Among these, the largest grouping of genes involved in one process are 
those controlling Pol II-dependent transcription. Likewise, in multicellular eukaryotes, 
5 to 10% of the coding capacity of their genome is implicated in transcription (Allison, 
2011), highlighting the importance of this fundamental cellular process.  
    One round of transcription can be sub-divided into four main stages: initiation, 
promoter escape, elongation and termination (Allison, 2011). This discussion will 
focus mainly on Pol II-mediated transcription.  
A common example of transcription initiation involves TATA-binding protein 
(TBP) and TATA box, a binding region in promoters. This is followed by the 
recruitment of general transcription factors (GTFs) and Pol II. Sometimes the term 
―basal‖ is preferred as the role of ―general‖ transcription factors is actually not so 
general. GTFs and Pol II are assembled at the promoter sequence upstream of the 
transcription start site in a stepwise manner (Fig. 1-2) (Martinez, 2002). In detail, 
initially, the TATA box within a core promoter is recognised by TBP, which forms 
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the TFIID complex with other TBP-associated factors (TAFs). This is followed by the 
entry of the other two GTFs, TFIIA and TFIIB, which stabilise the contact between 
TBP and DNA. This allows subsequent recruitment of TFIIF together with Pol II. 
Finally, the incorporation of TFIIE and TFIIH completes the assembly of an intact 
preinitiation complex (PIC) (Martinez, 2002; Sikorski and Buratowski, 2009). The 
helicase activity of TFIIH unwinds double-stranded DNA in an ATP-dependent 
manner and transforms the PIC from a closed state to an open state (Martinez, 2002), 
a structure which is competent for transcription.  
The action of the helicase comes melting of the DNA and the polymerase moves 
into the gene, leading to the formation of a ―transcription bubble‖. During this period, 
a short mRNA precursor of around 10 residues is produced. This is followed by 
―bubble collapse,‖ caused by reannealling of DNA upstream of the bubble (Allison, 
2011; Hahn and Young, 2011). After the PIC is completely assembled and 
transcription initiated, RNA Pol II needs to move away from promoter regions into 
the gene body, which is called ―promoter clearance‖ or ―promoter escape,‖ to produce 
a full length transcript. Promoter clearance, as well as the subsequent elongation 
phase, requires phosphorylation of the Pol II CTD at multiple sites by the kinase 
activity of TFIIH. The exit of Pol II from the promoter region leaves all other GTFs 
behind except TFIIF, and this marks the transition from the initiation to elongation 
phase (Allison, 2011; Hahn and Young, 2011). 
During elongation, it is key that the polymerase does not detach prematurely, and 
this is assisted by other associated factors in the elongation complex (Allison, 2011; 
Treutlein et al., 2012). During transcription termination, the Pol II CTD is 
de-phosphorylated, and the components of the general transcription machinery 
dissociate from DNA before reassembling for reinitiation of a subsequent round of 
transcription (Martinez, 2002).  
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Figure 1-2. Model for stepwise assembly and function of a pre-initiation complex (PIC). (Adapted 
from (Martinez, 2002)). 
 
Transcription initiation is the main focus of this study. Hence, all the components 
and the details of transcription initiation process mentioned above will be discussed 
further below. 
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1.11. Transcription initiation 
 
As described in section 1.10, transcription initiation is a complex process and is 
characterised by a series of highly ordered steps. Exemplified by RNA Pol II 
transcription apparatus, transcription begins with recognition of a DNA core promoter 
by TBP, which in turn recruits other GTFs. They interact with RNA Pol II and 
cooperatively facilitate PIC assembly. However, with only GTFs, only a low level of 
basal transcription is triggered. In most transcription events, transcription is up- or 
down-regulated by transcription factors including activators and repressors, which are 
a different subset of proteins from GTFs, and they are activated in response to cellular 
signals. To transmit regulatory signals from transcription factors to GTFs, 
coactivators or corepressors such as Mediator are required (Hahn and Young, 2011; 
Thomas and Chiang, 2006).  
  All these transcription-involving components will be introduced in detail in 
the following sections. First are a variety of DNA core promoters that have been 
identified so far. Then all the GTFs including TFIIA, TFIIB, TFIIF, TFIIE, TFIIH, 
and TFIID will be described individually, and the assembly of PIC by these factors 
will also be covered. Subsequently, different types of RNA polymerases and their 
compositions will be introduced, followed by the transcription factors as well as the 
general cofactors such as coactivators and Mediators. Last but not least, the 
introduction of transcription will focus on the TFIID component TBP, which is the 
leading role of this study. This will involve the structure and the function of TBP, 
TBP-recognised DNA elements and their interactions, TBP regulators and the 
regulatory mechanisms, TBP-containing complexes, and TAFs.  
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1.12. Polymerase II Core promoters 
 
1.12.1. Diverse core promoter elements 
 
    The core promoter is defined as a minimal DNA segment which is necessary and 
sufficient to initiate ―basal transcription‖ by Pol II and GTFs in vitro (Martinez, 2002). 
A core promoter is situated within a region of up to 40 bp either side of the 
transcription start site. It serves as a platform to coordinate various activated and 
repressed transcriptional signals, nucleating the assembly of a functional PIC which 
contains Pol II and GTFs (Baumann et al., 2010; Yang et al., 2007).  
    Core promoters can be categorised as focused and dispersed promoters. The 
former contains either a single or a cluster of transcription start sites, while the latter 
comprises several start sites scattered over 50–100 nucleotides. Focused promoters 
are more common in all eukaryotes except in vertebrates, which possess half as many 
focused core promoters as dispersed ones (Juven-Gershon et al., 2008).  
    Core promoters consist of different combinations of various short regulatory 
DNA motifs, which interact with different sets of factors and thereby trigger 
transcription via different mechanisms, demonstrating that functional diversity of each 
core promoter (Baumann et al., 2010; Juven-Gershon et al., 2008). Common core 
promoter elements include the TATA box, BRE, Inr, MTE, DPE, and DCE (Fig. 1-3 
and described in detail below), all of which are typically present in focused promoters 
(Juven-Gershon et al., 2008). On the other hand, the most common dispersed 
promoters are CpG islands, which are DNA stretches of CG dinucleotides containing 
multiple transcription start site (TSS) spanning over 100 bp. Due to the prevalence of 
dispersed core promoters in vertebrates, the vast majority of promoter elements found 
in human and mouse genome are CpG islands (Baumann et al., 2010).  
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TATA box, the first core promoter element to be identified, consists of 
consensus A/T-rich TATA(A/T)A(A/T)(A/G) sequence situated around 30 bp 
upstream of TSS (+1) in human (Thomas and Chiang, 2006). However, its location in 
S. cerevisiae is more variable, ranging from 40 to 100 bp upstream of the TSS (Butler 
and Kadonaga, 2002). It is the most ancient and common promoter motif seen in 
nature (Juven-Gershon et al., 2008). 
 
 
 
Figure 1-3. Pol II-mediated core promoter motifs and their recognition factors. The prevalence of 
these promoter elements ranges from 1% - 30%, and they are not mutually exclusive. A core promoter 
may contain one, several or all these elements. Among these, the Inr is likely the most common one. 
TBP is responsible for recognition of TATA box and subsequent TFIID recruitment, while the other 
motifs, with the exception of BRE, interact with TBP-associated factors (TAFs) instead of TBP in 
TFIID. In S. cerevisiae, the existence of TATA and Inr have been identified. n.a., not available. (The 
diagram is adapted from (Juven-Gershon et al., 2008) and the table is from (Thomas and Chiang, 
2006)) 
 
BRE (TFIIB recognition element) is also conserved from Archaea to humans, 
and it is identified as a DNA motif specifically bound by TFIIB, one of the GTFs. 
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There are two types of BRE, named BRE
u
 and BRE
d
, situated immediately upstream 
and downstream of the TATA box, respectively.  
The initiator (Inr) is a DNA element surrounding the TSS, and it is mainly 
recognised by TFIID. Although in S. cerevisiae, they lack the same Inr elements as 
that in human or Drosophila, they have Inr-like sequences.  
DPE (downstream core promoter element) comprises consensus sequence 
(A/G)G(A/T)CGTG, localised about 30 bp downstream of TSS and functioning in 
conjunction with Inr. It is also conserved from Drosophila to human. Although TFIID 
is the primary transcription factor interacting with DPE via component TAF6/ TAF9, 
negative cofactor 2 (NC2) is also shown to be capable of promoting transcription 
initiation from DPE in Drosophila (Thomas and Chiang, 2006).  
MTE (motif ten element), positioned in proximity and upstream of DPE, also 
functions cooperatively with Inr.  
DCE (downstream core element) often coexists with the TATA box in a core 
promoter. It is characterised by its three discontinuous sub-elements downstream of 
the TSS and is shown to interact with TAF1 (Juven-Gershon et al., 2008; Thomas and 
Chiang, 2006).  
 
1.12.2. Recognition of diverse core promoters by a variety of factors 
 
    It was thought that TATA elements were central motifs present in all promoters, 
and its interacting factor TBP might therefore play the major role in all promoter 
recognition and interaction process. However, it is now widely recognised that a 
diversity of core promoters comprising different combinations of core promoter 
elements exist and together with their corresponding sets of transcription factors 
constitute a highly complicated transcription initiation network. The TATA box is not 
ubiquitously present, and none of the other elements described above universally 
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exists. In terms of promoter-bound proteins, many transcription factors such as TAFs 
and TFIIB have their own binding targets, and the interactions do not require 
participation of TBP, indicating that the role of TBP in transcription is not as general 
as initially thought (Müller et al., 2007). However, TBP occupancy as well as their 
binding dynamics at promoter regions are strongly correlated to gene expression level 
in S. cerevisiae (Kuras and Struhl, 1999; van Werven et al., 2009). Moreover, TBP 
has been demonstrated to be required in both TATA-containing and TATA-less 
promoters (Ahn et al., 2012; Pugh and Tjian, 1991; Smale et al., 1990; Wiley et al., 
1992), suggesting a critical role for TBP among transcription factors.  
 
 
1.13. General transcription factors (GTFs) and preinitiation complex 
(PIC) assembly 
 
1.13.1. Overview 
 
    RNA polymerases are incapable of starting transcription alone. In vitro, purified 
Pol II must be supplemented with crude cellular extracts in order to accurately 
synthesise transcripts from DNA templates (Weil et al., 1979). This cell extract was 
subsequently analysed, initially yielding four enzymatically active fractions under 
different salt concentrations (designated fraction A to D) (Thomas and Chiang, 2006). 
Among these, fraction A, C and D were found to be essential for transcription. 
Proteins required for transcription in fraction A and D are named respectively TFIIA 
and TFIID, in which ―TF‖ is the abbreviation of ―transcription factor,‖ and II 
represents the involvement in Pol II-mediated transcription. Protein factors TFIIB, 
TFIIE, TFIIF, and TFIIH were subsequently isolated from fraction C. These ―TFII-‖ 
subset of proteins are collectively categorised as ―general transcription factors‖ (GTFs) 
(Thomas and Chiang, 2006).  
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    The coordinated assembly of the transcription machinery occurs in a stepwise 
manner, beginning with the binding of the TFIID complex with template DNA to 
nucleate PIC assembly. In vitro studies show that TFIIA is the second GTF entering 
the complex, followed by TFIIB (Allison, 2011; Thomas and Chiang, 2006). TFIID, 
TFIIA and TFIIB then together provide a platform on the core promoter to recruit Pol 
II in complex with TFIIF. Eventually, the entry of TFIIE and TFIIH completes the 
formation of PIC. 
 
1.13.2. General transcription factors 
 
The main functions of the Pol II and all GTFs participating in Pol II-dependent 
transcription initiation are summarised in Table 1-2 (Sikorski and Buratowski, 2009). 
 
TFIID contains a central component, TBP, and a subset of accessory proteins. 
TBP is able to recognise specific promoter sequences and induce DNA bending upon 
binding (Pugh, 2000). TFIID will be introduced in section 1.14. 
TFIIA is not required for transcription initiation in a highly purified in vitro 
system. However, it becomes essential when partially purified fractions are used, 
suggesting that TFIIA may play a role in antagonising the repressive effects of other 
factors present in bulk extract (Thomas and Chiang, 2006). It has also been found that 
TFIIA alone has some stimulatory effects on basal transcription but only at certain 
core promoters, indicating the requirement of TFIIA is promoter-specific (Martinez, 
2002). Indeed, the conserved TAF N-terminal Domain (TAND) in TAF1, one of 
TBP-associated factors found in TFIID with TBP, disturbs DNA-binding of TBP 
through interacting with TBP DNA-binding surface, and TFIIA is required for 
alleviating this inhibition by contacting TAND (Papai et al., 2011). In addition, TFIIA 
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can also serve as a coactivator, interacting with activators and other components in the 
PIC to enhance their effects (Sikorski and Buratowski, 2009). 
 
Table 1-2. Complexes Involved in RNA Pol II PIC assembly * 
Protein complex Subunits Functions 
RNA Pol II 12 catalyses transcription of all mRNAs and a subset of 
noncoding RNAs including snoRNAs and miRNAs 
TFIIA 2–3 functions to counteract repressive effects of negative 
cofactors like NC2; acts as a coactivator by interacting 
with activators and components of the basal initiation 
machinery 
TFIIB 1 stabilises TFIID-promoter binding; aids in recruitment 
of TFIIF/Pol II to the promoter; directs accurate start 
site selection 
TFIID 14 (including TBP 
and TAFs) 
nucleates PIC assembly either through TBP binding to 
TATA sequences or TAF binding to other promoter 
sequences; coactivator activity through direct 
interaction of TAFs and gene specific activators 
TFIIE 2 helps recruit TFIIH to promoters; stimulates helicase 
and kinase activities of TFIIH; binds ssDNA and is 
essential for promoter melting 
TFIIF 2–3 tightly associates with RNA Pol II; enhances affinity of 
RNA Pol II for TBP-TFIIB-promoter complex; 
necessary for recruitment of TFIIE/TFIIH to the PIC; 
aids in start site selection and promoter escape; 
enhances elongation efficiency 
TFIIH 10 ATPase/helicase necessary for promoter opening and 
promoter clearance; helicase activity for transcription 
coupled DNA repair; kinase activity required for 
phosphorylation of RNA Pol II CTD; facilitates 
transition from initiation to elongation 
Mediator At least 24 bridges interaction between activators and basal factors; 
stimulates both activator dependent and basal 
transcription; required for transcription from most RNA 
Pol II dependent promoters 
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SAGA 20 interacts with activators, histone H3, and TBP; histone 
acetyltransferase activity; deubiquitylating activity 
NC2 2 binds TBP/DNA complexes and blocks PIC assembly; 
can have both positive and negative effects on 
transcription 
Mot1 1 induces dissociation of TBP/DNA complexes in ATP 
dependent manner; can have both positive and negative 
effects on transcription 
* Adapted from (Sikorski and Buratowski, 2009) 
 
TFIIB, in contrast to TFIIA, is an essential component in basal transcription 
initiation (Martinez, 2002). It functions to stabilise the TBP-DNA complex by making 
contacts with TBP and with the flanking regions of TATA box via its C-terminus. 
Meanwhile, the N-terminus of TFIIB interacts with Pol II as well as TFIIF, 
therebyfacilitating the entry of Pol II-TFIIF. TFIIB is also important in positioning the 
TSS at the active site of Pol II (Allison, 2011). Additionally, TFIIB is implicated in 
the recognition of BRE
u
, one of the core promoter elements (Hahn and Young, 2011; 
Thomas and Chiang, 2006). Apart from promoting PIC assembly, TFIIB also plays a 
role during the post-initiation stage. As the binding site of TFIIB on Pol II overlaps 
with the exit channel of newly-synthesised transcripts which might block the on-going 
extension of mRNA, release of TFIIB from Pol II is required for the transition from 
transcription initiation to elongation (Allison, 2011; Thomas and Chiang, 2006).  
TFIIF, containing respectively two and three subunits in human and in yeast, is 
found to be tightly bound on Pol II and facilitate the recruitment of Pol II to the PIC 
(Rani et al., 2004; Thomas and Chiang, 2006). Besides this, TFIIF has multiple roles 
in transcription, including enhancing the affinity between Pol II and the 
TBP-TFIIB-promoter complex, recruiting TFIIE and TFIIH, assisting start site 
1. INTRODUCTION 
- 26 - 
 
selection in collaboration with TFIIB, promoting Pol II initiation escape, and 
increasing transcription efficiency (Thomas and Chiang, 2006).  
At this point, TFIID-TFIIB-Pol II-TFIIF and promoter DNA together are 
sufficient to form a minimal closed promoter complex (CC). This complex is capable 
of directing transcription from supercoiled DNA plasmids and pre-melted DNA 
templates in vitro (Martinez, 2002). Once both TFIIE and TFIIH are recruited and 
bound slightly downstream of Pol II, it leads to the unwinding and melting of 
double-stranded DNA around TSS, which provides ssDNA as a template to be 
inserted into Pol II active cleft (Allison, 2011; Treutlein et al., 2012). This marks the 
transition from CC to open promoter complex (OC), a transcriptionally active state 
containing a DNA bubble, and this transition is essential for efficient transcription 
initiation from linear DNA in vitro (Martinez, 2002).  
TFIIE interacts with Pol II as well as the initiation point for melting of promoter 
DNA. This is consistent with its essential role in promoting DNA melting (Thomas 
and Chiang, 2006). Moreover, TFIIE can also recruit and stimulate the function of 
TFIIH, the next factor joining into the PIC (Sikorski and Buratowski, 2009; Thomas 
and Chiang, 2006).  
TFIIH is a versatile multiprotein complex. It is able to act as a protein kinase 
phosphorylating the CTD of Pol II, and an ATPase/ helicase mediating the opening of 
promoter DNA and promoter clearance in an ATP-dependent manner (Allison, 2011; 
Thomas and Chiang, 2006). Additionally, TFIIH is implicated in DNA repair and 
interactions with transcriptional activators (Allison, 2011; Thomas and Chiang, 2006).  
TFIID, -A, -B, -F, -E and -H together with Pol II and melted promoter DNA 
constitute a functional PIC and this is competent for transcription initiation (Martinez, 
2002). After initial synthesis of a short transcript, Pol II, in association with TFIIF, 
leaves the promoter region for subsequent RNA synthesis and enters the elongation 
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phase. TFIID and TFIIA might remain promoter-bound for reinitiation of the next 
round of transcription while TFIIB, TFIIE and TFIIH are released from DNA 
(Martinez, 2002). Nonetheless, the reinitiation intermediate constituting TFIID, TFIIA, 
TFIIH, TFIIE and Mediator (a coactivator, introduced below) was isolated, and this 
intermediate is stabilised by activators, suggesting the reinitiation process can be 
established on a pre-formed scaffold and therefore be more efficient (Yudkovsky et 
al., 2000).  
 
    The PIC assembly pathway is widely recognised as a stepwise process. The order 
of sequential recruitment of a diversity of GTFs and Pol II has been determined by in 
vitro studies as described above. Nevertheless, it is found that Pol II can be isolated as 
a preassembled holoenzyme complex with a subset of GTFs excluding TFIID, 
suggesting that the recruitment of a pre-assembled complex to promoters may also 
occur (Thomas and Chiang, 2006; Wu and Chiang, 1998).  
 
 
1.14. TFIID complex 
 
    It was mentioned above that purification of cell extract elutes several 
transcriptionally active fractions, and fraction D, now known to contain TFIID, is 
essential for transcription (Thomas and Chiang, 2006). TFIID was then identified as a 
complex able to bind with the TATA box (Thomas and Chiang, 2006). After much 
effort in further purification and characterisation of TFIID, a factor which was first 
identified in S. cerevisiae that was capable of substituting human TFIID in a 
reconstituted transcription system. This was subsequently characterised as a 27-kDa 
polypeptide (Cavallini et al., 1988; Hernandez, 1993), and the gene encoding this 
factor, known as TBP, was cloned. TBP was subsequently identified in other species 
based on sequence information of yeast TBP (Cavallini et al., 1989; Hernandez, 1993). 
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However, TBP alone was found to only be capable of promoting basal transcription 
but not activator-dependent transcription as TFIID could. Further identification of 
TFIID shows that, apart from TBP, it comprises a subset of TAFs, implying that 
interactions with activators are dependent on this group of factors (Hernandez, 1993).  
 
1.14.1. Organisation and structure of TFIID 
 
TFIID, one of the first GTFs arriving at promoters, is a macromolecular complex 
of around 750kDa, comprising TBP and a subset of TAFs (Thomas and Chiang, 2006). 
TFIID has been under intense study for many years due to the vital role of both TFIID 
and its central component TBP in transcription initiation. The composition of TFIID 
is highly conserved. There are 14 TAFs in S. cerevisiae, and only TAF14 is 
yeast-specific while TAF1-TAF13 are conserved in eukaryotes, leading to a unified 
nomenclature used for TAFs among species (Cler et al., 2009; Hahn and Young, 2011; 
Tora, 2002).  
    Microscopic studies show that the structural organisation of TFIID in yeast and 
in human is very similar, containing three lobes (designated as A, B, and C) and a 
linker region, forming a ‗horseshoe‘-shaped structure (Fig. 1-4A) (Cler et al., 2009; 
Hahn and Young, 2011). TAF1, TAF2, TAF7 and TBP together constitute the linker 
region, and all of them are present as a single copy. The remaining components, each 
present in two or more copies in the complex, pairing with other TAF and appearing 
as heterodimers, form the core three lobes of TFIID (Fig. 1-4B) (Cler et al., 2009). 
TFIID has a flexible structure. Structural studies by cryo-electron microscopy reveal 
that human TFIID adopts ―open‖ and ―closed‖ conformations, in which the former 
has a wider central cavity between the three lobes and the latter has a narrower one, 
suggesting the organisation of TFIID is flexible and perhaps changed in response to 
stimuli to produce different outcomes (Grob et al., 2006).  
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Figure 1-4. Structural organisation of yeast TFIID. (A). Two upper diagrams are opposite views of 
the TFIID complex showing the location of TAF1, TAF7 and TBP (white), TAF2 (blue) and a quasi 
symmetric core module (red). The lower panel indicates TAF localisation within TFIID. Numbers 
indicate the Taf subunit name. Black lines represent documented protein–protein interactions of histone 
fold domain-containing TAFs which are present as heterodimers. (B). Enlarged diagram of TFIID, with 
TAFs labelled with different colours. (Adapted from (Cler et al., 2009) and (Hahn and Young, 2011)) 
  
 
1.14.2. The Functions of TFIID beyond As a GTF 
 
    TFIID is the fundamental component in the general transcription machinery, 
capable of facilitating a low level of basal transcription without activators. In the 
meantime, TFIID also serves as a coactivator between activators and GTFs. In S. 
cerevisiae, a direct contact was found between TFIID and Rap1, a DNA-binding 
protein with multiple roles in yeast including as a transcriptional activator, 
contributing to the expression of ribosomal proteins (Garbett et al., 2007).  
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1.15.  RNA polymerases 
 
    In prokaryotes and Archaea, there is only one type of RNA polymerase. 
Instead, eukaryotes have three types of multi-subunit transcriptional enzymes, 
Polymerase I (Pol I), II (Pol II) and III (Pol III) (Egloff and Murphy, 2008). Recently, 
a fourth, non-essential polymerase has been identified in plants (Thomas and Chiang, 
2006). 
In budding yeast, Pol I transcribes 25S, 18S and 5.8S rRNA genes (Smith and 
Boeke, 1997). 5S rRNAs and tRNAs are transcribed by Pol III. Pol II is responsible 
for transcription of all protein-coding genes which give rise to mRNA. Consistent 
with these findings, Pol I localises in nucleoli, and Pol II, Pol III are found in the 
nucleoplasm (Thomas and Chiang, 2006).  
    Pol I, II and III respectively consist of 14, 12, and 17 subunits, which share a 
conserved 10-subunit catalytic core domain (Vannini and Cramer, 2012). The three 
higher order transcription initiation machineries in eukaryotes have distinct 
compositions. However, they share structurally and functionally conserved cores 
which include promoter DNA, Pol I/ II/ III and TBP and GTFs (Vannini and Cramer, 
2012). Although TFIIF, TFIIE and TFIIB do not exist in Pol I and III, TFIIF-like 
complex, TFIIE-related domain, and TFIIB-like factors replace their roles. Outside 
this conserved core, the composition and function of peripheral components in each 
transcription complex of the three polymerases is diverse (Vannini and Cramer, 
2012).  
Most genes are Pol II-dependent. Pol II consists of 12 subunits Rpb1-Rpb12 
which are numbered according to the size starting from the largest. These 12 subunits 
can be subdivided into the Rpb4/7 complex and the conserved enzymatic core 
composed of the other 10 subunits (Allison, 2011). Rpb1 contains a highly conserved 
C-terminal domain (CTD) comprising tandem heptapeptide repeats (YSPTSPS) (27 
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repeats in yeast). The CTD is characterised by its cycled phosphorylation on Ser2, 5, 
and 7, which is elaborately regulated by a variety of kinases in response to 
progression of transcription. Pol II with no phosphorylation on the CTD is 
preferentially recruited for PIC assembly. Afterwards, Ser5 and 7 are first 
phosphorylated during transcription initiation, followed by phosphorylation of Ser2 
while proceeding to elongation. Upon transcription termination, dephosphorylation of 
the CTD is required for the release of Pol II from DNA (Hahn and Young, 2011; 
Hirose and Ohkuma, 2007).  
 
 
1.16.  Transcription factors 
 
    Apart from GTFs, transcription factors are usually required for an efficient 
transcription in terms of the magnitude and the transcription rate. Unlike the general 
feature of GTFs, transcription factors are sequence-specific proteins and mediate 
gene-specific transcription regulation. Generally, regulation of gene expression occurs 
mostly at the level of transcription factors by changing their abundance or activity. 
There are activators and repressors modulating transcription in a positive and negative 
way, respectively (Allison, 2011). It seems TBP interacts more closely with activators 
and so I will focus on activators below.  
Studies show that the Pol II transcription machinery alone is inherently unable to 
be stably associated with DNA. In order to successfully initiate transcription, 
components of the transcription machinery need to be stably bound to promoters by 
activators (Struhl et al., 1998). For the vast majority of promoters tested in a study in 
yeast, association of TBP with promoters occurs only when activators are present 
(Kuras and Struhl, 1999; Pugh, 2000). By studying the interaction rate between an 
inducible TBP derivative and an appropriately mutated TATA elements in living 
yeast cells, it has been found that in the absence of activators, TBP can only start 
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basal transcription with hours of lag phase after inducing the expression of the TBP 
derivative. By contrast, the transcription which is activated by activator Gcn4 is 
induced rapidly upon the induction of the TBP derivative, indicating that activators 
allow efficient transcription initiation (Klein and Struhl, 1994). 
Typically, an activator can be divided into a DNA-binding domain (DBD), 
dimerisation domain, and activation domain (AD) (Allison, 2011). DBDs often 
contain structurally well-defined motifs which are commonly shared between a group 
of activators. By contrast, structures of ADs are elusive, but they are functionally 
autonomous. ADs remain functional in combination with different DBDs that bind at 
different positions in the promoter region (Allison, 2011; Struhl et al., 1998). During 
transcription activation, DBDs bound on DNA serve as an anchor for the stable 
bonding of Pol II machinery to promoters, and ADs is the connection between the 
anchor and factors possessing transcriptional activities such as GTFs.  
    Activators can interact directly with components in the general transcription 
machinery. Activators can increase transcription efficiency by several mechanisms. 
By studying a subset of TBP mutants which are defective in responding to activators 
shows that transcription defects originated from some of these TBP mutants are able 
to be restored by artificial recruitment of TBP to the promoter, indicating activators 
participate in the recruitment and binding of GTFs. Nevertheless, the activation 
activity of other TBP mutants fails to be restored even they are able to bind to DNA, 
suggesting that some activators are involved in post-recruitment steps of transcription 
initiation such as interactions between GTFs and the assembly of PIC. (Allison, 2011; 
Stargell and Struhl, 1995; Struhl et al., 1998). Besides these functions, activators can 
interact with cofactors such as chromatin modifying or remodelling factors to increase 
accessibility of promoters to GTFs (Allison, 2011). Indeed, TBP-mediated 
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transcription is severely impaired when TATA box is incorporated into nucleosomes, 
and factors such as SAGA can alleviate the inhibition (Imbalzano et al., 1994).  
 
 
1.17.  General cofactors 
 
    Typically, general cofactors serve as a bridge transmitting signals from 
gene-specific transcription factors to general transcription machinery (Thomas and 
Chiang, 2006). They up-regulate or down-regulate transcription activities via 
coactivators and corepressors, respectively, without binding to DNA directly. They 
either act as a scaffold for assembly of downstream transcription factors or possess 
enzymatic activities able to modify chromatin structure (Allison, 2011). Due to the 
role of TBP in transcription activation, this section will focus on coactivators.  
    One group of coactivators are chromatin modification complexes, which modify 
histone by acetylation, ubiquitylation, phosphorylation or methylation, and chromatin 
remodelling complexes, such as SAGA (Allison, 2011). Another well-studied 
coactivator is Mediator, which is highly conserved among eukaryotes.  
    Mediator, first discovered in yeast, is composed of 25 subunits, and 17 of them 
are conserved in all eukaryotes (Hahn and Young, 2011) (Table 1-2). In a partially 
reconstituted transcription system which carries out only basal transcription levels, 
addition of a cellular fraction containing specific factors is able to restore 
activator-dependent transcription, and these factors are subsequently termed 
―Mediator‖ (Flanagan et al., 1991).  
    The Mediator complex undergoes dramatic conformational changes upon 
association with Pol II (Thomas and Chiang, 2006). It can be divided into four 
modules: head, middle, tail and kinase, which are connected by flexible regions (Hahn 
and Young, 2011). The head module is implicated in interaction with PIC components 
including TBP and Pol II, thereby taking charge of communicating with the general 
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transcription machinery. The middle module is elongated and flexible, and it provides 
additional contacts with GTFs and Pol II. The tail module has been found to interact 
with several activators which are upstream in the transcription activation pathway. 
The kinase module is a controversial part, for which evidence of both positive and 
negative effects on transcription has been observed (Hahn and Young, 2011; Thomas 
and Chiang, 2006).  
 
 
1.18.  Kinetics of transcriptional complex formation 
 
    There are two proposed models for kinetic assembly of the transcriptional 
complex constituted by PIC and other activators/ repressors (Allison, 2011). In the 
first ―enhanceosome model,‖ the interaction of transcription factors with other 
transcription factors or with a DNA element is important for complex assembly and 
so is the spatial position of each factor in the complex. In this model, the assembly 
process occurs in a stepwise manner. However, more and more evidence shows that 
many nuclear proteins are highly mobile and their interactions with nuclear 
compartments such as chromatin is highly dynamic (Allison, 2011; Sprouse et al., 
2008a). This leads to the establishment of another model called ―hit and run,‖ in 
which all the components gather at proper sites in a stochastic way and the transient 
interaction is able to trigger transcription initiation (Allison, 2011). These two models 
are not mutually exclusive. It is possible that, although the complex formation is 
transient (model 2), the interaction and spatial regulation of each component can still 
affect each other‘s recruitment and also the assembly process (model 1) (Allison, 
2011). 
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1.19. TATA-binding protein (TBP) 
 
1.19.1. Carboxy- and amino-terminal domain 
 
TBP, the central subunit of TFIID, is highly conserved among eukaryotes, and it 
is required for transcription mediated by Pol I, Pol II and Pol III (Cormack and Struhl, 
1992). Crystal studies reveal that TBP is a symmetrical structure resembling a saddle 
and is initially identified to bind with TATA box (Fig. 1-5A) (Hernandez, 1993; Pugh, 
2000). As a matter of fact, the resolved TBP structure in the crystal of the TBP-DNA 
complex only contains the TBP core domain rather than full-length TBP, as the 
crystal was unable to form in the presence of the amino-terminal (N-terminal) region 
(Chasman et al., 1993).  
The Carboxy-terminal (C-terminal) core domain of TBP, which is highly 
conserved from Archaea to human, consists of 180 amino acids (Fig. 1-5B), and this 
domain is responsible for interacting with DNA, activators, repressors, and TAFs as 
well as other GTFs (Pugh, 2000). The C-terminal core domain alone is sufficient to 
support DNA binding, response to activators, and preinitiation complex formation 
(Horikoshi et al., 1990; Poon et al., 1991). 
In contrast to the evolutionarily conserved C-terminal domain, the N-terminal 
domain is divergent across species in terms of sequence and length (Fig. 1-5B). In S. 
cerevisiae, there are 60 amino acids in this domain, while in human TBP, constitutes 
around 150-160 residues which contain a consecutive glutamine stretch, which is 
variable in length (ranging from 29 to 42 subject to individuality) (Hernandez, 1993; 
Thomas and Chiang, 2006). As opposed to the vital role of C-terminus, the N-terminal 
domain is dispensable for viability, but it seems to serve as a regulator of the 
C-terminal domain (Lee and Struhl, 2001).  
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Figure 1-5. C-terminal core domain of TBP is highly conserved among species. (A). Space-filling 
model of the core 180 C-terminal amino acids of TBP (red) bound to a TATA box DNA (black and 
yellow). The yeast TBP structure is shown, although its structure is highly conserved from archaea to 
humans. (Adapted from (Pugh, 2000)) (B). Schematic representation of TBPs from different species. 
The conserved C-terminal domain is the solid region. In the human and Drosophila proteins, glutamine 
stretches are marked (boxes labelled Q). (Adapted from (Hernandez, 1993))  
 
1.19.2. Interaction of TBP with DNA 
 
As the name ―TATA-binding protein‖ implies, TBP was first discovered as a 
factor recognising the consensus TATA box, a sequence typically localised 
approximately 25 bp upstream of the TSS (Papai et al., 2011). However, later studies 
revealed that TBP is also present at promoters lacking TATA elements, which 
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actually represents the majority of promoters present in the genome (Ahn et al., 2012; 
Pugh and Tjian, 1991; Tokusumi et al., 2007; Tora and Timmers, 2010; Wiley et al., 
1992).  
The DNA binding ability of TBP is carried out by the conserved C-terminal 
domain. Most sequence-specific transcription factors bind to the major groove of 
DNA as it exhibits more specificity determinants compared to minor groove (Pugh, 
2000). However, TBP is unique in that it picks the minor groove as the target (Pugh, 
2000). TBP binds to the DNA template by inserting its ―foot,‖ which are two pairs of 
phenylalanine residues protruding from a concave surface (Phe284/Phe301 and 
Phe193/Phe210 for human TBP; Phe190/Phe207 and Phe99/Phe116 for yeast), into 
the two sides of the TATA box (Kim et al., 1993; Nikolov et al., 1996; Thomas and 
Chiang, 2006). One pair of phenylalanine side chains insert into the first two bases of 
TATA element, while the other pair penetrate between the last two bases. 
Co-crystallisation of TBP and a TATA box template showed that binding of TBP 
results in DNA-bending toward the major groove and considerable unwinding, 
exposing a widened minor groove which is contacting with the concave surface of the 
TBP saddle (Kim et al., 1993; Tora and Timmers, 2010).  
The binding of TBP with its target DNA is a two-step process, including the 
encounter and recognition of a specific promoter sequence by TBP, and then 
association of TBP and DNA, triggering DNA bending to form a stable TBP-DNA 
complex. This pathway follows a simple second-order rate kinetics, and the binding 
and bending occurs simultaneously (Hoopes et al., 1992; Parkhurst et al., 1996).  
 
 
1.20. TBP-binding targets- Beyond TATA box 
 
It is shown in vitro that binding affinity of human TBP with the TATA box is 
1000 folds higher than with TATA-less sequences (Coleman and Pugh, 1995). 
1. INTRODUCTION 
- 38 - 
 
However, TATA box-containing promoters in fact constitute the minority: 19% of 
promoters in yeast (Basehoar et al., 2004) and around 24% in human (including 
TATA-like promoters) (Yang et al., 2007). Although TBP is named for its binding to 
the TATA box, its requirement for Pol I and Pol III-mediated promoters (most of 
which do not contain TATA elements), as well as other TATA-less promoters, 
indicates that the role of TBP is not limited to TATA-containing promoters (Martinez 
et al., 1995; Pugh and Tjian, 1991; Tokusumi et al., 2007). 
What DNA sequences does TBP recognise in TATA-less promoters? A number 
of DNA elements other than the conventional TATA box have been identified. An 
early work identifying several TATA-less promoters shows that the TBP binding site 
is commonly present in a DNA element 30-bp upstream of TSS, albeit with a lower 
affinity than the TATA box. Though lacking a consensus sequence, the element has 
similar genetic properties to the TATA box and functionally initiates transcription in 
vitro. It was suggested in this report that, though without a unified sequence, a 
TBP-recognised element might commonly exist in the -30bp region of most 
TATA-less promoters (Wiley et al., 1992). In a more recent genome-wide study in 
human, through direct cloning and sequencing of the DNA fragments derived from 
ChIP of TBP, many TBP genomic binding sites were identified, including known and 
novel targets. Many of these novel TBP-binding sites localised in introns or in regions 
without gene annotation (Denissov et al., 2007). Subsequent testing shows many of 
these segments to be capable of directing transcription in vitro and in their genomic 
location in vivo (Denissov et al., 2007). This suggests that whilst not residing in 
typical promoter sites, these regions function as genuine promoters.  
    As previously described, there are a variety of core promoter elements in 
addition to the TATA box which mediates transcription in metazoans. However, apart 
from the TATA and Inr, the presence of most other DNA motifs in S. cerevisiae 
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remains unconfirmed. Therefore, much effort was made to identify a core promoter 
element in yeast which can substitute the function of the TATA box in TATA-less 
promoters. To search for such a motif, whose occurrence is frequent and is generally 
mutually exclusive of the TATA box, bioinformatic analysis was applied. A DNA 
element named GA element (GAE) comprising GAAAA was first discovered in S. 
cerevisiae and was subsequently found to be conserved in other species (Seizl et al., 
2011). The position of GAE relative to the TSS is similar to the position of TATA 
box. Like the TATA box, it is capable of recruiting TBP, supporting PIC assembly, 
and is able to functionally substitute the TATA element in vitro and in vivo (Seizl et 
al., 2011). Meanwhile, by stepwise deletion of small segments within a region 
upstream of the TSS of the RPS5 gene (a ribosomal protein gene with a TATA-less 
promoter) and testing transcription dependency on each of these segments, another 
study identified multiple distinct AT-rich stretches within the region between -174 
and -50bp upstream of the TSS (Sugihara et al., 2011). It is the number of A or T 
residues rather than the sequence itself critical to the transcription activity. These 
stretches are functionally redundant, and they can create ectopic TFIID-dependent 
initiation sites.  
Despite the identification of these independent TBP-binding sites in TATA-less 
promoters, a recent study performed a more systemic search by a technique called 
―lambda exonuclease to chromatin immunoprecipitates‖ (termed ChIP-exo, which can 
improve the resolution to a few nucleotides) to measure the precise location of 6,045 
PICs in S. cerevisiae (Rhee and Pugh, 2012). Surprisingly, they found that 99% of the 
PIC binding sites at TATA-less promoters contained a sequence with two or less 
mismatches to the consensus sequence of TATA box (TATAWAWR). Similar to 
yeast, nearly 85% of TFIIB/TBP binding locations in human cells are identified to 
contain a sequence with 0-3 mismatches to TATA consensus sequence (Venters and 
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Pugh, 2013), and TFIIB and TBP promoter occupancies are inversely correlated to the 
mismatches residing within TATA-like elements. These indicate that there are still 
―TATA-like‖ elements in TATA-less promoters, and this feature seems to be 
conserved. Moreover, studies in the human genome reveal that the vast majority of 
TATA elements are accompanied by BRE
u
, BRE
d
 and INR consensus sequences with 
three or less mismatches, and the spacing between these elements are constrained. 
These promoter core elements are also found in 97% of non-coding TFIIB-localised 
regions, demonstrating that a consensus promoter sequence does exist (Venters and 
Pugh, 2013).  
 
 
1.21. Regulators of TBP dynamics- Mot1 & NC2 
 
Although the affinity is sequence dependent, once TBP has bound to DNA, the 
binding is highly stable in vitro (Coleman and Pugh, 1995). However, a fluorescence 
recovery after photobleaching (FRAP) assay in living yeast cells revealed that TBP is 
highly mobile in vivo (Sprouse et al., 2008a), suggesting that TBP binding is regulated 
in vivo by other molecules not present in the in vitro study.  
Mot1 and NC2 have been identified as TBP regulators which can modulate TBP 
mobility (Table 1-2).  
 
1.21.1. Mot1 
 
TBP is highly mobile in living yeast cells, and this mobility is dependent on 
Mot1 (Sprouse et al., 2008a). Mot1 was originally isolated as an essential protein 
repressing genes involved in mating in S. cerevisiae (Davis et al., 1992). It was later 
identified as a member of the Snf2/Swi2 family with ATPase activity in its C-terminal 
domain, and as a global repressor of RNA Pol II-dependent transcription (Auble et al., 
1994). The Mot1 N-terminal domain interacts with the TBP concave underside and 
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thereby interferes with binding of TBP to both DNA and other transcription activating 
factors such as TAF1 (Pereira et al., 2001; Thomas and Chiang, 2006). Mot1 can also 
promote dissociation of TBP from DNA in an ATP-dependent manner (Auble et al., 
1997). It was demonstrated that binding of Mot1 to the TBP-DNA complex induces 
DNA unbending, and subsequent addition of ATP facilitates dissociation of TBP from 
DNA (Moyle-Heyrman et al., 2012).  
However, it seems Mot1 can not only act as a transcriptional repressor but also 
an activator, and these two opposite functions are exerted on different sets of genes 
(Collart, 1996; Prelich, 1997). Comparing the genome-wide transcription profiling 
between the wildtype and mot1 mutant, Mot1 was shown to regulate about 3-15% of 
yeast genome. In one study, most Mot1-dependent genes are inhibited by Mot1 (176 
out of 182 genes), while another report reveals that Mot1 positively and negatively 
regulates 10% and 5% of the yeast genes, respectively (Dasgupta et al., 2002; 
Geisberg et al., 2002). Overall, it is clear that Mot1 has dual and opposite roles in 
transcription regulation, depending on its target  
Given the ability of Mot1 to dissociate TBP from DNA, it is logical that Mot1 
can negatively regulate a subset of genes. Whereas, how Mot1 exerts its stimulatory 
function on the other class of genes is still unknown, although some hypotheses have 
been proposed. For instance, Mot1 may release and redistribute TBP to Mot1-induced 
genes. In a biochemical analysis, transcription from the HIS4 promoter induced by 
TBP was decreased when exogenous non-promoter DNA was added into the reaction. 
This is due to competition for TBP between these two types of oligonucleotides. 
Interestingly, addition of Mot1 restores HIS4 transcription, indicating Mot1 is able to 
redistribute TBP between specific and non-specific targets (Muldrow et al., 1999). 
This is supported by findings that deletion of the ATPase domain of Mot1 increases 
TBP occupancy and also the expression of a class of genes which are 
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Mot1-independent (Venters et al., 2011), which might result from the inability of 
redistributing TBP to those Mot1-dependent genes.  
Apart from indirectly affecting transcription activities as described above, Mot1 
seems to also play an active role in regulating target genes. ChIP analysis shows that 
Mot1 accumulates on promoters of both Mot1-activated and repressed genes. 
Moreover, its ATPase activity is required for both transcriptional activation and 
repression (Dasgupta et al., 2002; Geisberg et al., 2002). Mot1 associates with 
promoters in a manner that is strongly correlated with TBP occupancy (Geisberg et al., 
2002), which is in turn correlated to transcriptional activities (Kuras and Struhl, 1999). 
Under activated conditions, Mot1 is rapidly recruited to inducible promoters 
(Geisberg et al., 2002), and it is also found to be essential for TBP recruitment and 
stably binding to specific promoters, where Mot1 shows transient accumulation 
(Andrau et al., 2002). It is shown in another study that, in a mot1 mutant, TBP is still 
highly accumulated at Mot1-stimulated genes while promoter occupancy of TAF1, 
TFIIB, and Pol II are reduced and transcription is abolished, suggesting Mot1 can 
facilitate the removal of transcriptionally inactive DNA-bound TBP (Dasgupta et al., 
2005). Consistent with this, appropriate PIC assembly on URA1 has been shown to 
involve removing mis-oriented promoter-bound TBP by Mot1 (Sprouse et al., 2008b). 
This mechanism may also be conserved as BTAF1 (mammalian homolog of Mot1) is 
able to stabilise the binding between DNA and a TBP mutant defective in DNA 
binding in vitro (Klejman et al., 2005).  
 
1.21.2. NC2 
 
Another TBP repressor is negative cofactor 2 (NC2), a highly conserved 
heterodimeric transcriptional regulator composed of Bur6 and Ydr1 (in S. cerevisiae; 
NC2α and NC2β in mammals) (Goppelt and Meisterernst, 1996; Kim et al., 1997; 
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Mermelstein et al., 1996). NC2 was initially identified as a global transcriptional 
repressor, as mutation of NC2 increased transcription of certain genes without the 
need for an enhancer, and overexpression of NC2 decreased mRNA accumulation in 
vivo (Kim et al., 1997; Prelich and Winston, 1993). NC2 acts as a molecular clamp 
via histone fold domains to grip the upper and lower surface of TBP, thus forming a 
ring-like structure with TBP. This could physically impede the interaction of the 
TBP-DNA complex with other GTFs such as TFIIA or TFIIB and therefore disrupt 
PIC assembly (Thomas and Chiang, 2006).  
Similarly to Mot1, NC2 also directly participates in transcription stimulation. 
Global transcription profiling of wildtype and bur6 mutants in S. cerevisiae revealed 
that expression of 17% of yeast genes are changed two-fold or more in the mutant. 
Among these Bur6-affected genes, half of them are down-regulated while the rest are 
up-regulated, showing that NC2 can both positively and negatively regulates selected 
genes (Geisberg et al., 2001). Analysis has shown that NC2 is largely recruited to 
NC2-induced promoters, while occupancy at NC2-repressed promoters is comparable 
with NC2-independent genes (Geisberg et al., 2001). A genome-wide expression 
analysis of a bur6 mutant and a TBP mutant defective in binding with NC2 revealed 
that, due to an extensive overlap of the transcripts which have decreased expression 
levels in these two mutants, the interactions between TBP and NC2 seemed to be 
crucial to the transcription activation by NC2. It was further demonstrated that this 
interaction is vital for gene induction in vivo, exemplified by GAL1 (Cang and Prelich, 
2002). In a study combining biochemical and FRET analysis, the NC2 complex was 
shown to induce a conformational change of the TBP-DNA complex, which 
weakened the binding between TBP and DNA although without dissociating TBP. 
This renders the NC2-TBP complex capable of sliding along DNA (Schluesche et al., 
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2007). However, whether this behaviour negatively (e.g. promoter clearance) or 
positively (e.g. searching promoters) affects transcription remains elusive.  
 
1.21.3. Interaction between Mot1 and NC2 in transcription 
 
    Both Mot1 and NC2 act as transcriptional regulators of TBP and regulate similar 
sets of genes (Spedale et al., 2012). Several lines of evidence support this idea that 
Mot1 and NC2 function cooperatively, and a physical interaction between the two is 
shown to be involved (Klejman et al., 2004). It has also been found that the promoter 
occupancy of NC2 in a mot1 yeast strain is drastically elevated compared to that in 
the wildtype, implying that Mot1 and NC2 are likely to have redundant functions 
which can be compensated by each other (Geisberg et al., 2002). Moreover, TBP, 
NC2 and Mot1 coexist at transcriptionally active Pol II promoters, a stable TBP–
NC2–Mot1–DNA complex can be isolated, and NC2 and DNA are released from the 
TBP-Mot1 complex upon ATP hydrolysis (van Werven et al., 2008). A genome-wide 
expression profile obtained from yeast cells with nuclear depletion of either Mot1 or 
Ydr1 (one of NC2 subunits) showed a significant overlap between the Mot1- and 
Ydr1-affected genes and that the majority (80%) of these genes are repressed by 
Mot1/Ydr1 (Spedale et al., 2012). Intriguingly, a regulatory circuit between TBP, 
Mot1 and NC2 is correlated to the presence of TATA-containing/ TATA-less 
promoters. Among those 80% of genes repressed by Mot1 and Ydr1, a considerable 
proportion have a TATA box in their promoters (while natural occurrence of TATA 
element is about 20% in the yeast genome) and are enriched for binding of SAGA (a 
TBP-containing complex which is dominant in TATA-containing promoters while 
TFIID is mainly responsible for TATA-less transcription, which will be described in 
section 1.23) and stress-related transcription factors. By contrast, the other 20% which 
are up-regulated by Mot1 and Ydr1 are TFIID-dominated and are the targets of 
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transcription factors responsible for regulating housekeeping genes such as ribosomal 
genes (Spedale et al., 2012). In line with this finding, analysis by RNAi depletion or 
overexpression of TBP, Mot1 and NC2 shows that TBP activates TATA-dependent 
transcription and represses DPE-dependent transcription; by contrast, both Mot1 and 
NC2 inhibit TATA-containing genes and stimulate transcription from DPE promoters, 
likely by acting via TBP which is downstream of Mot1 and NC2 in this transcription 
circuit (Hsu et al., 2008).  
 
 
1.22. Other regulatory mechanisms of TBP transcriptional activities 
 
In addition to the modulation from Mot1 and NC2 described above, there are 
multiple mechanisms negatively or positively regulating TBP-DNA interaction 
(reviewed in (Thomas and Chiang, 2006)).  
 
1.22.1. Negative regulation of TBP 
 
The concave surface of TBP C-terminal domain is responsible for interaction not 
only with DNA or other transcriptional factors but also with another TBP monomer, 
forming a TBP dimer which is unable to contact DNA. As TBP shows affinity with 
non-TATA as well as non-promoter regions, dimerisation may help prevent it from 
unnecessary binding or degradation (Pugh, 2000). Although dimerisation of TBP core 
domain has been demonstrated by different strategies in vitro, dimerisation of the 
full-length TBP is highly dependent on ions, salt, buffer, and protein concentrations 
(Thomas and Chiang, 2006). Additionally, TBP activity can be repressed by TAF1. 
Studies both in Drosophila and in yeast show that TAF1 N-terminal domain can be 
divided into subdomains TAND1 (TAF N-terminal domain 1) and TAND2; the 
former interacts with the concave underside of TBP, interrupting TBP-DNA 
interaction, and the latter binds to the TBP convex surface, where the binding site of 
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TBP positive regulator TFIIA is, thereby competing with its binding to TBP and 
acting as a repressor (Kokubo et al., 1998; Liu et al., 1998; Thomas and Chiang, 2006; 
Wang and Wang, 2013).  
 
1.22.2. Positive regulation of TBP 
 
    TBP is also subject to positive regulation via several mechanisms. These are 
mainly achieved by antagonising effects from negative regulators. Both TFIIA and 
TFIIB promote the binding of TBP to DNA and further stabilise TBP-DNA complex 
(see above). Alternatively, as alluded to in the previous paragraph, TFIIA alleviates 
the inhibitory influence of TAF1 by competing with its binding to TBP. Moreover, it 
has been shown that TFIIA facilitates dissociation of TBP dimers, thereby increasing 
formation of TBP-DNA complex (Coleman et al., 1999).  
Furthermore, DNA is wrapped around nucleosomes, rendering promoter regions 
inaccessible to TBP, and this obstruction needs to be removed by chromatin modifiers. 
There are two major classes of chromatin modifier. The first class contains chromatin 
modifying factors, covalently modifying histones by acetylation, deacetylation, 
phosphorylation, and methylation. They increase the accessibility of promoter DNA 
to TBP possibly by loosening the interaction between DNA and nucleosomes. 
Examples in this class include a variety of histone acetylases (HACs) and histone 
deacetylases (HDACs). The second class are chromatin remodelling factors, involved 
in moving nucleosome position in an ATP-dependent manner (Narlikar et al., 2002; 
Thomas and Chiang, 2006). The SWI/SNF family, which contain TBP-interacting 
complex SAGA (discussed below), is one of the best-studied chromatin remodelling 
complexes.  
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1.23. TBP-containing multi-protein complexes other than TFIID  
 
TBP was originally identified as a subunit of the TFIID complex but was 
subsequently found to be present in various multi-subunit complexes. By its 
involvement in multiple complexes, TBP supports the transcription of different sets of 
genes.  
 
1.23.1. Pol I- and Pol III-dependent complexes 
 
It has been mentioned in section 1.14 that all the three transcription apparatuses 
in eukaryotes have a conserved central core which contains TBP. While TBP forms 
TFIID complex with other TAFs in the Pol II machinery, it is involved in the 
complexes designated SL1 and TFIIIB in the Pol I and Pol III transcription machinery, 
respectively (Pugh, 2000).  
 
1.23.2. SAGA complex 
 
In addition to TFIID, SL1 and TFIIIB, TBP is also associated with another 
well-known complex called SAGA (Spt-Ada-Gcn5 acetyltransferase) for Pol II- 
dependent transcription (Baker and Grant, 2007) (Table 1-2). The nuclear histone 
acetyltransferase (HAT) activity of Gcn5 was first discovered in S. cerevisiae; 
however, Gcn5 alone failed to modify histones incorporated in nucleosomes. Later, 
Gcn5 was found to be present in a 1.8MDa SAGA complex containing other proteins 
which were required for histone acetylation (Baker and Grant, 2007; Grant et al., 
1997). A series of biochemical and genetic analyses reveal that SAGA has 21 subunits 
and mediates a variety of transcription-related functions including structural integrity, 
nucleosome acetylation, and interaction with TBP (Rodriguez-Navarro, 2009; Sterner 
et al., 1999). The complexes with similar composition to yeast SAGA are also found 
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in other species including Drosophila and in human (eventually named SAGA as well) 
(Pijnappel and Timmers, 2008; Rodriguez-Navarro, 2009), revealing the highly 
conserved role of the SAGA complex. These SAGA subunits are categorised into five 
modules involved in different functions, including a HAT module, a ubiquitin 
protease module, an activator-binding module, TAF module, and a core module 
responsible for SAGA integrity and TBP binding (Hahn and Young, 2011). These 
spatially separated and functionally distinct modules reflect the versatility of the 
SAGA complex.  
SAGA and TFIID are both Pol II-dependent and share some components such as 
TAFs, yet they participate in transcription of different subsets of genes. SAGA is 
linked to highly regulated, stress-induced or tissue-specific genes, and TFIID is 
implicated in housekeeping and stress-repressed genes (Huisinga and Pugh, 2004; 
Zanton and Pugh, 2004). The targets of the former are generally TATA-containing 
genes that account for about 20% of the yeast genome, while the latter are mostly 
found in TATA-less promoters representing 80% of all genes, indicating that SAGA 
targets are mainly TATA elements and TFIID dominates promoters that lack the 
TATA box (Basehoar et al., 2004; Huisinga and Pugh, 2004; Tora and Timmers, 2010; 
Weake et al., 2011; Weake and Workman, 2012). Despite the presence of TBP in both 
TFIID and SAGA, its roles in the two complexes are not similar. In TFIID-mediated 
transcription, TBP is one of the first components arriving at the promoter, followed by 
recruitment of other associated factors. For SAGA-driven transcription, however, the 
SAGA complex first interacts with activators and then recruits TBP via Spt3 and Spt8 
in the core module (Baker and Grant, 2007; Dudley et al., 1999; Mohibullah and 
Hahn, 2008; Sermwittayawong and Tan, 2006). Apart from serving as a coactivator 
during transcription initiation, recent research also uncovered roles for SAGA in 
transcription elongation as well as mRNA exit (Rodriguez-Navarro, 2009).  
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Overall, these data suggest that TBP has a conserved role in transcription, and it 
is able to interact with various factors that constitute distinct higher-order complexes 
responsible for expression of different subsets of genes responding to diverse 
conditions.  
 
 
1.24. Differential transcriptional regulatory strategy and TBP behaviour 
between TATA-containing and TATA-less promoters  
 
    It was mentioned above that, although the TATA box is the classic example of a 
promoter element, it is actually the minority in the genome, representing around 20% 
of genes (Basehoar et al., 2004). It is further shown that TATA-containing genes are 
mostly highly regulated (for instance tissue-specific) or stress-stimulated, and 
SAGA-controlled. By contrast, a large proportion of genes which are classified as 
TATA-less tend to play housekeeping roles and are TFIID-dependent.  
    Recently, a study showed a difference in TSS positioning mechanisms utilised by 
TFIID and SAGA at TATA-less and TATA-containing promoters, respectively 
(Buratowski, 2012; Rhee and Pugh, 2012). They found that a TSS at a 
SAGA-dependent promoter usually overlaps with the first nucleosome (+1 
nucleosome). Given the histone modification activity of SAGA, it is suggested that 
SAGA may acetylate the histones within this nucleosome to displace it and expose the 
TSS for Pol II. This may also help Pol II progress into the gene body, leading to 
highly productive transcription which is characteristic of this class of genes (highly 
regulated genes). For TFIID-controlled promoters, TSS are positioned near the 
upstream boundary of +1 nucleosomes, and TAFs in the TFIID complex are shown to 
interact with the DNA region surrounding the +1 nucleosome downstream of the TSS. 
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This interaction of TAFs with +1 nucleosome may establish a barrier for nucleosome 
invading TSS (Buratowski, 2012; Rhee and Pugh, 2012).  
    TBP dynamics also seem to be varied between TATA-containing and TATA-less 
genes. As described in the previous section, the binding of TBP to the TATA box 
induces an obvious DNA bending. Moreover, TBP turnover was proved to be the 
highest at SAGA-mediated, TATA-containing promoters (though in this case SAGA 
occupancy is a more important determinant than the presence of TATA), whereas 
TFIID-bound promoters are characterised by low TBP turnover (van Werven et al., 
2009). Taking these findings together, it is proposed that the DNA bending at the 
TATA-containing promoters, induced by the binding of TBP, serves as a ―spring,‖ 
rendering DNA-bound TBP more dynamic (Tora and Timmers, 2010). This is 
consistent with the role of this gene group, which is highly regulated and needs to be 
switched on/off rapidly. As TBP promoter turnover rate is correlated to Mot1 
dependence, and FRAP analysis in yeast also showed that high TBP dynamics is 
dependent on Mot1 (Sprouse et al., 2008a; van Werven et al., 2009), Mot1/ NC2 may 
also play a key role in the dissociation process (Tora and Timmers, 2010).  
 
 
1.25.  TBP-associated factors (TAFs) 
 
    In yeast, all conserved TAFs are essential for viability (Hahn and Young, 2011). 
Many of the TAFs are identified to have amino acid sequences very similar with 
histone cores, and nine out of fourteen TAFs contain a histone fold domain (HFD) 
(Gangloff et al., 2001; Papai et al., 2011; Thomas and Chiang, 2006). It is suggested 
that this motif might be critical for inter-molecular interaction, which in turn is 
important for the assembly and the integrity of TFIID (Cler et al., 2009; Thomas and 
Chiang, 2006).  
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    Apart from providing stability for TFIID, TAFs are involved in facilitating 
transcription. It has been demonstrated that TAFs are essential for transcription 
activation mediated by oestrogen receptors in a highly purified in vitro transcription 
system (Wu et al., 1999). It is also known that TAF1 can act as an acetyltransferase 
for histone modification, which is also required for certain types of transcription. 
Moreover, a number of studies have demonstrated that TAF1 possesses multiple 
enzymatic activities capable of modifying other GTFs and cofactors, including 
phosphorylation, acetylation and ubiquitylation (Thomas and Chiang, 2006). 
Additionally, TAFs may negatively regulate transcription activities. For instance, 
TAF1 competes for the binding of TBP with TFIIA or DNA (see above).  
    In yeast, Pol II-mediated genes are divided into TAF-dependent and 
TAF-independent categories. As displayed in ChIP assays, TBP and TAFs have 
similar occupancies at TAF-dependent promoters. By contrast, while TBP is still 
efficiently recruited, TAFs are almost absent from TAF-independent promoters, 
implying that TBP is able to be recruited alone to this type of promoter without 
assistance from TAF-containing complexes such as TFIID (Li et al., 2000). 
Genome-wide transcription profiling of temperature-sensitive yeast mutants defective 
in each TAF shows that 84% of genes require at least one TAF, while the other 16% 
of yeast genes are TAF-independent, and their regulation comes from their ability to 
recruit TBP or PIC assembly (Shen et al., 2003). TAFs are also shown to interact with 
multiple activators (Chiang and Roeder, 1995). This is consistent with the finding that 
TAFs are recruited to promoters in response to activators even upon deletion of TBP, 
though subsequent assembly of other GTFs and Pol II are abolished (Li et al., 2000).  
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1.26. Meiosis and Sporulation in Saccharomyces cerevisiae 
 
    In Saccharomyces cerevisiae, there are some cellular events that requires 
genome-wide transcription reprogramming, for instance when cells face a shortage of 
nutrients. Sporulation is a well-studied cellular process that diploid yeast cells use to 
survive under such conditions. Among the entire yeast genome comprising more than 
6000 genes, over 1000 genes show significant changes in RNA levels during 
sporulation (Chu et al., 1998).  
Sporulation is a gametogenesis-like process in S. cerevisiae, characterised by 
reduction of the diploid genome into a haploid state via DNA replication and two 
rounds of chromosome segregation (reviewed in (Neiman, 2005, 2011; Piekarska et 
al., 2010; van Werven and Amon, 2011)). 
 
1.26.1. Requirements for the onset of sporulation 
 
Sporulation of yeast cells only occurred under the condition where all the 
necessary requirements are met. These include the genetic requirement and the 
nutrition requirements (Mitchell, 1994).  
There are two mating types, MATa and MATα, in S. cerevisiae haploid cells, 
and the choice is determined by expression of either the MATa or MATα genomic 
locus. Crossing between MATa and MATα haploid cells generates MATa/α diploid 
cells. Only cells expressing both MATa and MATα alleles (therefore only diploid 
cells) are capable of sporulation under appropriate circumstances. This is the genetic 
requirement for sporulation.  
Nutritional restriction acts as an important signal for triggering sporulation. 
Under nutrient-rich conditions, all budding yeast cells undergo efficient mitosis and 
cell division known as vegetative growth. Haploid cells cope with nutrient limitation 
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via entry into stationary phase. Additionally, in response to nitrogen shortage, both 
haploid and diploid cells are able to switch from budding to a filamentous growth 
state named pseudohyphae (Ceccato-Antonini and Sudbery, 2004). In such growth 
mode, cell shapes become elongated, and continuous growth of buds without 
separating from mother cells leads to the formation of a chain of cells. This type of 
growth favours wider exploration of the environment with lower energy costs. 
However, the complete absence of nitrogen from the environment along with 
depletion of fermentable carbon source triggers the onset of sporulation in diploid 
cells. Lack of a fermentable carbon source means that cells need to turn to aerobic 
metabolism; that is, respiratory-competent cells are required in order to utilise non- 
fermentable carbon source by respiration. Overall, three conditions including the 
absence of nitrogen, deprivation of a fermentable carbon source and the presence of a 
non-fermentable carbon source must co-exist in order to promote sporulation 
development (Piekarska et al., 2010). 
 
1.26.2. Developmental programme of sporulation: Meiosis and spore 
morphogenesis 
 
Sporulation is a complex process consisting of two major events: meiosis and 
spore morphogenesis (Neiman, 2011; Piekarska et al., 2010; van Werven and Amon, 
2011).  
 
Meiosis 
The first stage of meiosis is a prolonged premeiotic DNA synthesis phase in 
which chromosomes are duplicated (Fig. 1-6A). This is followed by pairing and 
recombination between homologous chromosomes. Afterwards, cells go through two 
rounds of chromosome segregation along with cell division, which are termed meiosis 
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I and meiosis II, and this produces four haploid nuclei. Meanwhile, the spindle pole 
bodies (SPBs), the microtubule-organising centres in budding yeast, are duplicated 
twice from a single copy prior to, and after, meiosis I. SPBs serve as nucleation site 
not only for microtubules to pull homologous chromosomes and sister chromatids 
apart, but also for prospore membrane growth (see below). 
 
Spore morphogenesis 
    Spore morphogenesis is initiated during meiosis II (Fig. 1-6A). The first stage of 
spore morphogenesis is the formation of the prospore membrane, a double membrane 
which is derived from Golgi-secretory vesicles recruited to the cytoplasmic side of the 
nuclear envelope-anchored SPBs. During meiosis II, four prospore membranes are 
expanded to encompass each haploid nucleus and eventually fuse and close off at the 
ends to generate four intact prospores. Meanwhile, organelles are distributed among 
four progeny cells as well as original ascal mother cells. The next stage is spore wall 
assembly. During this process, the outer prospore membrane breaks down, and the 
inner membrane becomes the plasma membrane of the spore. Once the spore wall is 
formed, the mother cell is remodelled and shrinks to serve as an ascus encapsulating 
four mature spores, the tetrad, and to complete spore maturation. At this stage, some 
cellular processes and haploid spore organisation return to a more vegetative-like state. 
The spore wall renders spores resistant to various environmental stresses and enables 
survival under harsh conditions. Each of these spores is able to develop into a single 
haploid cell and proliferate when the environmental conditions are favourable.  
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Figure 1-6. The morphogenetic events of spore formation are driven by an underlying 
transcriptional cascade. (A) The landmark events of meiosis and sporulation are shown in temporal 
order. Orange lines indicate the mother cell plasma membrane (which becomes the ascal membrane). 
Grey lines indicate the nuclear envelope. Blue and red lines represent homologous chromosomes. 
Green lines represent spindle microtubules. Prospore membranes are indicated by pink lines and the 
lumen of the prospore membrane is highlighted in yellow. After membrane closure, the prospore 
membrane is separated into two distinct membranes. The one closest to the nucleus serves as the 
plasma membrane of the spore, while the outer membrane, indicated by thin, dashed pink line, breaks 
down during spore wall assembly. Blue hatching represents the spore wall. Chromosome events are 
described by words in dark red; spore formation processes are in dark blue; ascus formation is in dark 
green. (B) The shaded arrows indicate the relative timing of the different transcriptional classes with 
respect to the events in A. The black arrows indicate the points at which the transcription factors Ime1 
and Ndt80 become active. Functions of genes involved in different periods of spore morphogenesis are 
indicated. (Adapted from (Neiman, 2011)) 
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1.26.3. Transcriptional regulation during sporulation development 
 
Programmed sporulation is a highly coordinated and elaborate event, 
characterised by sequential expression of a series of relevant genes and induction of 
signalling pathways (Neiman, 2011; Piekarska et al., 2010).  
Genome-wide studies reveal that the expression pattern of a huge number of 
genes are changed during sporulation; half of them are induced whereas the rest are 
repressed (Chu et al., 1998; Primig et al., 2000). These genes are temporally regulated 
and are grouped according to their induction stages during sporulation. It is found that 
genes in the same group share common regulatory sequences in their promoters and 
are modulated by the same transcription factors (Mitchell, 1994; Vershon and Pierce, 
2000). 
Immediately after switching cells to sporulation media (no nitrogen, no 
fermentable and non-fermentable carbon source), genes involved in responding to 
metabolic stresses such as starvation are activated. After this immediate response, 
sporulation-specific genes, which are repressed in vegetative growth, are expressed 
sequentially in several induction waves (Fig. 1-6B).  
The first set of genes, termed early genes, are induced by Ime1 (Inducer of 
Meiosis I) in meiotic prophase I and are responsible for meiotic chromosomal events 
such as pairing and recombination, and they are also required for activation of the 
next set of genes. Signals from various sporulation-promoting factors such as nutrient 
availability are integrated and converge on transcriptional regulation of Ime1, whose 
expression determines cell fate toward sporulation.  
The second induction wave for ‗middle genes‘ is induced by the general activator 
Ntd80. Expression of Ntd80 only occurs upon completion of chromosome 
recombination, and it is essential for exit from meiotic prophase. This class of genes 
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are required for the two meiotic divisions as well as most processes through spore 
morphogenesis such as formation of the prospore membrane and cell wall. The 
induction of Ntd80 also seems to be a control point of ―commitment to sporulation.‖ 
That is, beyond this point, even if the environmental conditions no longer favour 
sporulation (e.g. nitrogen and glucose are supplied), cells will still complete 
sporulation rather than return to mitotic cell cycle.  
The ‗late genes‘, whose functions are related to spore wall assembly, stress 
response, and maintaining haploid state, are expressed at the final stage of spore 
formation. The major regulator of this step is still not clear.  
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2. Materials And Methods 
 
 
 
CHAPTER 2 
 
 
Materials and methods 
 
 
 
2.1.  Yeast strains and general yeast methods 
 
2.1.1. Media 
 
Yeast extract peptone (YP: 1% yeast extract, 2% peptone) and synthetic drop out 
media lacking various amino acids were prepared according to the standard protocol. 
For solid media, 2% of agar powder was supplemented. Cells were provided with 
different carbon sources including glucose (D), galactose (G), and raffinose (R), all at 
a final concentration of 2%. Antibiotics were used at following final concentrations: 
100 μg/ml nourseothricin for NAT; 300 μg/ml hygromycin B for HPH; 200 μg/ml 
geneticin for KAN; 50 μg/ml doxycycline for Dox.  
Standard sporulation solid media contained 1% of potassium acetate, 0.1% of 
yeast extract, 0.05% of glucose and 2% of agar. Pre-sporulation took place in YPA 
media (1% of potassium acetate, 1% of yeast extract, 2% of peptone), and sporulation 
was induced in SPO media (1% of potassium acetate, 0.02% of raffinose).  
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2.1.2. General growth conditions 
 
Liquid cultures were inoculated from freshly streaked plates and grown 
overnight. Cells were then switched to fresh media at approximately 0.25 OD595 and 
were grown until mid-log phase or indicated cell densities. The culture density was 
determined photometrically (OD595 of 1 is approximately equal to 2x10
7
 cells/ml). 
Normally, yeast cells were grown at 30°C (temperature sensitive strains at 25°C) in an 
SM1003 shaking incubator (Kuhner) at 150 rpm.  
To induce DNA damage, 0.1% methyl methanesulfonate (MMS) (Sigma, 
129925-100G) was added 1h before cell harvesting. To induce transcription from the 
GAL promoter, cells were grown in YPR media plus 0.5% glucose for overnight and 
then switched to fresh YPR media. 2% of galactose was added into culture 2h prior to 
cell harvesting. To repress tetO promoters, cells were cultured with 50 μg/ml of 
doxycycline (for both liquid and solid media).  
 
2.1.3. Cell viability- tested by drop assay 
 
Cells freshly growing on plates were picked and subjected to 10-fold serial 
dilutions in water. They were subsequently dropped onto YPD plates or selective 
media. Five drops were taken for each strain (2.5μl/drop). The first drop was taken 
from the dilution containing approximately 1×10
7
- 2×10
7
 cells, with 10-fold dilutions 
in each subsequent drop. Cells were incubated at 30°C for 2-3 days depending on 
growth rates before an image was taken.  
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2.1.4. Yeast mating and sporulation 
 
Yeast mating 
To create diploid cells, the same volume of an appropriate Mata strain and 
Matα strain were mixed on YPD plates and incubated for 24-48h. Subsequently cells 
were transferred to a selection plate to select for diploid cells by a combination of 
markers derived from each of the two parental haploid strains. To ensure that the 
diploid strain obtained was correct, single colonies of diploid cells were re-isolated to 
a new selection plate. Diploid cells could be verified by their ability to sporulate or 
their inability to mate with either mating type.  
 
Induction of sporulation 
To induce sporulation on solid media, diploid cells were grown on sporulation 
plates.  
To induce sporulation in liquid media, diploid cells were first grown in YPD 
overnight and switched to YPA media for 24h. Cells were then shifted to YPO media 
resulting in sporulation.  
Successful sporulation was confirmed under the microscope.  
 
Tetrad dissection 
    Tetrads were resuspended in 0.5mg/ml zymolyase and incubated at 30℃ for 10 
minutes. An appropriate amount of treated tetrads were dropped on one side of a YPD 
plate for tetrad selection and dissected by tetrad dissector apparatus.  
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2.2.  General bacterial methods 
 
2.2.1. General growth conditions 
 
Bacterial cells were grown in LB media or on LB agar plates at 37°C. The 
selection of transformed bacteria was performed by the addition of ampicillin (50-100 
μg/ml) to the media.  
 
2.2.2. Purification of plasmid DNA from E. coli 
 
Colonies were cultured in either 5 ml or 50 ml LB with selection. The QIAprep 
Spin Miniprep kit (Qiagen) or the Plasmid Midi Kit (Qiagen) was used to extract 
plasmid DNA from the small and large cultures respectively, according to the 
manufacturer‘s instructions. 
 
2.2.3. Transformation 
 
One Shot
®
 TOP10 chemically competent cells (Invitrogen, DH10B™ strain, F- 
mcrAΔ (mrr-hsdRMS-mcrBC) Φ80lacZΔ M15Δ lacX74 (recA1 araD139Δ (araleu) 
7697 galU galK rpsL (StrR) endA1 nupG) were routinely used for bacterial 
transformation, according to the manufacture‘s instructions. For transformation of 
ligation products, 50μl of competent cells were used, and around 17μl of cells were 
used for plasmids transformation. Competent cells were thawed on ice, mixed with 
DNA and incubated on ice for 30 min. Cells were heat shocked for 30s at 42°C, 
followed by a 2 minute incubation on ice. 250μl S.O.C medium was added, and the 
cells were incubated at 37°C for 1h with shaking. Transformed cells were selected by 
plating the cell suspension on ampicillin-containing LB agar plates and incubating the 
plates overnight at 37°C. 
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2.3.  Molecular Biology methods 
 
2.3.1. Preparation of DNA for transformation: PCR amplification, digestion of 
GeneCust constructs 
 
All the S. cerevisiae strains and plasmids used in this study are listed respectively 
in Appendix II and Appendix III (the products from the GeneCust were synthesised 
by GeneCust Europe, Dudelange, Luxembourg). To fuse myc or HA to the C-terminal 
of a gene of interest, epitope tags with a marker gene were amplified from the pYM 
plasmid collection. To replace the endogenous TBP promoter with a repressible 
promoter, the tetO7 promoter cassette was amplified from the pCM plasmid collection. 
Amplified PCR products were transformed into cells via homologous recombination. 
For GeneCust constructs, inserts on centromeric plasmids were introduced directly, 
and integrative plasmids were linearised by digestion with StuI and AflII respectively 
for pRS406 (URA3) and pRS405 (LEU2) at 37℃ prior to transformation.  
For integration of cassettes by homologous recombination, the insert sequences 
were amplified from templates by primer pairs containing homologous sequences 
flanking the genomic insertion site. All primers were design based on Janke et al. 
(2004) and constructions were under standard yeast genetic procedures outlined in 
Knop et al. (1999). To create a new 6His-FLAG (HF-Smt3) strain, the HF-Smt3 
cassette was amplified by PCR from a previous HF-Smt3 SUMO strain (CCG4620) 
(Zhou et al., 2004) and was inserted into the endogenous Smt3 locus of DF5a. Insert 
cassettes were amplified by PCR using the Expand High Fidelity PCR System (Roche) 
with primers at 0.3 μM and deoxyribonucleotide triphosphate mix (dNTPs) at 300 μM. 
Conditions for PCR reactions were as followed: initial denaturation step of 95°C for 3 
minutes, followed by an amplification cycle of 94°C for 1 minute, 52°C for 30s, 72°C 
for 1minute/kb repeated 10 times then 94°C for 1 minute, 55°C for 30s, 72°C for 
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1minute/kb repeated 20 times. Subsequently a final extension step of 72°C for 10 
minutes was used.  
To amplify longer DNA sequences, Expand Long Template PCR System (Roche) 
was used with primers at 0.3 μM and deoxyribonucleotide triphosphate mix (dNTPs) 
at 350 μM. Conditions for PCR reactions were as followed: initial denaturation step of 
94°C for 3 minutes, followed by an amplification cycle of 94°C for 30s, 55°C for 30s, 
68°C for 1minute/kb repeated 10 times then 95°C for 30s, 58°C for 30s, 68°C for 
1minute/kb plus 5s more than previous cycle repeated 25 times. Subsequently a final 
extension step of 68°C for 10 minutes was used. 
 
2.3.2. Creation of a strain with endogenously mutated TBP (TBP 6KR) for double IP 
 
For the double pull-downs in Figure 5-6, since expression of ectopic TBP alleles 
were much lower than that of endogenous TBP, the signal was undetectable after two 
rounds of purification. Hence, a strain endogenously expressing TBP 6KR was 
created. This was done by replacing the whole endogenous TBP allele with a mutated 
TBP cassette. Figure 2-1 is a schematic representation of the strategy. Briefly, the 
amplification from a plasmid carrying endogenous TBP promoter-driven 3HA-TBP 
6KR yielded the product PCR1, which contained the second half of the promoter and 
the first half of 3HA-TBP with 6KR mutation. The amplification from another strain 
whose native TBP was tagged with a 6HA epitope produced PCR2, which was a 
cassette containing the second half of TBP-6HA (wild-type) followed by a his marker. 
Using PCR1 plus PCR2 as templates generated PCR3, which consists of half of the 
TBP promoter, 3HA-TBP 6KR-6HA and a His gene. PCR3 was transformed into a 
strain where endogenous TBP was C-terminally tagged with 3HA and a 
hygromycin-resistant gene. By the expression of different selection markers and 
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different HA copy numbers, a strain endogenously expressing 3HA-TBP 6KR-6HA 
could be selected. Additionally, a wild-type counterpart was generated to serve as a 
control. By using the same strategy, a PCR3 product carrying a wild-type 
3HA-TBP-6HA allele was produced and was introduced into an HF-Smt3 strain and 
also an Smt3 untagged strain.  
 
 
 
Figure 2-1. The Schematic principle of creating a strain endogenously expressing TBP 6KR for 
double-purification experiments. A PCR amplification from a plasmid carrying a normal TBP 
promoter-driven 3HA-TBP K47R allele produced PCR1, which contained the second half of the 
promoter and the first half of 3HA-TBP allele with the K47R mutation. The amplification from another 
strain whose native TBP was tagged with 6HA produced PCR2, a cassette containing the second half of 
TBP-6HA (wild-type) followed by a his marker. Using PCR1 plus PCR2 as templates generated PCR3, 
which consists of half of the TBP promoter, a complete TBP K47R allele with a 3HA at the N-terminus 
as well as a 6HA at the C-terminus, and a His gene. PCR3 was transformed into a strain where 
endogenous TBP was C-terminally tagged with 3HA and a hygromycin-resistant gene. Colonies which 
had a complete intake and recombination of PCR3 cassettes were His autotrophic, hygromycin 
sensitive, and the size of TBP proteins on a Western Blot gel would correspond to the size of TBP plus 
a 9HA epitope. 
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2.3.3. Yeast transformation  
 
Competent cell preparation 
Cells from an exponentially growing culture in YPD were harvested (3000rpm, 5 
minutes), washed in sterile water followed by SORB solution (100mM LiOAc, 10mM 
Tris-HCl pH8, 1mM EDTA pH8, 1M sorbitol). The cell pellet was resuspended in 
360μl SORB per 50ml culture (Knop et al., 1999). Salmon sperm DNA was denatured 
by incubation at 95℃ for 5 minutes and cooled on ice before being added into a 
competent cell solution to a final concentration of 1mg/ml. Competent cells were 
stored in 50μl aliquots at -80°C until use.  
 
Transformation 
    For transformation of circular plasmids, 0.2μg (usually 1μl from mini or midi 
prep) of plasmids were added into 10μl of competent cells. To transform DNA 
cassettes by homologous recombination, 1μg (usually 10μl) of PCR products were 
used in 50μl of competent cells (Knop et al., 1999). For GeneCust DNA cassette 
carried on integrative plasmids, 5μl of linearised plasmids were mixed with 25μl of 
competent cells. Six volumes of PEG (100mM LiOAc, 10mM Tris-HCl pH8, 1mM 
EDTA pH8, 40% (w/v) PEG-3350) were added and the cell suspension was incubated 
for 30 minutes at room temperature. DMSO was subsequently added to a final 
concentration of 10%, and the cells were incubated at 42°C for 15 minutes. For 
transformants involving introduction of antibiotic selection markers, cells were 
incubated in YPD for around 2h before plating. For auxotrophic selection such as 
URA3 and LEU2, pelleted cells were resuspended in sterile water and plated directly.  
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2.3.4. Colony PCR 
 
Transformant colonies were confirmed by colony PCR. A small amount of cells 
were picked directly from a colony and were resuspended in 25μl Go Taq Flexi DNA 
polymerase (Promega) PCR reaction mix (primers at 0.15μM and dNTP mix at 
300μM). Conditions for PCR reactions were as followed: initial denaturation step of 
95°C for 5 minutes, followed by an amplification cycle of 94°C for 30s, 55°C for 30s, 
72°C for 1minute/kb repeated 40 times. Subsequently a final extension step of 72°C 
for 10 minutes was used.  
2.3.5. Molecular Cloning: DNA digestion, purification from gel, ligation 
 
For subcloning of GeneCust synthetic DNA cassettes from pRS406 to pRS415 or 
pRS405: 
 
DNA digestion 
Restriction enzymes SalI and SacI were employed for cleavage of the DNA 
cassette from pRS406 as well as empty vectors according to the manufacturer‘s 
instructions (New England Biolabs). For the digestion of DNA, an appropriate 
amount of restriction enzymes were used (Based on instructions of New England 
Biolabs: one unit of enzyme is able to digest 1 µg of λ DNA in 1 hour at 37°C in a 
total reaction volume of 50 µl). Reaction samples were incubated at 37°C (for SalI 
and SacI) for at least 1h. To prevent self-ligation, after digestion with restriction 
enzymes, vector DNA was incubated with 10 units of Shrimp Alkaline Phosphatase 
(Promega) for 10 minutes at 65℃ to remove phosphate at both ends.  
 
Purification of DNA from agarose gels 
DNA samples in loading buffer (Promega) were run on 0.8% agarose gels, 
containing 0.5μg/ml ethidium bromide at 100V in TBE buffer. DNA could be 
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visualised using an UV transilluminator (324nm). The DNA fragment was 
subsequently excised from the gel using a clean razor blade. DNA was purified using 
a QIAquick Gel Extraction Kit (Qiagen) according to the manufacturer‘s instructions. 
 
Ligation of DNA cassettes with vectors 
Digested and purified inserts and vectors were ligated using the Rapid DNA 
ligation kit (Roche), according to the manufacturer‘s instructions. Around 15ng of 
vectors were used for 45ng of insert DNA.  
 
2.3.6. Genomic DNA purification 
 
10ml of culture at OD595 0.5 were harvested, washed in PBS and resuspended in 
500 μl of lysis buffer (1% SDS, 100 mM NaCl, 50 mM Tris-HCl pH 8.0, 10 mM 
EDTA. The cell wall was removed by incubation with 40 units/ml Lyticase (Sigma) 
and 1% β-mercaptoethanol (Sigma) at 37°C for 10 min. DNA was then extracted by 
addition of 500 μl of phenol/chloroform/ iso-amylalcohol (25:24:1) to each sample. 
This was mixed with a pipette. The phenol emulsion was transferred to phase lock gel 
tubes (5Prime) and spun down at 12.000 r.p.m. for 5 minutes. The aqueous layer was 
transferred to a fresh eppendorf. DNA was precipitated by addition of 2 volumes of 
100% ethanol followed by a 30-minute 14.000 r.p.m. spin at 4°C. The precipitation 
was washed with 70 % ethanol by a 10-minute 14.000 r.p.m. spin before being 
air-dried and re-solubilised in 10mM Tris pH8.0. 
 
 
 
 
 
 
2.  MATERIALS AND METHODS 
- 68 - 
 
2.4.  Biochemical Methods 
 
2.4.1. Whole cell extract preparation for protein purification 
 
For Western Blot, 10ml of cultures were diluted to OD595 0.25 and grown for 2h 
before harvesting. For pull-down, normally 50ml of cultures were diluted to OD595 
0.2-0.3 depending on their growth rates and grown until OD595 0.5-1.0. Cell pellets 
subject to pull-down were kept cold on ice, washed by ice-cooled water and 
centrifuged at 4°C. For double purification, 200ml of cells at OD595 2 were collected.  
To purify proteins for pull-down assays, cell pellets were resuspended in 
pull-down buffer A (see below section 2.4.2.). For Western Blotting, approximately 
100 μl of RIPA (10 mM sodium phosphate, 150 mM NaCl, 10 mM EDTA, 0.1% SDS, 
1% NP40) together with a similar volume of glass beads were added. Cells were 
broken using a Fastprep machine (MP Biomedicals) for two 20s cycles (power 5.5). 
The base of each eppendorf was pierced twice using a 21-gauge needle. Eppendorfs 
were then inserted into the top of new ones and centrifuged at 2.000 r.p.m. for 2 
minute at 4°C. Samples in the new eppendorf were then further centrifuged at 14.000 
r.p.m. for 10 minutes at 4°C. The supernatant was transferred to a fresh tube. Thirty to 
fifty μg of proteins were usually used for detection.  
 
2.4.2. His Affinity purification (His pull-down) 
 
To isolate His-tagged proteins (Smt3), affinity purification assays were applied. 
The whole process below was performed on ice or at 4°C. Cell pellets were 
resuspended in 200-250μl Buffer A (8M Urea, 100mM NaH2PO4, 10mM Tris-HCl, 
0.05% Tween-20, adjusted to pH8.0), and an equal volume of glass beads were added. 
Cells were broken in a Fastprep machine (power 5.5, 20 sec twice). Cell extracts were 
recovered to another tube by spinning and followed by another 10min full-speed spin. 
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The supernatant with specific concentration of proteins (around 8-20mg of proteins 
were used for most of the case) was recovered and total volume was brought to 1ml 
by addition of Buffer A. To reduce non-specific binding to beads, 20mM of imidazole 
was added before saving 3μl whole cell extract for Western Blot. 50μl of a 50:50 
slurry of Ni-NTA beads (Qiagen) were prepared by washing twice with Buffer A and 
mixing beads with cell extract. Subsequently samples were incubated for 2h at 4°C in 
an orbital roller. The mixtures were subsequently washed carefully (without removing 
beads) three times with 1ml of Buffer A plus 2mM imidazole and five times with 1ml 
Buffer B (8M Urea, 100mM NaH2PO4, 10mM Tris-HCl, 0.05% Tween-20, adjust to 
pH6.3). Finally, proteins were eluted with 16μl 2X loading buffer (0.2M imidazole, 
2X NuPAGE loading buffer, 8% β-mercaptoethanol, water) for 5min at 95°C and 
spun before loading the supernatant into NuPAGE gels. 
 
2.4.3. Double affinity purification  
 
    A double affinity purification includes a His pull-down followed by a FLAG 
pull-down. The His pull-down was performed as described in the previous section 
except that after the last wash of buffer B, the proteins were eluted by 700μl of 
Elution Buffer (EB, 50mM KH2PO4, 50mM K2HPO4, 250mM NaCl, 15mM 
Imidazole, 0.05% Tween-20, pH8) plus 300μl of 1M Imidazole for 10min at 4°C in 
an orbital roller. The mixtures then went through a column, and the flow-through was 
mixed with 30μl of anti-FLAG beads (ANTI-FLAG M2 Affinity Gel, Sigma) which 
had been washed by 1ml of EB for 5min at 4°C three times. The mixtures, with 
addition of protease inhibitor (Roche, cOmplete Protease Inhibitor Cocktail Tablets), 
were incubated at 4°C in an orbital roller for 2h and subsequently washed three to five 
times with 1ml of EB. After the last wash, EB was removed from the mixture by 
2.  MATERIALS AND METHODS 
- 70 - 
 
going through a column. To detach the proteins from beads, beads were incubated in 
25μl of pre-warmed 1X SR (2% SDS, 0.125M Tris-HCl pH7) in the column at 37°C 
for 3min, and the flow-through was collected. Finally, the proteins were eluted with 
1/3 volume (6.67μl) of 4X loading buffer (4X NuPAGE loading buffer, 8% 
β-mercaptoethanol) for 2min at 95°C and spun before loading the supernatant into 
NuPAGE gels.  
 
2.4.4. Western Blotting 
 
To detect the proteins of interest with an epitope tag, Western Blotting was 
applied. For colony check, 10% acrylamide gels (resolving casting solution: 33.3% 
ProtoGel Acrylamide solution (National Diagnostics), 25% ProtoGel Resolving 
Buffer, 0.1% ammonium persulphate, 0.1% N,N,N1,N1 tetramethylethylenediamine 
(TEMED; National Diagnostics); stacking casting solution: 13% ProtoGel 
Acrylamide solution, 25% ProtoGel Stacking Buffer, 0.1% APS, 0.1% TEMED) were 
used with the Bio Rad Mini-PROTEAN 3 system. Stacking gels were run at 60-70V 
and gels were run at 200 V in Trisglycine- SDS running buffer (National Diagnostics). 
For pull-down, the NuPAGE gels (Invitrogen) was used. Pre-cast 4-12% Bis-Tris gels 
and 3-8% Tris-acetate gels were used for separating proteins with lower and higher 
molecular weights, respectively. 4-12% Bis-Tris gels were run in NuPAGE MOPS 
running buffer at 200V, and 3-8% Tris-acetate gels were run in NuPAGE Tris-acetate 
running buffer at 150V. For immunoblotting, anti-c-myc IgG1κ antibody 9E10 
(Roche), anti-HA IgG1 antibody 12CA5 (Roche), and anti-FLAG IgG2 antibody M2 
(Sigma) were used in the ratio of 1:5000, 1:2500 and 1:1000, respectively. The 
secondary antibody, sheep anti-mouse IgG Horseradish Peroxidase-linked antibody 
(GE Healthcare) was used at 1:10000 dilution. For detection of double IP, anti-HA 
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high affinity antibody 3F10 (Roche) was used in the ratio of 1:5000, and the 
secondary antibody, goat anti-rat IgG-HRP (sc-2006, santa cruz) was used at 
0.6:10000 dilution. The membrane was developed by ECL Plus Western Blotting 
Detection System (GE Healthcare). 
 
2.4.5. Measurement of TBP protein half-lives 
 
To measure TBP protein half-lives, ectopic expression of GALS promoter-driven, 
3HA-tagged TBP was induced by galactose for 1.5h following the standard protocol 
(see section 2.1.2). Cells were then switched to media containing glucose to repress 
TBP expression. Degradation rates of TBP proteins were obtained by monitoring the 
reduction of total amount of TBP proteins within 8h. Cells were harvested at indicated 
time points after adding glucose, and TBP proteins were detected by Western Blot 
using an antibody against HA. PGK1 was used as an internal control. Western Blot 
signals were quantified by Adobe Photoshop, and the degradation curves were plotted 
and the half-lives were calculated.  
 
2.4.6. Chromatin immunoprecipitation (ChIP) 
 
This protocol is based on (Nelson et al., 2006). For ChIP analysis, 50ml of 
culture (at OD595~0.5-1) was fixed with formaldehyde (final concentration 1.42%) for 
15 minutes at room temperature. For cross-linking kinetic (CLK) analysis, cells were 
fixed from 5sec to 30min as indicated. 
The formaldehyde was quenched with glycine (final concentration 125mM for 
conventional ChIP and 250mM for CLK) for 5 minutes at room temperature and the 
cells harvested by centrifugation (4000rpm, 2 minutes). The pellet was washed with 
PBS, transferred to a screw cap tube and stored at -80°C. Pellets were resuspended in 
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100μl IP buffer (150mM NaCl, 50mM Tris-HCl (pH 7.5), 5mM EDTA, NP-40 (0.5% 
v/v), Triton X-100 (1.0% v/v)) containing PMSF (final concentration 1mM) and 
Complete protease inhibitor cocktail (Roche), and 500μl glass beads were added. 
Cells were lysed by two 20s cycles, power 6.5 in a Fastprep FP120 (BIO 101) 
machine, with 5 minutes on ice in between cycles. 300μl IP buffer containing PMSF 
and protease inhibitors was then added. Tubes were pierced with a hot needle and 
placed on top of fresh eppendorfs and spun (2000rpm, 2 minutes) to collect lysate 
minus glass beads. Samples were pelleted (13000rpm, 10 minute, 4°C). The nuclear 
pellet was resuspended thoroughly in 1ml IP buffer containing PMSF and protease 
inhibitors. The chromatin was sonicated for 1 hour (15s ON 15s OFF at high power at 
4°C) (Diagenode Biorupter). At this point, sonicated chromatin could be stored at 
-80°C.  
200μl (30% of sample) was taken for IP, and 100μl was taken for the input 
sample. Input DNA was precipitated from the supernatant by the addition of KaOAc 
to a final concentration of 0.3M and 2.75 volumes of ethanol. The mixture was 
incubated at -20°C for 30 minutes, then spun (13000rpm, 5 minutes) at 4℃ and the 
supernatant discarded. 250μl 10% (w/v) Chelex 100 suspension was added to the 
dried pellet and the sample boiled for 20 min. The supernatant was cleaned using the 
PCR purification kit (Qiagen) according to the manufacturer‘s instructions, and the 
DNA eluted in 250μl water. DNA was stored at -20°C.  
α-HA IgG1 antibody 12CA5 (Roche) was added to 200μl chromatin for the IP in 
the ratio of 1:2500, and the samples were incubated in an ultrasonic water bath for 30 
min at 4°C. As a negative control, another 200μl chromatin aliquot was incubated 
under the same condition without antibodies. After clarification (13000rpm, 2 minutes, 
4°C) the supernatant was added to 100μl of a 50:50 slurry of Protein A and Protein G 
beads (Roche), which had been pre-equilibrated in IP buffer. The sample and beads 
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were incubated for 2 hours on a rotating platform at 4°C. The beads were then washed 
4 times in IP buffer, and then 250μl 10% (w/v) Chelex 100 suspension was added and 
the sample boiled for 20 minutes. After spinning down (13000rpm, 1 minute) the 
supernatant was transferred into a fresh tube and stored at -20°C. 
 
2.4.7. Real-time PCR 
 
PCR reactions were performed using the Sensimix NoRef Kit (Quantance). 
Reactions were carried out according to the manufacturer‘s instructions in a total 
volume of 20μl containing either 2μl Input, non-Ab control or IP DNA and 
oligonucleotide primer pairs (final concentration 1.5μM). For CLK, TBP binding was 
examined at the promoter regions of 5S rDNA, 35S rDNA, Act1 and Suf1 genes 
respectively by the primer pair 3-4, 7-8, Act1-4, and Suf1-4 as indicated in Figure 7-2, 
and the signal detected at the HMR was used as background noise control. 
Amplification was performed in a Bio-Rad C1000 thermal cycler in conjunction 
with the Bio-Rad CFX96 Real-time-system and analysed using CFX manager 
(Bio-Rad). The melting curve of each primer pair was analysed to confirm the 
absence of contaminant PCR products.  
 
2.4.8. Quantification of IP signals 
 
For conventional ChIP, the relative occupancy of the immunoprecipitated factor 
(the recovery rate relative to total input DNA) at a locus was estimated using the 
following equation: [2
(CtInput – CtIP)
/2
(CtInput – CtNon-Ab)
]×100%, where CtIP, CtNon-Ab 
and CtInput are mean threshold cycles of PCR done in duplicate respectively on IP 
DNA samples, Chromatin incubated without Ab, and Input. In this equation, the ChIP 
signal was input normalised and shown as the fold increase relative to the background 
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signal from no-antibody controls. For CLK, the equation was amended as followed: 
[(2
–CtIP
-2
–CtNon-Ab
)/2
-CtInput
]×100%. In this equation, the IP signals which had 
subtracted the mock IP signals were normalised to input. The results were presented 
as the percentages of the recovery over the input.  
For conventional ChIP, the background signals from the intergenic regions 
(amplified by primer pair 1 or from HMR) were presented individually rather than 
normalised with IP signals. For CLK, background signals amplified from HMR were 
subtracted from the IP values.  
 
 
2.5  Fluorescence Recovery After Photobleaching (FRAP) 
 
FRAP experiments were carried out on a Leica TCS SP5 confocal microscope 
using a resonance scanner. Cells ectopically expressing N-terminally GFP-conjugated 
TBP WT or TBP 6KR, which were driven by GALS promoters, were imaged at low 
laser intensity (2%) to reduce bleaching caused by imaging. Bleaching was done by 
an argon laser operation at high laser power twice and targeted half of the nucleus. 
Fluorescence recovery image frames were recorded every 18ms. Twenty pre-bleached 
and 300-800 post-bleached images were taken. Images were analysed by Leica LAS 
AF Lite. Intensities of selected regions in the bleached area, the non-bleached area of 
the nucleus, and in background area were quantified, and the final intensity values of 
bleached regions were calibrated by the background and the fluorescence loss from 
imaging process. 
 
 
2.6.  Computational modelling 
 
To obtain a TBP 3D structure with N-terminal domain by computational 
modelling, the sequence of the first 60 amino acids of TBP was submitted to the 
website ―The Protein Model Portal" (http://www.proteinmodelportal.org), and the 
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sequence was subsequently calculated by ModWeb server and M4T server 
(Fernandez-Fuentes et al., 2007a; Fernandez-Fuentes et al., 2007b; Rykunov et al., 
2009). The 3D model obtained from M4T contained TBP C-terminal domain and an 
incomplete N-terminal domain, while that from ModWeb was the structure of TBP 
N-terminus which partially overlapped with the model from M4T. The results from 
these two servers were then combined together by the software UCSF Chimera, and 
the six lysine residues in the N-terminal domain were labelled. 
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3. Results: Identification of Novel SUMO Substrates 
 
 
 
CHAPTER 3 
 
 
IDENTIFICATION OF 
NOVEL SUMO SUBSTRATES 
 
 
 
3.1.  Aims 
 
․ To confirm potential SUMO substrates identified in a large-scale proteomic screen 
․To identify suitable SUMO substrates for further investigation 
 
 
3.2.  Approach: examination of SUMOylation of 10 potential SUMO 
substrates by affinity purification 
 
The work from a previous PhD student in the Aragon laboratory identified a list 
of potential SUMO substrates. However, the screen was done through proteomic 
analysis using large-scale purification of SUMOylated proteins from Saccharomyces 
cerevisiae cells cultured in the presence and absence of DNA damage caused by 
methyl methanesulfonate (MMS). While the proteomic identification of substrates 
provided me with a list of potential substrates, further experimental validation of the 
proteomic results were needed in order to confirm that the identified proteins are 
indeed SUMOylated.  
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The following ten proteins were selected from the proteomic screen for 
experimental validation; Scc2, Mtw1, Sir3, Sir4, Tfb2, Hmo1, TBP, Mcm5, Rrm3 and 
Pds5. A summary of their known functions and potential information relating these 
proteins to the SUMO pathway is shown in Table 3-1.  
 
 
Table 3-1. Proteins under investigation by SUMO pull-down assay 
Protein Description 
Interaction with 
Smt3/Ubc9 
Reference 
Scc2 
Subunit of cohesin loading 
factor 
-  
(Ciosk et al., 2000; 
Ström et al., 2004) 
Mcm5 
Component of the hexameric 
MCM complex; important for 
initiation of DNA replication 
and elongation 
-  (Tye, 1999) 
Rrm3 DNA helicase -  
(Ivessa et al., 2000; 
Makovets et al., 2004) 
Mtw1 
Essential kinetochore 
component 
- 
(Goshima and 
Yanagida, 2000) 
Pds5 
Essential protein required for 
chromatid cohesion and 
condensation 
+ (Stead et al., 2003) (Hartman et al., 2000) 
Sir3 Silencing protein 
+ (Wohlschlegel et al., 
2004) 
(Aparicio et al., 1991) 
Sir4 Silencing protein 
+ (Wohlschlegel et al., 
2004) 
(Aparicio et al., 1991) 
Tfb2 
Subunit of TFIIH and 
nucleotide excision repair 
factor 3 complexes, involved in 
transcription initiation 
- (Feaver et al., 1997) 
Hmo1 
Chromatin associated high 
mobility group (HMG) family 
member; participates in 
transcription of rDNA 
+ (Yu et al., 2008; Zhou 
et al., 2004) 
(Merz et al., 2008) 
TBP 
Essential general transcription 
factor recognizing TATA box 
+ (Wohlschlegel et al., 
2004) 
(Cormack and Struhl, 
1992) 
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    To validate the proteins as bona fide SUMO substrates, the following 
experimental approach was taken. Yeast strains were generated where the proteins of 
interest were individually tagged with either 9myc or 3HA epitopes. In addition to the 
strains carried 6His-FLAG-Smt3 (SUMO gene tagged with a 6His-FLAG), strains 
where Smt3 was not tagged were used as a control.  
Pull-downs were performed against the 6His epitope on Smt3. Experiments were 
carried out in the presence and absence of DNA damage (DNA damage was induced 
by incubation in 0.1% MMS for 1h). Whole cell extracts and immunoprecipitates 
were assayed by western blotting using antibodies against the epitopes in the proteins 
of interest (myc or HA). 
 
 
3.3.  Confirmation of potential SUMO targets 
     
    The pull-down analysis confirmed that Mtw1, Pds5, Sir3, Sir4, Tfb2, Hmo1 and 
TBP are SUMOylated (Fig. 3-4 to Fig.3-10), and the SUMOylated forms of Scc2, 
Mcm5 and Rrm3 were not detected (Fig. 3-1 to Fig.3-3). Notably, Rrm3 seemed to be 
modified upon incubation with MMS (Fig.3-3). Scc2, together with Scc4, facilitates 
the loading of cohesin complex and is required for DNA repair (Ciosk et al., 2000; 
Ström et al., 2004). Mcm5 is a subunit of MCM complex involved in DNA replication 
initiation and elongation (Tye, 1999). Both Scc2 and Mcm5 were not SUMOylated in 
the experiments (Fig.3-1 and Fig.3-2). Rrm3 is a helicase promoting progression of 
replication forks (Ivessa et al., 2000). Although Rrm3 was not modified by SUMO in 
cells cultured under normal conditions, it appeared to be modified upon DNA damage 
as a slightly slower migrating band was observed on SDS-PAGE gels (Fig.3-3). Since 
the molecular weight of Smt3 is 11.6 kDa, this modification was too small to be 
caused by SUMO conjugation. The slight alteration in mobility is likely due to 
phosphorylation, suggesting Rrm3 might be phosphorylated upon DNA damage.  
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Mtw1 is a subunit of the MIND complex, which acts as an essential scaffold for 
kinetochore assembly (De Wulf et al., 2003). A ladder of His-Smt3-dependent bands 
were observed in IPs of asynchronously grown cells or after addition of MMS 
(Fig.3-4). DNA damage appeared to have little effect on the level of Mtw1 
SUMOylation as the difference between the cells with or without MMS was 
indistinguishable.   
Pds5 cooperates with the cohesin complex in the establishment and maintenance 
of sister chromatid cohesion (Hartman et al., 2000). Three His-Smt3-dependent bands 
were observed (Fig.3-5), indicating that Pds5 is a SUMO target. Importantly, this 
pattern was not affected by DNA damage.  
Sir3 and Sir4 form a silencing complex with Sir2 to maintain and spread 
silencing state in mating-type loci and telomeres (Aparicio et al., 1991). SUMO 
conjugation was observed for both Sir3 and Sir4 in asynchronous cells. Treatment 
with MMS led to pronounced SUMOylation on Sir3 and Sir4 (Fig.3-6, 3-7).  
 
 
Figure 3-1. Scc2 is not SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Scc2 was C-terminally tagged with 9myc in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Scc2 was detected by antibodies against myc. For comparison, 
the whole cell extract without purification is also shown. 8mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 24μg. The unmodified form of Scc2 is 
pointed by a red arrow.  
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Figure 3-2. Mcm5 is not SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Mcm5 was C-terminally tagged with 3HA in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Mcm5 was detected by antibodies against HA. For comparison, 
the whole cell extract without purification is also shown. 18mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 54μg. The unmodified form of Mcm5 is 
pointed by a red arrow.  
 
 
Figure 3-3. Rrm3 is not SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Rrm3 was C-terminally tagged with 9myc in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Rrm3 was detected by antibodies against myc. For comparison, 
the whole cell extract without purification is also shown. 26mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 78μg. The unmodified form of Rrm3 is 
pointed by a dashed red arrow.  
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Figure 3-4. Mtw1 is SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Mtw1 was C-terminally tagged with 9myc in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Mtw1 was detected by antibodies against myc. For comparison, 
the whole cell extract without purification is also shown. 23mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 69μg. The unmodified form of Mtw1 is 
pointed by an arrow, and SUMOylated forms are marked with arrow heads.  
 
 
 
Figure 3-5. Pds5 is highly SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Pds5 was C-terminally tagged with 9myc in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Pds5 was detected by antibodies against myc. For comparison, 
the whole cell extract without purification is also shown. 8mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 24μg. The unmodified form of Pds5 is 
pointed by an arrow, and SUMOylated forms are marked with arrow heads.  
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Figure 3-6. SUMOylation of Sir3 occurs in cells cultured under normal condition and is enhanced 
by MMS treatment. Endogenous Sir3 was C-terminally tagged with 9myc in yeast strains either with 
or without 6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For 
MMS-treated cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were 
subsequently purified by pull-down via His tag and Sir3 was detected by antibodies against myc. For 
comparison, the whole cell extract without purification is also shown. 30mg of proteins were used for 
purification, and the protein concentration of the whole cell extract was 90μg. The unmodified form of 
Sir3 is pointed by an arrow, and SUMOylated forms are marked with arrow heads.  
 
 
 
Figure 3-7. SUMOylation of Sir4 occurs in cells cultured under normal condition and is enhanced 
by MMS treatment. Endogenous Sir4 was C-terminally tagged with 9myc in yeast strains either with 
or without 6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For 
MMS-treated cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were 
subsequently purified by pull-down via His tag and Sir4 was detected by antibodies against myc. For 
comparison, the whole cell extract without purification is also shown. 30mg of proteins were used for 
purification, and the protein concentration of the whole cell extract was 90μg. The unmodified form of 
Sir4 is pointed by an arrow, and SUMOylated forms are marked with arrow heads.  
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Tfb2 is a subunit of transcription complex TFIIH, and it participates in 
nucleotide excision repair (Feaver et al., 1997). As shown in Fig.3-8, a single faint 
His-Smt3-dependent band of Tfb2 was observed in untreated cells. Tfb2 modified 
forms were greatly enhanced by DNA damage.  
Hmo1 belongs to the high mobility group (HMG) family of proteins which is 
involved in genome maintenance and RNA Pol I transcription at rDNA (Gadal et al., 
2002; Lu et al., 1996). The pull-down experiment showed two His-Smt3-dependent 
bands in both asynchronous and MMS-treated cells (Fig.3-9).  
TBP is the TATA-binding protein required for transcription initiation mediated 
by RNA Pol I, Pol II and Pol III (Cormack and Struhl, 1992). Purification of 
His-Smt3 species gave rise to a single strong TBP band and several weaker bands 
(Fig.3-10). DNA damage had a limited effect.  
 
 
 
Figure 3-8. SUMOylation of Tfb2 occurs in cells cultured under normal condition and is 
enhanced by MMS treatment. Endogenous Tfb2 was C-terminally tagged with 9myc in yeast strains 
either with or without 6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. 
For MMS-treated cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins 
were subsequently purified by pull-down via His tag and Tfb2 was detected by antibodies against myc. 
For comparison, the whole cell extract without purification is also shown. 8mg of proteins were used 
for purification, and the protein concentration of the whole cell extract was 24μg. The unmodified form 
of Tfb2 is pointed by an arrow, and SUMOylated forms are marked with arrow heads.  
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Figure 3-9. Hmo1 is SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous Hmo1 was C-terminally tagged with 9myc in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and Hmo1 was detected by antibodies against myc. For comparison, 
the whole cell extract without purification is also shown. 8mg of proteins were used for purification, 
and the protein concentration of the whole cell extract was 24μg. The position of Hmo1‘s unmodified 
form is pointed by an arrow, and the SUMOylated forms are marked with arrow heads.  
 
 
 
 
Figure 3-10. TBP is SUMOylated in either untreated or MMS-treated budding yeast cells. 
Endogenous TBP was C-terminally tagged with 3HA in yeast strains either with or without 
6His-FLAG tag on native Smt3. Cells were cultured in YPD until O.D.595 0.5-1.0. For MMS-treated 
cells, 0.1% MMS was added 1h prior to harvesting. Cellular SUMOylated proteins were subsequently 
purified by pull-down via His tag and TBP was detected by antibodies against HA. For comparison, the 
whole cell extract without purification is also shown. 18mg of proteins were used for purification, and 
the protein concentration of the whole cell extract was 54μg. The unmodified form of TBP is pointed 
by an arrow, and potentially SUMOylated forms are marked with arrow heads.  
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3.4.  TBP (TATA-binding protein) was selected as the target for further 
investigation 
     
Amongst 10 proteins examined, TBP, Mtw1, Pds5, Sir3, Sir4, Tfb2, and Hmo1 
were confirmed to show bands dependent on His-Smt3 in my pull-down experiments. 
These potentially represent SUMOylated forms of the proteins. To further investigate 
the potential function of SUMOylation in these proteins, the most ideal target was 
chosen from these seven proteins by a number of criteria (Table 3-2). First, the 
number of lysine residues the protein contained. SUMO modifies the substrate via 
lysine. Therefore, more lysine residues represent more potential SUMO-modified 
sites, and our previous lab experience suggests that this enhances the likelihood of 
redundancy between the different sites. This also increases the difficulties in the 
subsequent mapping of SUMO sites. Under this criterion, Sir3, Pds5, and Sir4, which 
contained near 100 lysine residues or more, were filtered out. This left TBP, Tfb2, 
Hmo1 and Mtw1 as potential candidates (Table 3-2). The second criterion was the 
number of His-Smt3-dependent bands shown in the pull-downs. Greater number of 
bands increased number of potential SUMO sites. However, the four proteins showed 
similar number of His-Smt3-dependent bands. The next criterion was the cellular 
abundance as well as the level of His-Smt3-dependent modifications. As 
SUMO-conjugated forms represent only a small proportion of the whole population, 
abundant proteins with a higher level of His-Smt3-dependent bands in the pull-downs 
should be easier to be analysed in future experiments. The last criterion was the 
functional importance of the protein. Combining these two selection criteria, TBP 
appeared to be the most ideal target. It has high cellular abundance and an essential 
role in transcription. The information of all 10 protein candidates can be found in 
Table 3-2.  
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Table 3-2. SUMO-relevant information of protein candidates 
Protein SUMOylation 
Cellular 
Abundance 
(molecule/cell)* 
Number of 
Lys** 
Number of 
Bands*** 
TBP V**** 20000 22 3 
Tfb2 V 8900 42 1-3 
Hmo1 V 19000 34 2 
Mtw1 V 2610 32 3 
Sir3 V 1400 94 2-3 
Pds5 V 7720 >100 3 
Sir4 V N/A >100 3-4 
Scc2 X****    
Mcm5 X    
Rrm3 X    
* Proteins with higher cellular abundance make the SUMO-modified population, which is the minority, 
easier to be detected. 
** Lysine residues are SUMO-targeted sites. More Lys residues means more potential SUMO sites, 
which are often redundant, and makes the following work for identifying SUMO sites more difficult.  
*** More SUMO bands increases the likelihood of more SUMO sites.  
**** V indicates that the SUMO band was observed; X indicates that no SUMOylation was found 
 
 
TBP is a highly conserved basal transcription factor among all eukaryotes and 
Archaea. As one of the first factors recruited to the core promoter, TBP facilitates 
transcription initiation by anchoring to the DNA templates and facilitating the 
assembly of other components of the transcription apparatus. TBP was first 
recognised as a DNA-binding protein associated with the TATA box elements. It is 
now known to be involved in transcription events driven by both TATA-containing 
and TATA-less promoters (Pugh and Tjian, 1991; Tora and Timmers, 2010). 
Moreover, the requirement of TBP for cell viability and for transcription mediated by 
all three RNA polymerases reveals that it plays a central role in the basic biological 
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processes (Cormack and Struhl, 1992). TBP is an abundant protein which consists of 
240 amino acids including 22 lysine residues. Collectively, I decided to choose TBP 
for further study.  
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4. Results: SUMOylation of TBP 
 
 
 
CHAPTER 4 
 
 
SUMOylation of TBP 
 
 
 
4.1.  Aims 
 
․ To confirm the SUMOylation of TBP 
 
 
4.2.  Specific purification of SUMOylated TBP : optimisation of 
pull-down conditions 
 
The isolation of TBP through the His pull-down assays showed a ladder of bands 
above the unmodified TBP which were correlated with the presence of His epitope on 
Smt3 (Fig. 3-10). However, unmodified TBP was also immunoprecipitated 
independently of the presence of the His tag, which suggested nonspecific binding to 
beads. Therefore, it is also possible that those higher molecular weight bands 
correspond to other post-translational modifications dependent on the His epitope on 
Smt3. In order to verify that TBP is SUMOylated, I aimed to seek alternative proof.  
The Ni-beads pull-down takes advantage of the affinity between the His epitope 
and the beads. During the experiment, Imidazole, which mimics the His epitope and 
therefore competes with the binding to the Ni-beads, is added to reduce non-specific 
binding. To reduce the copurification of unmodified TBP which did not carry a His 
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tag, a more stringent condition was used. Generally, 20mM of Imidazole is added 
when incubating the samples with Ni beads, and 200mM is sufficient to elute all the 
bead-bound proteins. To search for the ideal concentration of Imidazole, so that 
non-specific binding of unmodified TBP can be eliminated, six concentrations in the 
range between 0 to 150mM were tested. As can be seen in Figure 4-1, the 
His-Smt3-dependent conjugates were enriched the highest when 20mM of Imidazole 
was used. The amount of His-Smt3-specific bands was lower when Imidazole was 
doubled, which was similar to the amount obtained when no Imidazole was added. 
Above (and including) 70mM of Imidazole, no His-Smt3-dependent modified forms 
remained after the purification. Strikingly, the unmodified TBP was still present when 
150mM of Imidazole, which was the highest concentration tested, was used, even 
though the His-Smt3-dependent bands were lost at concentrations far below 150mM. 
This indicates that the affinity of unmodified TBP to the Ni beads is higher than the 
affinity between the His epitopes and the beads. Therefore, I ruled out the use of 
increasing Imidazole concentration to test whether the His-Smt3-dependent bands 
were caused by TBP SUMOylation.  
 
 
 
Figure 4-1. High affinity of unmodified TBP to Ni-beads. Endogenous TBP was C-terminally 
tagged with a 3HA epitope in a yeast strain with a 6His-FLAG tag on native Smt3. Proteins were 
purified by pull-down against His tag and TBP was detected by antibodies against HA. Six different 
concentrations of imidazole from 0-150 mM were used. The whole cell extract without purification is 
also shown. 
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4.3.  Sequential purification with nickel column and α-FLAG 
antibodies 
 
An alternative approach was used to test TBP SUMOylation. The Smt3 His- 
tagged allele carried a FLAG epitope in addition to the 6His tag. Therefore, sequential 
pull-down with His and FLAG were used to test whether TBP is SUMOylated. 
To this end, the elution of the proteins from the His pull-down was subject to 
another purification against the FLAG epitope. In this experiment, a strain containing 
TBP tagged with 3HA and untagged Smt3 was used as a control. Additionally, the 
parent strain without any tagging was included. After double purification, the 
unmodified TBP band disappeared (Fig. 4-2, the left panel). Although the signal is 
lower than that in single purifications, a clear higher molecular weight band can be 
observed in the HF-Smt3 sample (lane 1) but not in the other controls, indicating that 
TBP is SUMOylated. Lower molecular weight bands shown in all pull-down samples 
were α-FLAG antibodies which detached from the beads during the elution step and 
were subsequently recognised by the secondary antibodies in the western blotting.  
Overall, this result confirms that TBP is indeed SUMOylated.  
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Figure 4-2. Double purifications demonstrate that TBP is SUMOylated. Endogenously expressed 
TBP-3HA in a 6His-FLAG-Smt3 strain was purified by a pull-down against His followed by a 
pull-down against FLAG. A high molecular weight band which correlated to SUMO conjugates was 
shown in this strain but not in an Smt3 untagged strain or in a completely untagged parent strain. The 
non-specific binding of the unmodified TBP (refers its position to the whole cell extract) was 
completely eliminated after two rounds of purifications. A non-specific band above the SUMO band 
was shown in all strains, and the FLAG antibodies which dissociated from the beads during the eluting 
step was coreactive with the secondary antibodies of the HA epitope. 
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5. Results: Mapping of TBP SUMO Sites 
 
 
 
CHAPTER 5 
 
 
Mapping of tbp sumo sites 
 
 
 
5.1.  Aims 
 
․ To identify the SUMO accepting lysine residues on TBP 
․ To analyse the location of SUMO accepting sites on TBP structure  
 
 
5.2.  The prediction of potential TBP SUMO sites: K47 
 
TBP SUMOylation pattern shows that TBP has a main lysine residue 
SUMOylated as well as some secondary sites (Fig. 4-2).  
A previous PhD student developed a strategy to identify putative 
SUMO-accepting lysines by mass spectrometry. The data from two independent 
experiments showed that TBP K47 is a potential SUMO site. To validate this result, I 
examined whether TBP was SUMOylated when K47 was mutated to the 
non-SUMOylatable aa arginine (TBP K47R).  
I used a strain DF5a, which carried several mutant marker alleles, to tag Smt3 
with 6His-FLAG. Several transformants were selected and tested for expression (Fig. 
5-1).  
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To test whether mutations of TBP lysine 47 prevented SUMOylation, I used 
GAL expressed TBP WT and TBP KallR (where all lysines on TBP were substituted 
by R) as controls. I inserted a synthesised TBP K47R allele carried on an integrative 
plasmid (GeneCust Europe, Dudelange, Luxembourg) into the strain DF5a. This TBP 
allele is N-terminally tagged with 3HA and is driven by a GALS promoter. As shown 
in Figure 5-2, no SUMO conjugates can be observed in TBP KallR. On the other hand, 
TBP K47R was still SUMOylated, and its SUMOylation was comparable to that of 
the wildtype. 
 
 
 
Figure 5-1. Confirmation of the presence of 6His-FLAG cassette on Smt3 in selected 
transformants. To create Smt3-tagged strain with correct genetic background, the 6His-FLAF-Smt3 
cassette was amplified from CCG4620 and introduced into CCG3144. Cellular SUMO proteins, either 
free molecules (6His-FLAF-Smt3, 16kDa, indicated by arrow) or those conjugated with substrates (the 
smear showed by green line), were purified by pull-down via His tag and Smt3 was detected by 
antibodies against FLAG. The 6His-FLAF-Smt3 tagged strain (CCG4620, HZY1017 background) used 
in previous experiments served as a positive control, while the parent strain (CCG3144, DF5a 
background) without tagging served as a negative control. Eight of the nine tested colonies showed 
positive results, and the new 6His-FLAF-Smt3 tagged strain was selected from them. 
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5.3.  The prediction of potential TBP SUMO sites: K35, K47, K97, K127 
 
My results showed that in addition to or alternative to K47, other SUMO 
conjugating sites must exist in TBP. During mass spectrometry analyses, K47 was 
identified as a potential SUMO site of TBP. However, K35 and K97 were also 
identified. In addition, the SUMOylation site prediction programme SUMOsp 2.0 
revealed that K127 lied in the consensus SUMO-accepting sequence ΨKXE, where Ψ 
is a large hydrophobic amino acid; K is the lysine residue modified by SUMO; X is 
any residue; E is a glutamic acid (Johnson, 2004). Collectively, K35, K47, K97 and 
K127 were potential SUMO accepting sites amongst 22 lysines of TBP. Therefore, I 
sought to examine the SUMOylation of TBP when these four lysines were mutated.  
 
 
 
Figure 5-2. The His pull-down shows that TBP K47R is SUMOylated. The GALS promoter-driven 
TBP WT, TBP K47R, or TBP KallR (all Lys were mutated to Arg) with an N-terminal 3HA epitope 
were expressed in a strain possessing 6His-FLAG tag on native Smt3 (HF-Smt3) on integrative 
plasmids. The expressions of these ectopic TBP alleles were induced by addition of galactose for 2h. 
Cellular SUMOylated proteins were purified by pull-down against the His epitope and TBP was 
detected by antibodies against HA. TBP KallR was used as a non-SUMOylatable negative control, 
while wild-type TBP served as a positive control. The whole cell extract without purification was also 
shown. Unmodified TBP is pointed by an arrow, and SUMOylated forms are marked with arrow heads. 
 
To this end, an ectopic 3HA tagged TBP K35, 47, 97, 127R expressed by the 
GALS promoter (synthesised by GeneCust) was expressed in a HF-Smt3 strain, and 
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its SUMOylation was checked by a pull-down assay against the His epitope. Although 
the GALS promoter was moderately leaky without galactose induction (Fig. 5-3, 
WCE in the left panel), overexpression of TBP did not affect the cell viability (Fig. 
5-4). As shown in Figure 5-3, the pattern of SUMO bands in TBP K35, 47, 97, 127R 
is comparable to the endogenous TBP (lane 1) or ectopic TBP WT (lane 3), indicating 
that TBP is still SUMOylated in the absence of lysine 35, 47, 97 and 127.  
 
 
Figure 5-3. Mutation of K35, K47, K97, and K127 did not abolish TBP SUMOylation. Either 
wild-type TBP or TBP K35, 47, 97, 127R mutant (Lys 35, 47, 97, 12 on TBP were all mutated to Arg) 
with 3HA tag on N-terminus was driven by GALS promoter, and the entire cassette was carried by 
integrative plasmids which were inserted into URA3 gene locus of the strain possessing 6His-FLAG 
tag on native Smt3 (HF-Smt3). The expression of ectopic TBP WT or TBP K35, 47, 97, 127R was 
induced or repressed respectively by addition of galactose 2h prior cell harvesting or by growing cells 
in the media with glucose. Cellular SUMOylated proteins were subsequently purified by pull-down via 
His tag and TBP was detected by antibodies against HA. For comparison, whole cell extract without 
purification is also shown. Expression and SUMOylation of endogenous TBP with N-terminal 3HA tag 
in previous HF-Smt3 strain (HZY1017 background, lane 1) and the new HF-Smt3 strain used in this 
experiment (DF5a background, lane 2) were tested in parallel. Unmodified form of TBP is pointed by 
an arrow, and SUMOylated forms are marked with arrow heads. 
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Figure 5-4. Overexpression of ectopic wild-type or mutated TBP which were regulated by GALS 
promoters did not show defect in cell viability. A subset of GALS-mediated wild-type and 
Lys-mutated TBP versions carried on integrative plasmids were inserted into new HF-Smt3 strain with 
DF5a background. To understand the effect of overexpressing these additional copies of TBP, wildtype 
as well as three selected mutated TBP (covered by red line) including TBP KallR (all Lys residues 
were mutated to Arg), TBP KallR, R47K (all Lys residues except K47 were mutated to Arg, and K47 
resides in TBP N-terminal domain), TBP KallR, R211K (all Lys residues except K211 were mutated to 
Arg, and K211 resides in TBP C-terminal domain). In parallel, wild-type parent strain without any 
tagging (covered by blue line) was tested and served as an isogenic control. To do a drop assay, cells 
freshly growing on YPD plates were picked out and 10-fold serially diluted in water. They were 
subsequently dropped on repressed YPD plate or induced galactose-containing medium. Five drops 
were taken for each strain, and the first drop starting from the right contained approximately 2×107 
cells, with 10-fold dilutions in each subsequent drop toward the left. Plates were growing at 30℃ for 
2-3 days before the image was taken.  
 
 
 
5.4.  Mapping TBP SUMO sites: A newly identification of TBP SUMO 
regions 
 
    Since all the efforts mentioned above failed to fully identify TBP SUMO sites, I 
decided to examine the intrinsic accessibility of all TBP lysines to SUMO 
modification individually. TBP has 22 lysine residues. To examine them one by one, 
21 out of 22 lysines were mutated to arginine, leaving only one lysine present at a 
time. Hence, twenty-two KallR RXK mutant proteins (X indicates the position of the 
only lysine residue in TBP peptide) were tested. These TBP mutants were constructed 
by the same strategy as mentioned above. In the pull-downs, cells expressing ectopic 
wild-type TBP or TBP KallR mutant were used as positive and the negative controls, 
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respectively. A complete mapping result is shown in Appendix I. The TBP KallR 
mutant showed no SUMOylation as expected (Appendix I, Fig. A, lane 2). Its 
overexpression did not affect the cell growth viability (Fig. 5-4). Amongst 22 lysines, 
six of them appear to be SUMOylated when present as the sole lysine residue in TBP. 
These included K8, 11, 15, 35, 47 and 55. Notably, they are the first six lysines in the 
N-terminal region of TBP. Furthermore, they are the only six lysines residing in the 
N-terminal domain.  
To verify that lysine 8, 11, 15, 35, 47 and 55 were the only SUMO-accepting 
sites present in TBP, I next checked whether TBP was SUMOylated in the absence of 
these six lysines. To this aim, a strain bearing TBP K8, 11, 15, 35, 47, 55R (TBP 6KR) 
was generated, and its SUMOylation was examined by a pull-down assay against the 
His epitope. As shown in Figure 5-5, SUMOylation of TBP 6KR is entirely abolished. 
To further confirm the finding that TBP 6KR is not SUMOylated, I performed 
double pull-downs. Expectedly, a His pull-down followed by a FLAG pull-down 
contributed to a strong high molecular weight band and two weaker bands above it in 
the wild-type TBP strain but not in the TBP 6KR or the Smt3 untagged control (Fig. 
5-6). Therefore, I conclude that TBP 6KR is not SUMOylated.  
 
 Overall, these experiments demonstrate that TBP has six lysines modified by 
SUMO. Importantly, instead of randomly distributed, all the SUMO sites concentrate 
within a limited area at the N-terminal end, creating a previously unidentified ―SUMO 
surface‖ on TBP, and removing all the lysines in the TBP N-terminal domain is 
enough to create a SUMO-deficient TBP mutant. 
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Figure 5-5. Mutation of K8, K11, K15, K35, K47 and K55 together abolishes 
SUMOylation of TBP- by His pull-down. K8, K11, K15, K35, K47 and K55 of TBP were 
all mutated to arginine (lane 3), and its SUMOylation status was examined. TBP KallR was 
used as a non-SUMOylatable negative control (lane 2), while wild-type TBP (lane 1) served 
as a positive control. These TBP constructs, with N-terminal 3HA tag, were driven by GALS 
promoters and inserted into LEU2 locus of a HF-Smt3 strain. To induce their expression, 
galactose was added 2h prior to cell harvesting. Cellular SUMOylated proteins were 
subsequently purified by pull-down via His tag and TBP was detected by antibodies against 
HA. For comparison, whole cell extract without purification was also shown. Unmodified 
form of TBP is pointed by an arrow, and SUMOylated forms are marked with arrow heads. 
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Figure 5-6. Double purifications demonstrate that TBP 6KR is not SUMOylated. 
Endogenously expressed 3HA-TBP WT-6HA or 3HA-TBP 6KR-6HA in a 6His-FLAG-Smt3 
strain was purified by a pull-down against His followed by a pull-down against FLAG. A 
ladder of higher molecular weight bands which correlated to the SUMO conjugates were 
detected in TBP WT but not in 6KR mutant whose K8, K11, K15, K35, K47 and K55 were 
all mutated. Since the unmodified TBP bands were present only in the Smt3-tagged strains, 
the unmodified TBP proteins detected were originally SUMOylated but lost SUMO during or 
after purifications. The FLAG antibodies which dissociated from the beads during the eluting 
step was coreactive with the secondary antibodies of the HA epitope. 
 
 
 
 
5.5.  The locations of the six SUMO sites in the TBP structure 
 
It is well known that TBP C-terminal domain, constituted by 180 aa, adopts a 
saddle-like structure (Fig. 1-5A). Nonetheless, the structure of the N-terminal domain 
which contains 60 aa has not yet been resolved. This is because that the crystal 
structure of TBP cannot be formed in the presence of N-terminal domain (Chasman et 
al., 1993).  
Since the function of a protein motif/domain and its steric positions in the whole 
structure is sometimes correlated, I decided to attempt a 3D potential structure of the 
N-terminal domain as well as the location of the six lysine residues that can be 
SUMOylated. By the computational reconstruction, a 3D model of TBP N-terminal 
domain was combined with the saddle-like C-terminal domain (Figure 5-7). In this 
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model, the N-terminal domain is displayed as a bent tail extending beyond the saddle. 
Noticeably, a part of the TBP N-terminal domain goes down through the concave side 
of the C-terminal saddle. Apart from K47, five of the six SUMO-modified lysine 
residues are situated on this tail. Remarkably, K47 localises right beneath 
DNA-binding surface of TBP. It is conceivable to speculate that addition of SUMO at 
this position might affect TBP interaction with DNA. 
 
 
 
Figure 5-7. A computational model of TBP N-terminal domain with the known structure for the 
C-terminal domain. The snapshots from different angles are displayed. The saddle-like lower part is 
the C-terminal domain, and the upper part with triangle shape is the N-terminal domain. A DNA helix 
protrudes through the concave side of the saddle (not shown). The aa K47, which is pointed by an 
arrow, localises at the N-terminal domain which extends into the DNA-binding region.  
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CHAPTER 6 
 
 
Functional significance -  
TBP protein stability 
 
 
 
6.1.  Aims 
 
․ To investigate whether the SUMOylation affects TBP protein stability  
 
 
6.2.  Quantification of the protein half-lives of TBP WT and TBP 6KR  
 
    SUMOylation and ubiquitylation are tightly correlated (Praefcke et al., 2012). 
Since ubiquitylation often leads to degradation, if SUMOylation of TBP is linked to 
ubiquitylation of the protein, the modification (SUMO) could be indirectly related to 
TBP protein stability. To clarify whether blocking the SUMOylation of TBP altered 
its protein stability, TBP protein half-lives of 3HA-tagged TBP WT and TBP 6KR 
driven by GALS promoter were quantified (Fig. 6-1).  
To measure the half-lives of TBP, cells were grown in YP with galactose for 
1.5h to induce the expression of TBP WT or TBP 6KR and were subsequently 
transferred to media containing glucose to turn off the transcription of TBP. The 
degradation rates of TBP proteins were monitored by collecting cells at the indicated 
time points within 8h after they were transferred to glucose. The cellular amount of 
6.  RESULTS: Functional Significance- TBP Protein Stability 
- 102 - 
 
either TBP WT or 6KR was detected by Western Blotting, and PGK1 was used as an 
internal control. As shown in Figure 6-1A, TBP WT had a protein half-life of 
142.83±12.21min. This value was more than double in the TBP 6KR mutant, whose 
protein half-life was 365±90.98min (Fig. 6-1B), indicating that the protein stability of 
TBP SUMO-deficient mutant was largely increased.  
 
 
 
Figure 6-1. The protein half-lives of TBP WT and TBP 6KR. (A). The representative images of 
TBP protein stability examined by Western Blot. The expression of the ectopic 3HA-tagged TBP WT 
or TBP 6KR, which was driven by the GALS promoter, was induced by galactose for 1.5h, followed by 
the addition of glucose to turn off the GAL promoters. TBP protein half-lives were measured by 
collecting the cells at the indicated time points within 8h after switching off the GAL promoters. PGK1 
is an internal control for quantifying TBP half-lives. TBP and PGK1 were detected by antibodies 
against HA epitopes and PGK1 respectively. (B). A bar graph comparing the protein half-lives of TBP 
WT and TBP 6KR. The error bars represent the standard deviations of three independent experiments.  
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6.3.  Examining protein stabilities of TBP WT and SUMO mutants 
under the physiological condition 
 
    The result demonstrates that SUMOylation of TBP affects the degradation of 
TBP. This was done using over-expression from a copy which was driven by the 
galactose promoter. To ensure that over-expression did not skew the result, I used 
pulse-chase approach with cycloheximide, an inhibitor of protein synthesis which 
interferes the translation elongation step, to block the synthesis of TBP. Since K47 
was a prominent SUMO site on TBP, TBP K47R (only K47 is mutated) was included 
in this experiment.  
Strains expressing ectopic TBP WT, TBP 6KR or TBP K47R tagged with 3HA 
epitopes and expressed from endogenous TBP promoters were used. Exponentially 
growing cultures were treated with cycloheximide, and cells were collected every 30 
min after incubating with cycloheximide for 3h. As a control, cells were incubated 
with DMSO (the solvent of cycloheximide solution). The stability of TBP proteins 
was monitored by Western Blotting against the 3HA epitope. Since the effects of 
cycloheximide are systemic, PGK1, a long-lived protein, served as a reference.  
Consistent with the previous findings, TBP WT was almost undetectable at 3h 
after cycloheximide addition, while the level of TBP 6KR at this time point was 
similar to its original T0 level, and the DMSO counterparts of both TBP variants did 
not show any sign of degradation (Fig. 6-2). This supports the conclusion that 
SUMO-deficient TBP has higher protein stability. In contrast to the highly stable 6KR, 
the degradation of TBP K47R was clearly observed after adding cycloheximide, 
although its degradation was reduced compared to WT.  
 
 
6.  RESULTS: Functional Significance- TBP Protein Stability 
- 104 - 
 
 
 
Figure 6-2. The protein degradation of TBP WT, TBP 6KR and TBP K47R. An ectopic TBP WT, 
TBP 6KR or TBP K47R was tagged with a 3HA epitope and was regulated by the endogenous TBP 
promoter. Their protein stability was monitored by adding 100 μg/ml of cycloheximide into the culture 
(the left panel), which is an inhibitor of protein synthesis. DMSO was used as a control. Cells were 
collected every 30 min after adding the cycloheximide for 3h, and the protein levels were detected by 
Western Blotting against HA epitopes. A long-lived protein PGK1 was used as a reference.  
 
 
I conclude that the non-SUMOylatable TBP 6KR is significantly more stable 
than wild-type TBP, suggesting that reduced SUMOylation is linked to increase of 
protein stability.  
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CHAPTER 7 
 
 
Functional significance -  
Interaction with dna 
 
 
 
7.1.  Aims 
 
․ To investigate promoter occupancy and dynamics of SUMO-deficient TBP  
 
 
7.2.  Analysing occupancy of TBP WT, TBP 6KR and TBP K47R at gene 
promoters 
 
    TBP has a general role in almost all transcriptional events. To investigate 
whether and how SUMOylation of TBP affects transcription, I tested the occupancies 
of TBP at selected promoters by chromatin immunoprecipitation (ChIP) assays. To 
investigate whether SUMOylation affects the ability of TBP to associate to promoters, 
I compared occupancies of TBP WT and the SUMO-deficient TBP 6KR and TBP 
K47R.  
 
7.2.1.  Approach: strain construction 
 
For my ChIP analyses, I used a strain that carries a tetracycline-repressible 
endogenous allele of TBP and a copy of either TBP WT, TBP 6KR or TBP K47R 
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tagged with 3HA under the expression of the endogenous TBP promoter (Fig. 7-1A). 
A diagram describing the construction of the strain (Fig. 7-1B, C) and analysis of the 
expression of TBP alleles in these strains (Fig. 7-1D) as well as viability (Fig. 7-1D) 
is shown.  
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Figure 7-1. A tetracycline-regulated expression system to study TBP occupancy and dynamics by 
ChIP. (A). Construction of a strain solely expressing TBP WT or TBP 6KR without the effect from 
endogenous TBP. The ectopic 3HA- TBP WT/ 6KR was driven by endogenous TBP promoter. The 
promoter of endogenous TBP-3myc was replaced with tetracycline-repressible promoter ―pTetO2‖ or 
―pTetO7‖ which can be repressed by doxycycline (Dox). (B). To replace endogenous TBP promoter 
with a repressible promoter, a cassette was inserted upstream of the TBP gene. This cassette has a 
selection marker, KanMX4, a human promoter CMV-directed tTA-encoding DNA (tTA is constituted 
by tetR and activation domain of VP16), and a yeast CYC1 promoter along with either two (tetO2) or 
seven (tetO7) tetracycline operator boxes. (C). A schematic principle of the tetracycline-repressed 
system. tTA protein is constitutively expressed by CMV promoter. The TetR component of tTA binds 
to the tetO element where VP16 activation domain (VP16 AD) of tTA can activate the CYC1-directed 
TBP gene next to it. In the presence of doxycycline, it binds to tetR, preventing the binding of tTA to 
tetO and thereby inhibiting the expression of TBP. (D) Western Blot shows that the endogenous 
TBP-3myc is repressed by doxycycline. The expression of normal promoter- and tetO7 
promoter-regulated endogenous TBP-3myc is shown. The isogenic parent strain CCG3144 is a 
negative control. To repress tetO7-regulated TBP-3myc, cells were grown in YPD with 50ug/ml of 
doxycycline. Western Blot was performed by using antibodies against myc. Two images with different 
exposure times are shown. Expressions of TBP-3myc are indicated by arrow heads. (E). Viability assay 
of the strains. Cells were 10-fold serially diluted and dropped on plate with or without 50ug/ml of 
doxycycline. Five drops were taken for each strain, and the first drop starting from the right contained 
approximately 2×107 cells, with 10-fold dilutions in each subsequent drop toward the left. Plates were 
grown at 30℃ for 2 days.  
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7.2.2.  TBP SUMO mutants have lower promoter occupancies relative to the 
wildtype 
    To investigate the promoter occupancy of TBP, a number of promoters were 
selected. TBP is involved in transcription mediated by all RNA Pol I, Pol II, and Pol 
III (Cormack and Struhl, 1992). In addition, Smt3 have been reported to extensively 
accumulate in constitutive promoters, as well as inducible promoter regions. 
Interestingly, disruption of Ubc9, the SUMO-conjugating enzyme, had different 
effects on these two types of promoters (Rosonina et al., 2010). Therefore, I chose 
promoters to represent transcription by all the RNA polymerases in my analyses. The 
promoters selected had been previously analysed in TBP studies (van Werven et al., 
2009). 
 
Constitutive promoters: Actin gene, tRNA gene and rDNA 
    Act1 and Suf1 are two representative regions for genes that are constitutively 
expressed. Act1 is transcribed by Pol II promoter. The gene encodes the essential 
cytoskeletal element actin which participates in many cellular processes (Ng and 
Abelson, 1980). Suf1, a tRNA gene, is transcribed by Pol III. Different primer pairs 
were designed to amplify regions around the Act1 and Suf1 genes. These included 
promoter regions, the gene bodies and the terminator regions (Fig. 7-2A, B). I used an 
intergenic region which was far upstream of the gene as a control for the regions 
analysed. The corresponding genomic locations amplified are shown below each ChIP 
graphs (Fig. 7-2). To compare the promoter occupancies of the wild-type TBP and the 
SUMO-deficient TBP, cells expressing ectopic TBP WT, TBP 6KR and TBP K47R 
were cultured in YPD with doxycycline (which represses expression of the untagged 
copy). TBP-bound chromatin was immunoprecipitated using antibodies recognising 
the HA epitope. The enrichment of TBP at different locations was analysed by 
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real-time PCRs, and the IP signals were normalised to the input (see Materials and 
Methods). The data is shown as fold changes relative to the no-antibody controls.  
ChIP analysis showed that TBP WT was highly enriched within the region 
500bps upstream the Act1 gene, and the peak appeared at 200-300bps of this region 
(Pair 4: Fig. 7-2A). Interestingly, both TBP 6KR and TBP K47R showed a lack of 
enrichment on the corresponding region. Likewise, a significant level of TBP WT was 
detected over 100bps upstream of the Suf1 gene as well as its gene body (Fig. 7-2B). 
The levels of TBP 6KR and TBP K47R at this region were six-fold less than that of 
WT. Note that the Suf1 tRNA gene is very small, with only 72bps. 
In yeast, ribosomal DNA (rDNA) consists of 100-200 tandem repeats, and each 
repeat comprises genes encoding different rRNAs (Venema and Tollervey, 1999). 
Among these, the 5S gene is transcribed by Pol III, while the 35S gene is transcribed 
by Pol I. The sequences covered by the seven primer pairs used to analyse TBP 
enrichment were kindly provided by Dr. van Werven (van Werven et al., 2009). A 
pair covered the HMR locus and the other six covered regions containing 5S gene, 
35S gene, and the non-transcribed spacer 2 (NTS2). The HMR serves as a control and 
is presented in the graphs independently. As shown in Figure 7-2C, TBP WT was 
largely enriched on the promoter regions of the 5S and 35S genes, which 
corresponded to the positions of primer pair 3-4 and 7-8, respectively. The level of 
TBP 6KR at these two regions was four-times less than wildtype, and the enrichment 
of TBP K47R was only slightly higher than TBP 6KR but was significantly lower 
than WT.  
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Figure 7-2. Analysis of TBP occupancies at various promoters. The occupancies of TBP WT, TBP 
6KR and TBP K47R at (A). Act1 (B). Suf1 and (C). rDNA locus were analysed by ChIP against the 
3HA epitopes on these ectopic TBP which were carried by integrative plasmids. The IP signals were 
input normalised and presented as the fold changes relative to the no-antibody controls. Below each set 
of ChIP bar graphs is the gene diagram with indicated gene length, the transcription start site (bent 
arrow) and the corresponding genomic positions of all the DNA segments amplified by the primer pairs 
indicated. The signals from the intergenic regions or HMR amplified by the first primer pair represent 
background signals. Cells were grown in YPD with doxycycline to repress the endogenous TBP whose 
promoter had been replaced with a doxycycline-repressible tetO7 promoter. The error bars represent the 
standard deviations of two independent experiments.  
    
Collectively, disrupting the SUMOylation of TBP dramatically decreases the 
promoter occupancies of TBP at all constitutive promoters tested in this study, 
regardless of the RNA Pol that transcribes the genes. Mutating K47 decreases TBP 
occupancy to almost the same extent as mutating all six SUMO accepting sites. This 
demonstrates that the SUMOylation of TBP plays an important role in regulating TBP 
recruitment to promoters or occupancy and TBP-DNA interaction, and K47 appears to 
significantly contribute to this function.  
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Inducible promoter: Heat shock genes 
Hsp30, codes for plasma membrane protein, is a Pol II-mediated 
stress-responsive gene induced by a variety of stresses such as heat shock, 
stationary-phase entry and ethanol treatment (Panaretou and Piper, 1992; Piper et al., 
1994). Eight pairs of primers were designed to cover regions spanning the regions 
upstream and downstream of the Hsp30 gene and the gene body, as indicated in 
Figure 7-3. The primer pair 1 targeted an intergenic region where no transcription 
factors bind in order to use this primer pair as a control for TBP recruiting.  
The endogenous untagged TBP was repressed by doxycycline throughout the 
experiment. To monitor the recruitment and the release of tagged TBP from the 
Hsp30 promoter, the cells were transferred from 30℃ to 39℃ for 30 min to activate 
the gene and then returned to 30℃. Cells were collected at 0 min, 5 min, 10 min, 20 
min, and 30 min after the heat induction, and 5 min, 10 min, 20 min after they were 
returned to 30℃. The occupancies of all three types TBP WT, TBP 6KR and TBP 
K47R were undetectable at T0 (Fig. 7-3). Following temperature shift, the recruitment 
of TBP WT was very quick, reaching a maximum 5 min after induction. The 
enrichment of TBP WT decreased with time. The level 30 min after the induction was 
half of the maximal level at 5min. In contrast to the efficient recruitment of TBP WT, 
TBP 6KR did not show a significant recruitment during the experiment (Fig. 7-3). 
The position of primer 4 was the only site displayed a slight increase of TBP 6KR, 
whose maximal level was one-sixth as much as that of TBP WT, and the recruitment 
was also less efficient, which reached maximum at 10 min instead of 5 min after the 
induction. The enrichment of TBP K47R was also detected, but it was significantly 
lower than WT. After switching back to 30℃, TBP WT, TBP 6KR and TBP K47R 
disappeared from the promoter in 5 min. Hence, the data for the later time points is 
not shown.  
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Figure 7-3. Analysis of TBP occupancies at Hsp30 promoter upon and after heat-induced 
activation. The occupancies of TBP WT, TBP 6KR and TBP K47R at Hsp30 locus were analysed by 
ChIP against the 3HA epitopes. Cells were switched to 39℃ to induce Hsp30 and switched back to 
30℃ to inactivate it, and samples were collected at indicated times. Doxycycline was used to repress 
the endogenous TBP expression. The IP signals were input normalised and presented as fold changes 
relative to the no-antibody controls. The error bars represent the standard deviations of three 
independent experiments. (B). An Hsp30 gene diagram with indicated gene length, the transcription 
start site (bent arrow) and the corresponding genomic positions of all the regions amplified by the 
primer pairs are indicated. The signal from the intergenic regions amplified by the first primer pair was 
used as a control. 
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These results reveal that the lack of SUMOylation of TBP significantly reduces 
its promoter occupancy in the inducible Hsp30 gene promoter. An intermediate defect 
was observed for K47R. This is consistent with the observations on the constitutive 
promoters, where the SUMOylation of TBP is important for normal occupancy. 
To summarise, these results suggest a role of SUMOylation of TBP in 
maintaining a normal TBP-promoter interaction on both constitutive and inducible 
promoters.  
 
 
7.3.  Analysing the promoter dynamics of TBP WT, TBP 6KR and TBP 
K47R by cross-linking kinetic (CLK) analysis 
 
    TBP has been shown to be highly dynamic in vivo, and it is also reported that the 
kinetics of a transcription factor are important for transcription (Lickwar et al., 2012; 
Sprouse et al., 2008a). From the computational modelling of TBP in previous chapters, 
the presumably primary SUMO site K47 localises at the DNA-binding interface. 
Moreover, all six SUMO sites of TBP are distributed throughout the N-terminal 
domain, which is implicated in negatively regulating the binding stability between 
TBP and DNA (Horikoshi et al., 1990; Kuddus and Schmidt, 1993; Lee and Struhl, 
2001; Lieberman et al., 1991). Therefore, it is curious that whether the SUMOylation 
of TBP affects its dynamics at promoters.  
 
7.3.1.  The principle of the CLK analysis 
Some approaches have been reported to quantitatively measure the 
chromatin-binding dynamics of proteins (Lickwar et al., 2012; Poorey et al., 2013; 
van Werven et al., 2009). After several trials between different methods, the CLK 
analysis was used. Figure 7-4 illustrates the principle of CLK, which was developed 
by Poorey et al. (2013). The interactions of many proteins with chromatin are 
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short-lived, and the signals in a ChIP assay are obtained from cross-linking these 
interactions in a population of cells by formaldehyde within a time period. The 
dynamic binding of proteins to chromatin continues when the cross-linking reaction 
proceeds, and the number of occupied binding sites trapped by formaldehyde are 
increased. The ChIP signal increases with cross-linking time until all the binding sites 
present in the whole population are occupied and reach saturation (Fig. 7-4A). Figure 
7-4B shows a simplified model of how CLK curves of two transcription factors with 
different promoter dynamics behave. There is an early rapid rise of the curve which 
occurs in a few seconds (<5s), and this increase is entirely cross-linking reaction 
limited (Poorey et al., 2013). After a turning point which represents the real 
steady-state occupancy of the transcription factor, a second phase appears, where the 
curve grows more gradually and the slope is dependent on the kinetics of the 
transcription factor on chromatin. Highly dynamic proteins have a steeper slope and 
also reach saturation within a shorter time period (the left panel in Fig. 7-4B).  
 
7.3.2.  Comparing promoter dynamics between TBP WT, TBP 6KR and TBP K47R 
by CLK analysis 
    To investigate whether the SUMOylation of TBP plays a role in regulating TBP 
dynamics, the promoter kinetics of TBP WT, TBP 6KR and TBP K47R were 
analysed by CLK. The same tetO7 strains used before were used in this experiment. 
Cells were grown in YPD with doxycycline to prevent the effects from the 
endogenous TBP. To understand how TBP occupancy varies with different incubation 
times with formaldehyde and compare the results between WT and mutants, cells 
expressing TBP WT, TBP 6KR or TBP K47R were cross-linked for 5 sec, 20 sec, 1 
min (60 sec), 3 min (180 sec), 5 min (300 sec), 10 min (600 sec), 15 min (900 sec), 20 
min (1200 sec), and 30 min (1800 sec), and the binding of TBP on selected promoters 
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were analysed by ChIP using real-time PCRs. The experiments followed the standard 
protocol except that 250mM of Glycine was used (normally 125mM) after fixation to 
ensure that the formaldehyde reactions were quenched immediately. TBP binding was 
examined at the promoter regions of 5S rDNA, 35S rDNA, Act1 and Suf1 genes. A 
region on the HMR was used as background noise control. To quantify the enrichment 
of TBP at these sites, the IP signals were normalised to input and further normalised 
to the HMR signals. The results are presented as a percentage of the recovery over the 
input (Figure 7-5).  
    As can be seen in Figure 7-5, the occupancies of the TBP WT at all four 
promoters examined increased steadily with the increase of cross-linking time, 
showing a three to four-fold increase of occupancy at 30 min of incubation with 
formaldehyde relative to the first time point (5 sec). By contrast, the value of TBP 
6KR did not increase as significantly as WT, gaining a two-fold increase within 30 
min of cross-linking. Generally, the overall trend of the occupancy of TBP K47R lay 
between the WT and the 6KR values at most promoters apart from the Act1 promoter. 
These results suggest that TBP WT is much more dynamic than non-SUMOylatable 
6KR, and the promoter kinetics of TBP K47R is also decreased.  
At three of the four promoters analysed, the occupancies of TBP WT at the first 
time point, which reflected the steady-state occupancy, appeared to be slightly higher 
than TBP 6KR and TBP K47R (Figure 7-5). However, since the early rapid-rise phase, 
which is crosslinking-reaction-limited, is too short to be accurately measured 
manually, the first time point in this experiment might be in the early 
kinetics-dependent phase already and therefore the values obtained are higher than the 
real steady-state occupancies. This discrepancy would be larger when the proteins are 
more dynamic. Given that TBP WT has higher kinetics, it is very likely that the 
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steady-state occupancies of TBP WT, TBP 6KR, and TBP K47R are actually the 
same.  
 
 
Figure 7-4. A schematic principle of CLK analysis. (A). A simplified model describing the 
dependence of the ChIP signal on cross-linking time. Without cross-linking, the transcription factors in 
cells (in white) dynamically interact with the two binding sites on the chromatin. Upon treatment with 
formaldehyde, the binding of the protein on one of the binding sites are caught in some cells (in light 
pink), and some cells have both of their binding sites cross-linked with proteins (in dark pink), while 
the other cells have no binding at both sites (in white). The proportion of these three groups of cells, 
and thus the ChIP signal, changes over time, in which the white group decreases and the pink groups 
increase until all the binding sites in all cells are occupied and reach saturation. (B). An overview of the 
plot patterns of transcription factors with different DNA-interacting dynamics extracted from CLK 
analysis. At time zero, none of transcription factors are cross-linked at the binding site in all four cells. 
The cross-linking reaction occurs rapidly which can capture the initial binding of the protein within a 
few seconds (one second in this model). This short period of time is displayed in the curve as a steep, 
fast-growing phase which is crosslinking-limited. After a turning point (indicated by a blue arrow) 
which reflects the real occupancy at steady state, the increase of the signal slows down and is 
dependent on the kinetics of the transcription factor on the chromatin. Since the high dynamic 
transcription factor has high on-rate, the number of cells with their binding sites occupied and 
cross-linked increases more rapidly than its counterpart which has low on-rate. Therefore, the plot of 
the transcription factors with higher dynamics have steeper slope and reaches to a plateau in a 
relatively short time compared to the transcription factors with lower kinetics. Figure B is adapted from 
(Poorey et al., 2013). 
7.  RESULTS: Functional Significance- Interaction With DNA 
- 118 - 
 
 
 
 
Figure 7-5. The promoter dynamics of TBP WT, TBP 6KR and TBP K47R analysed by CLK. 
The accumulated occupancies of TBP WT, TBP 6KR and TBP K47R were obtained by cross-linking 
cells for various lengths of time (from 5 sec to 30 min), and the upward trend of the occupancies which 
was increased with cross-linking time reflects their promoter dynamics. Cells were grown in YPD with 
doxycycline to repress the endogenous TBP whose promoter had been replaced with a 
doxycycline-repressible tetO7 promoter. The ChIP was performed against the 3HA epitopes on the 
ectopic TBP WT/6KR/K47R at the promoter regions of rDNA loci (primer pair 3-4, 7-8), Act1 (primer 
pair 4) and Suf1 (primer pair 4). The IP signals were input normalised, and the background signals 
detected at the HMR regions were further subtracted. The TBP enrichment is presented as the recovery 
rates relative to the input. The error bars represent the standard deviations of three independent 
experiments.  
 
This experiment suggests that interpreting the information obtained from a 
conventional ChIP can be misleading. As shown in Figure 7-5, the steady-state 
occupancies of TBP were not altered by SUMO, and the occupancy difference 
observed in the conventional ChIP assays came from the accumulated occupancy of 
dynamic molecules over 15 min of cross-linking time. In this situation, the molecules 
with higher dynamics touch the promoters more frequently, thereby having higher 
accumulated occupancy.  
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7.4.  Analysing TBP dynamics by fluorescence recovery after 
photobleaching  (FRAP) 
 
    The results from the ChIP analyses revealed that SUMOylation of TBP plays a 
role in regulating TBP dynamics on promoters. To further confirm the conclusion, I 
sought to analyse the TBP dynamics by FRAP analysis. This technique has been used 
before to analyse TBP dynamics in the live yeast cells (Sprouse et al., 2008a).  
 
7.4.1.  Approach: The principle of FRAP 
    FRAP is an imaging technique capable of monitoring the mobility of 
fluorescently labelled molecules in living cells. Under the exposure of a strong laser 
beam focusing on a spot in the sample which is called the ―region of interest‖ (ROI), 
all the fluorescent signals of fluorophores in the ROI are quickly diminished 
(bleached), and the ROI becomes a dark spot. When the target proteins outside the 
ROI start moving into the bleached region and replace those proteins having lost 
fluorescent probes, the fluorescence recovery in the ROI can be observed. By 
monitoring the kinetics of fluorescence recovery, the dynamics of the target proteins 
can be quantified.  
To see whether SUMOylation of TBP alters its molecular dynamics, the strains 
expressing TBP WT or TBP 6KR which were N-terminally labelled with a green 
fluorescent protein (GFP) and were driven by GAL promoters were used. The in vivo 
molecular dynamics of the TBP WT and TBP 6KR were analysed and compared 
using FRAP.  
 
7.4.2.  TBP 6KR has a larger immobile population 
    Yeast nuclei are much smaller than mammalian nuclei, making it technically 
challenging for FRAP. The bleached spot needs just to be limited to a fairly tiny area 
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to avoid the loss of most fluorophores in the entire nucleus. However, as the intensity 
of the GFP that I used was dim, the difference of fluorescent intensities between the 
pre-bleached and the post-bleached images was not large. This means that minimising 
the ROI would reciprocally enlarge the sample deviation during the quantification. To 
counterbalance the small size of the nucleus and the dim signals, I decided to bleach 
half of the nucleus, and the deviation was minimised by increasing the sample size. 
The most challenging part of this experiment was the extremely high molecular 
dynamics of TBP in vivo, whose fluorescence recovery after photobleaching occurs in 
less than one second (Fig. 7-6). In such a short time, it was very difficult to collect the 
first post-bleaching image before the signal was fully recovered. This was 
circumvented by minimising the length of each recording time frame (the experiment 
was done by a confocal microscope) and by taking the first image after 
photobleaching within the shortest time that the microscope was able to achieve. 
Images were taken every 0.02 seconds. After 20 pre-bleaching image frames, cells 
were quickly bleached by a strong laser beam twice to get a more complete bleaching 
result, and another 300-800 image frames were further recorded, which lasted for 5-14 
seconds.  
Figure 7-6A shows that the majority of the fluorescence of both TBP WT and 
6KR was recovered almost immediately after photobleaching, revealing its high 
dynamic nature. The 6KR mutant appeared to have similar recovery time to that of the 
wildtype. Nonetheless, the lower intensity of 6KR after recovery (0.76 and 0.69 for 
6KR vs. 0.85 and 0.84 for WT) suggested a lower mobile fraction in TBP 6KR 
population (Fig. 7-6B). Given that only a small proportion of the total cellular SUMO 
substrates are modified by SUMO at any given time, this result reflects the difference 
caused by the small SUMOylated group. Overall, this suggests that, relative to the 
wildtype, the non-SUMOylatable TBP 6KR has a larger population which is 
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immobile within the entire period of observation, and this result is in agreement with 
the ChIP results.  
 
 
 
 
Figure 7-6. FRAP analysis of WT and 6KR. The expression of GALS promoter-driven and 
GFP-tagged ectopic TBP WT or 6KR was induced by galactose and monitored by the microscope. (A). 
The graphs display the kinetics of TBP fluorescent signal recovery from photobleaching. Results from 
two independent experiments are shown. Fluorescence of half of the nucleus was bleached twice. 
Twenty pre-bleached images were taken, and 300 (Exp1) and 800 (Exp2) post-bleached images frames 
were recorded. The entire recording time was approximately 5.8 and 14.8 sec for Exp1 and Exp2, 
respectively. The Intensities of selected regions in the bleached, non-bleached area of the nucleus as 
well as background area were quantified, and the final intensities of bleached regions were calibrated 
using the background and the fluorescence loss during the recording period. Number of cells recorded: 
n=67 (WT) and 35 (6KR) in Exp1; n=29 (WT) and 30 (6KR) in Exp2. (B). A table shows the immobile 
fraction among the entire TBP WT or TBP 6KR population.  
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To summarise, the results from the ChIP and FRAP analyses demonstrate that 
the SUMOylation of TBP plays a role in regulating TBP dynamics. Blocking TBP 
SUMOylation significantly reduces TBP molecular dynamics by restricting its 
mobility on the promoters.  
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8. Results: Functional Significance- Sporulation 
 
 
 
CHAPTER 8 
 
 
Functional significance -  
sporulation 
 
 
 
8.1.  Aims 
 
․To examine the functional significance of TBP SUMOylation during sporulation 
 
 
8.2.  Relationship between TBP promoter dynamics and transcription 
plasticity 
 
    SUMOylation of TBP significantly reduces its mobility on the promoters. 
Therefore, it is conceivable that TBP SUMO-deficient mutant could suffer defects 
when transcription plasticity i.e. when gene expression needs to be rapidly switched 
on/off or up/down-regulated.  
    To find out whether blocking the SUMOylation of TBP has an effect on 
transcription plasticity, I sought to investigate cell fitness during transcription 
reprogramming. To this aim, the yeast sporulation is well-known for involving 
transcription reprogramming.  
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8.3.  Construction of diploid strains with SUMO-deficient alleles of 
TBP 
 
    To study sporulation, a diploid strain containing TBP WT and TBP 6KR was 
created. Strain CCG10564 and CCG10566 were haploid tetO7 strains (Mata) of WT 
and 6KR described earlier. Matαversions were generated by cross. The strain were 
named CCG10674 for TBP WT and CCG10676 for TBP 6KR. The repression of 
endogenous TBP by doxycycline in these strains was confirmed by Western Blotting 
(Fig. 8-1). These strains were then respectively mated with CCG10564 and 
CCG10566 to create the diploid cells of TBP WT (CCG10720) and TBP 6KR 
(CCG10722) (Fig. 8-1). The diploid strain of TBP K47R was created using the same 
approach.  
 
 
8.4.  Comparing the sporulation efficiency between the wildtype and 
the TBP SUMO mutants 
 
    The ability of diploid cells to give rise to viable spores is the most direct 
parameter to assess the sporulation efficiency. To this end, the sporulation of diploid 
strains containing TBP WT, TBP 6KR and TBP K47R was evaluated by a standard 
protocol described in Materials and Methods, and the ratio of viable spores were 
quantified (Figure 8-2). To inhibit the expression of endogenous TBP, the diploid 
cells or the isolated spores were cultured with doxycycline at all times.  
As shown in Figure 8-2A, the colony sizes of the SUMO mutants, in particular 
6KR, were variable, as opposed to the consistent size of TBP WT, indicating that 
some spores produced by the SUMO mutants appeared to grow more slowly than 
others. Moreover, many 6KR and K47R cells failed to give rise to four viable spores.  
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Figure 8-1. Construction of diploid tetO7 strains to measure sporulation efficiency. (A). The 
mating type α strains with a repressible ptetO7 promoter on the endogenous TBP and an ectopic TBP 
WT or TBP 6KR allele were generated by crossing previous haploid ptetO7 strains (CCG10564 for the 
WT and CCG10566 for the 6KR, both are Mata) with a wild-type αstrain CCG4702, and selecting for 
progenies with desired genotypes (CCG10674 for TBP WT and CCG10676 for TBP 6KR). The 
behaviour of ptetO7 promoters in these strains was tested by Western Blotting, where the expression of 
endogenous TBP-3myc in the presence or absence of doxycycline was detected by antibodies against 
myc. Isogenic parent strain (CCG4702) was used as a control. Arrow heads indicates TBP-3myc. (B). 
The diploid ptetO7 strains with ectopic TBP WT/ 6KR were created by crossing CCG10564 with 
CCG10674 for TBP WT and CCG10566 with CCG10676 for TBP 6KR, and they were named as 
CCG10720 (WT) and CCG10722 (6KR).  
 
The percentage of viable spores produced by TBP WT, 6KR and K47R were 
quantified in Figure 8-2B. More than 60% of the wild-type diploid cells had a 
successful round of meiosis that produced four viable spores. By contrast, TBP 6KR 
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showed merely 20% of cells producing four viable spores. The sporulation efficiency 
of TBP K47R was also significantly decreased, with around 80% of asci producing 
1-3 viable spores, and nearly 10% of asci showed no viable spores in the tetrad.  
 
 
 
Figure 8-2. Spore viability of the wildtype and the SUMO-deficient TBP. (A). Representative 
images of tetrad dissection analysis for TBP WT, TBP 6KR and TBP K47R. Eighteen asci of diploid 
cells were dissected to four spores. Spores were spotted separately on the plates and were grown for 
2-3 days. (B). Quantification of the number of viable spores produced by TBP WT, 6KR and K47R per 
ascus. The error bars represent the standard deviations of three independent experiments. 
 
 
These results demonstrate that SUMOylation of TBP is important for meiosis 
and the production of viable spores. This is consistent with TBP SUMO-deficient 
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mutant having defects on transcription reprogramming, probably caused by its lower 
promoter dynamics.  
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9. Discussion 
 
 
 
CHAPTER 9 
 
 
discussion 
 
 
 
9.1.  Confirmation of the SUMOylation of a variety of proteins 
 
In this study, by using the affinity purification, I have explored the SUMOylation 
of 10 proteins in S. cerevisiae cells with and without MMS-induced DNA damage and 
have confirmed that seven of them are SUMO substrates. Among the proteins which 
are SUMOylated, the SUMOylation of Pds5, Sir3, Sir4, Hmo1 and TBP have been 
discovered (Stead et al., 2003; Wohlschlegel et al., 2004; Yu et al., 2008; Zhou et al., 
2004), and Mtw1 and Tfb2 are newly-identified SUMO targets in budding yeast.  
The SUMOylation of Sir3, Sir4 and Tfb2 are increased significantly by MMS, 
which is consistent with their roles in DNA repair. Tfb2 is required for nucleotide 
excision repair (Feaver et al., 1997), and Sir3 and Sir4 are both involved in 
non-homologous end joining (NHEJ) (Hegde and Klein, 2000). These results suggest 
an important role of SUMOylation in DNA repair which has also been widely 
reported (Bartek and Hodny, 2010; Bergink and Jentsch, 2009).  
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9.2.  The role of K47 of TBP in SUMOylation 
 
Compared to the other SUMO targets listed in Chapter 3, the SUMO pattern of 
TBP is unique since most of the modified species are monoSUMOylated 
predominantly. This indicates that, despite the presence of six SUMO sites on TBP, 
mainly a single lysine is modified. 
Three independent mass spectrometry analyses had been done in the lab either by 
targeting SUMO species (against His-tagged Smt3) or TBP (against His-tagged TBP), 
and K47 was reproducibly identified in two experiments. Although mutating K47 
alone does not completely prevent SUMOylation of TBP, it largely reduces it (data of 
double purifications not shown), suggesting that K47 is a prominent site. From these 
findings, K47 seems to play an important role, and it is likely to be the dominant 
SUMO site amongst the six identified.  
Computational modelling revealed that K47 localises at the DNA-binding 
surface of TBP (Fig. 5-7), where the addition of SUMO could interfere with the 
interaction between TBP and DNA. Consistent with this hypothesis, my CLK analysis 
shows that blocking SUMOylation of K47 alone significantly decreases TBP 
dynamics on promoters (Fig. 7-5). Furthermore, the sporulation defects caused by 
mutating K47 are not different from those caused by mutating all six SUMO sites (Fig. 
8-2), reinforcing the idea that K47 is functionally important for TBP SUMOylation.  
 
 
9.3.  How does SUMO affect TBP dynamics on promoters? 
 
In this study, I showed that blocking SUMOylation of TBP largely decreases its 
dynamics on promoters. However, how does SUMO regulate the interaction between 
TBP and DNA is unclear.  
The yeast TBP is composed of a 180 aa C-terminal core domain and a 60 aa 
N-terminal domain, and the latter is dispensable for either cell viability or 
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transcription. Thus, the functional significance of TBP N-terminal domain is not yet 
clearly defined. In this study, it was surprising to find that all the six TBP SUMO sites 
concentrate within the N-terminal domain. There have been numerous studies 
showing that the TBP-DNA binding stability is altered by TBP N-terminal domain 
(see below). Here, I was able to link SUMO modification of TBP with its promoter 
dynamics, and the N-terminal domain is the bridge between the two.  
 
9.3.1. TBP N-terminal domain exerts a negative effect on the binding stability 
between TBP and DNA 
Deletion of N-terminal domain of TBP leads to higher affinity binding to DNA 
in vitro, suggesting that the presence of the N-terminal domain brings instability to the 
interaction of TBP with DNA (Horikoshi et al., 1990). A negative effect from the N 
terminus is also observed in human TBP. Removal of N-terminal 95 residues makes 
TBP bind more efficiently to TATA box of the human U6 snRNA promoter (Mittal 
and Hernandez, 1997). Another study in yeast showed that, in contrast to C-terminal 
core domain which is highly resistant to proteolytic cleavage, TBP N-terminal domain 
is sensitive to proteolytic cleavage by chymotrypsin and trypsin (Lieberman et al., 
1991). In addition, as shown by gel electrophoresis mobility shift assays, a truncation 
of the N terminus either by chymotrypsin or trypsin largely enhances the binding 
stability between TBP and DNA, and the truncated mutant also exhibits a two to 
four-fold increase in DNA-binding affinity. Moreover, truncated TBP is capable of 
binding to TATA box at 0°C, while full-length TBP is not (Lieberman et al., 1991). 
Another example of the negative role of N-terminal domain comes from the study of 
an N-terminally truncated yeast TBP (TBP△57) by Kuddus and Schmidt (1993). 
Although in solution, the association and dissociation rate constants of TBP-DNA 
binding have just a minor difference between the mutant and the wild-type form, the 
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TBP-DNA interaction formed by TBP△57 is much more stable and is 16-fold less 
likely to dissociate. Furthermore, binding of TBP induces DNA bending, but deletion 
of 57 residues from TBP N-terminus results in a decrease of the bending angle 
(Kuddus and Schmidt, 1993), indicating that the N-terminal domain affects both the 
structure and the stability of TBP-DNA complex by increasing DNA bending and 
destabilising TBP-DNA. This reinforces the notion that N-terminal domain itself is a 
negative factor for the stability of interaction between TBP and DNA. In addition, 
truncation of TBP N-terminal region rescues transcriptional defects in a subset of TBP 
mutants defective in DNA binding or that fail to interact with activators (Lee and 
Struhl, 2001). In terms of the activation energy required for TBP-DNA complex 
formation, it is higher for wild-type TBP than for N-terminus truncated mutant 
(Kuddus and Schmidt, 1993). Although full-length TBP is retained on DNA for 
rounds of transcription in vitro which means that it tends not to dissociate 
immediately after transcription even in the presence of N-terminal domain (Zawel et 
al., 1995), it is possible that the intrinsic stability of TBP-DNA complex is relatively 
low due to interference from N-terminal domain.  
Like in yeast, the N-terminal region of TBP is also dispensable in mammalian 
cells (Mittal and Hernandez, 1997), and a number of reports indicate that TBP 
N-terminus is also a key factor affecting DNA binding in mammalian cells (Davidson, 
2003; Zhao and Herr, 2002), which suggests a conserved role of TBP N-terminal 
domain in transcription. 
Therefore, the N-terminal domain of TBP is negatively correlated with its DNA 
binding stability.  
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9.3.2. A conformational change of TBP N-terminal domain upon DNA binding 
It has been mentioned above that the binding of TBP induces DNA bending. 
Several lines of evidence indicate that not only DNA but also TBP itself undergoes a 
conformational change upon binding, in particular the N-terminal domain of TBP. As 
mentioned above, TBP is composed of a proteolysis-sensitive N-terminal domain and 
a relatively proteolysis-resistant C-terminal domain which can only be digested in a 
prolonged incubation with proteases (Lieberman et al., 1991). The binding to 
TATA-containing oligonucleotide protects the C-terminal domain from being 
attacked even under an extensive period of digestion. Since the saddle-like C-terminal 
domain is responsible for holding DNA and forming the interaction, it is conceivable 
that binding to DNA could obstruct the proteolytic cleavage sites within this region. 
In contrast to the C-terminal domain, DNA binding renders the N-terminal domain 
more sensitive to digestion, suggesting a conformational change upon binding. A 
study taking advantage of the autofluorescence of a tryptophan positioned at aa 26 in 
the TBP peptide found that the fluorescence emission spectrum of this tryptophan 
goes through a massive red-shift upon interacting with TATA-containing DNA 
(Perez-Howard et al., 1995). Furthermore, in terms of the position of N terminus 
relative to the whole TBP structure, the unbound TBP adopts two types of 
configurations: the ―close conformation‖ where the N-terminal end holds tightly to 
the entire protein body; and the ―open conformation‖ where N-terminal domain is 
exposed to solvent and is further from C-terminal domain. Nevertheless, only the 
―open conformation‖ occurs after binding with DNA. This provides an explanation 
why the N-terminal domain of a DNA-bound TBP, which exists as an open 
conformation, is more vulnerable to proteolytic cleavage.  
It is noted that the accelerated proteolysis of N-terminal domain described above 
is facilitated only by binding to TATA-containing DNA but not to a non-specific 
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oligonucleotide (Lieberman et al., 1991). Binding of TBP to a non-specific site is 
different to that of a TATA box in several ways (Hoopes et al., 1992). The association 
with the non-target is more sensitive to salt concentration or the reagent dissociating 
TBP-DNA complex, and its association kinetics is slower than the binding with a 
TATA box. These facts suggest that only binding to a functional promoter is capable 
of inducing the conformational change of TBP N-terminal domain efficiently. 
 
9.3.3. A close link between SUMO and the N-terminal domain of TBP 
TBP can form crystals only when the N-terminal domain is removed. It has been 
speculated that the N-terminus does not have a discrete structure and thus interferes 
with crystal formation (Chasman et al., 1993), suggesting a highly flexible nature for 
N-terminal domain. In my study, I found that all the six SUMO sites of TBP form a 
SUMO surface in the N-terminal domain which is implicated in destabilising 
TBP-DNA complex. Moreover, as shown in my TBP 3D model, the presumed 
primary SUMO site K47 localises at the DNA binding surface. It is possible that 
addition of a SUMO moiety at this position physically interferes with DNA binding 
stability.  
Taken together, it is plausible that the negative influence of TBP N-terminal 
domain on its DNA-binding stability is linked to its SUMO modification. SUMO 
might disturb the binding between TBP and DNA via triggering a conformational 
change at the N-terminal domain or simply serving as a hindrance.  
 
9.3.4. TBP is relatively immobile in vitro but is highly dynamic in vivo 
Template competition assays using in vitro reconstituted transcription system 
found that, instead of recycling after each round of transcription initiation, TBP 
remains DNA-bound after transition from transcription initiation to elongation (Zawel 
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et al., 1995). Although this assay was performed without any proteins other than the 
essential components of the transcription complex, it indicates a natural property for 
TBP to be tightly associated with DNA in the absence of external regulation.  
In vivo, however, FRAP analyses have shown diverse results regarding TBP 
dynamics in mammalian and yeast cells. TBP is highly dynamic in budding yeast cells 
(Sprouse et al., 2008a). The results in mammalian cells seem to be more diverse. 
Although by monitoring transiently overexpressed GFP-TBP in HeLa cells, TBP was 
found to bind to mitotic chromosome throughout mitosis with a fluorescence recovery 
time of around 20 min in interphase (Chen et al., 2002), another report showed by 
FRAP that the majority of stably-expressed GFP-TBP in both HeLa and U2OS cell 
lines displays short recovery time (in seconds), while the relatively immobile 
population is trapped for 2-3 min (de Graaf et al., 2010). Overall, this suggests that 
TBP tends to have low mobility in vitro but is highly mobile in vivo. The same study 
from de Graaf et al. (2010) also showed a decrease in the proportion of mobile TBP 
from 70% to less than 50% when BTAF1 (mammalian homologue of yeast Mot1, 
which negatively regulates TBP function) was inactivated, indicating TBP might need 
some regulators to maintain dynamic in vivo.  
I found that SUMOylation of TBP regulates TBP dynamics on promoters in vivo. 
Therefore, SUMO modification is also a regulator of TBP dynamics.  
 
9.3.5. A proposed mechanism for SUMO regulation of TBP dynamics 
The data from others as well as this current study together provides insight into 
the role of SUMO in TBP. First, the N-terminal domain has a negative effect on 
binding stability between TBP and DNA. Second, free TBP molecules adopt either an 
―open‖ or a ―close‖ configuration, and the difference between the two lies in the 
position of N-terminal domain relative to the TBP core. Importantly, only the open 
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configuration is observed in DNA-bound TBP. Third, a SUMO surface on TBP 
containing all SUMO sites localises to the N-terminal domain. Fourth, the N-terminal 
domain of TBP is highly flexible, and a conformational change upon SUMOylation is 
commonly observed amongst SUMO substrates. Fifth, TBP SUMO site K47 localises 
in the N-terminal tail which penetrates through DNA-binding surface.  
Based on these facts above, it is tempting to speculate that the ―open 
configuration‖ where the N-terminal domain is exposed is not SUMOylated but is 
highly accessible to SUMO modification and able to bind to DNA. By contrast, the 
―close configuration‖ where N-terminal domain tightly holds the TBP core might be 
the SUMOylated form which is not favourable to DNA-binding. In my scenario, 
SUMO regulates the switch between these two configurations which has opposite 
DNA-binding affinity, thereby influencing TBP dynamics.  
The model is illustrated in Figure 9-1.  
 
 
9.4.  How does SUMO affect TBP protein stability? 
 
    The protein half-life of TBP is greatly enhanced by blocking its SUMOylation, 
suggesting that triggering proteolysis might be one of the most prominent functions of 
TBP SUMOylation. However, how does SUMO alter TBP protein stability remains 
unclear. SUMOylation of TBP might direct participate in regulating its stability. 
Alternatively, the longer half-life of TBP 6KR could be an indirect effect caused by 
other defects in the SUMO-deficient mutant. Both of these two possibilities will be 
discussed below.  
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Figure 9-1. A proposed model for function of SUMOylation on TBP promoter dynamics. (A). A 
structural model illustrating the ―open‖ and ―close‖ configurations of TBP, which are defined by the 
position of the N-terminal domain relative to the TBP main body. The C-terminal core domain is a blue 
saddle. The black stick is the N-terminal domain containing six SUMO sites labelled in red. The 
position of K47 is underneath the concave side of the saddle. The switch between two configurations is 
regulated by SUMOylation (green oval). (B). The open form of TBP can be stably bound to DNA, and 
the exposure of SUMO sites promotes SUMOylation. Once SUMOylated, the physical hindrance from 
K47 as well as the ―closing‖ of the N-terminal domain renders TBP unstable on DNA, which in turn 
releases TBP from DNA. Unbound TBP are able to rebind to DNA as soon as it is deSUMOylated and 
switched to an open form.  
 
 
9.4.1. SUMOylation of TBP might actively promote proteolysis of TBP proteins 
    A recent report revealed that SUMOylation of Gcn4, which is a yeast 
transcription activator, facilitates its promoter clearance via Srb10-mediated 
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degradation (Rosonina et al., 2012). In this study, Gcn4 is SUMOylated via two lysine 
residues within the activation domain, and, compared to its wild-type counterpart, 
SUMO-deficient Gcn4 displays higher promoter occupancy at Gcn4-targeted genes 
and leads to elevated expression levels of these targets when Srb10- and SUMO- 
independent degradation pathway is inhibited. In this case, SUMOylation directly 
facilitates degradation of a transcription factor.  
As mentioned in the Introduction, a protein family named ―SUMO-targeted 
ubiquitin ligases‖ (STUbLs) is able to recognise SUMOylated substrates and facilitate 
SUMO-dependent ubiquitylation, thereby promoting protein degradation (Praefcke et 
al., 2012). In Saccharomyces cerevisiae, two classes of STUbL have been identified. 
These include Uls1 and the Slx5-Slx8 complex (Lescasse et al., 2013; Mullen and 
Brill, 2008; Uzunova et al., 2007). They have been shown to be involved in 
proteolytic control of SUMO conjugates. If SUMO directly facilitates 
ubiquitin-dependent degradation of TBP, STUbL could be the bridge between the 
modifications.  
Many studies have pointed out the importance of quantitative and temporal 
control of transcription factors. The overexpression of a transcription factor or 
expressing it at improper timing could result in deleterious consequences. For instance, 
the cellular level of Myc, which activates genes involved in cell growth and 
proliferation, is tightly regulated by ubiquitin-mediated proteolysis, and its 
de-regulation is associated with oncogenic activity (King et al., 2013; Thomas and 
Tansey, 2011). Another example is p53, whose turnover is rapid under normal 
condition and whose stability is increased upon DNA damage to trigger cell cycle 
arrest (Blattner et al., 1999; Pellegata et al., 1996). Similar quantity controls are 
observed in TBP. In mouse F9 embryonal carcinoma cells as well as C2C12 
myoblasts, TBP and its associated factor TAF4 are selectively depleted via 
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proteasome-dependent degradation during cell differentiation, and the phenomenon is 
not observed when the differentiation is impaired or abolished (Perletti et al., 2001). 
This represents another line of evidence which highlights a critical role for cellular 
TBP levels. In chicken DT40 lymphoid cells, reducing TBP protein population by half 
contributes to slow growth, delayed mitosis and increased apoptosis. By contrast, 
overexpression of TBP can lead to oncogenic transformation, and TBP levels are 
indeed greatly increased in Ras oncogene transformed cells (Bush et al., 2008; 
Davidson, 2003). Overall, these findings imply that expression of TBP might be under 
tightly spatiotemporal regulation. 
 
9.4.2. Higher protein stability of TBP 6KR might be caused by longer retention on 
promoters  
In this study, I observed an extended protein half-life for TBP after blocking its 
SUMOylation. Based on Gcn4 where SUMOylation directly triggers its degradation 
and facilities the clearance from promoters, it might be tempting to speculate that 
SUMO plays an active role in regulating proteolysis of TBP. However, TBP is 
different from Gcn4 in many aspects.  
Firstly, in contrast to the high promoter occupancy of non-SUMOylatable Gcn4, 
TBP 6KR has much lower enrichment at all the promoters I tested. It was 
subsequently proved by CLK and FRAP that the low occupancy is caused by 
decreased promoter dynamics. Therefore, non-SUMOylatable TBP is less mobile 
upon binding to DNA, thereby remaining in a bound-state. Secondly, a recent report 
revealed a vital role for de-ubiquitylating enzyme Ubp3 (ubiquitin-specific protease 3) 
in TBP-mediated transcriptional activation (Chew et al., 2010). Deletion of ubp3 not 
only reduces TBP protein stability and causes transcriptional defects but also 
contributes to an accumulation of poly-ubiquitylated TBP when the proteasome-based 
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proteolysis system is impaired. Furthermore, ChIP analysis revealed that Ubp3 is 
recruited to GAL1 and HIS3 promoters upon induction, suggesting that 
promoter-bound TBP is prevented from degradation by the de-ubiquitylation activity 
of Ubp3. 
According to this evidence, promoter-bound TBP is less likely to be degraded 
due to protection by Ubp3, and promoter-bound TBP 6KR is less likely to be released 
from DNA due to its low mobility. These facts together imply that the higher protein 
stability of non-SUMOylatable TBP 6KR is an indirect consequence of its low 
dynamics on the promoters rather than a direct effect from SUMOylation.  
 
 
9.5.  The relationship between transcription factor promoter dynamics 
and transcription  
 
    SUMO is extensively involved in promoter regions and is closely related to 
transcriptional activities (Rosonina et al., 2010). There have been numerous examples 
describing how SUMO regulates transcription, such as affecting other 
post-translational modifications, modulating cellular localisation, protein-protein 
interactions or protein stability of transcription factors.  
    In this study, I identified a novel role of SUMO in TBP transcription. SUMO 
regulates transcription by maintaining dynamics of the transcription factor on 
promoters. The importance of the dynamics to transcription is discussed below. 
 
9.5.1. The relationship between the transcription factor promoter dynamics and the 
plasticity of transcription regulation 
    To maintain a relatively unstable interaction between TBP and DNA could be 
beneficial under certain circumstances, for example when gene expression needs to be 
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adjusted rapidly, as this gives cells better transcription plasticity in response to stimuli 
or to stress.  
If SUMOylation of TBP regulates promoter dynamics and thereby affects 
transcription plasticity, the N-terminal domain, which contains all the SUMO sites 
and is dispensable for cell growth, would become important under conditions that 
require transcription plasticity. In one study, it was found that cells expressing 
N-terminally truncated TBP (thus a non-SUMOylatable TBP mutant) exhibit slightly 
slower growth rate than wild-type cells. It was also reported in another study that 
some yeast strains with deletion of TBP amino-terminal residues 2-57 leads to a 
considerably decrease in growth rate (Zhou et al., 1991). This suggests that, although 
TBP N-terminal domain is dispensable for viability, it is particularly important when 
cells face stress. Moreover, a study comparing two TBP-containing transcription 
complexes, TFIID and SAGA, observed a higher TBP turnover rate at SAGA-bound 
promoters, which are largely involved in stress response (van Werven et al., 2009). 
Thus, maintaining a dynamic ability seems to provide transcription factors with 
flexibility to respond to stimuli more efficiently. In my study, I also found a defect for 
SUMO-deficient TBP mutants in sporulation, which is a cellular event involving 
transcription reprogramming. Therefore, SUMOylation of TBP might contribute to 
transcription plasticity by controlling promoter dynamics.  
 
9.5.2. Transcription factor promoter kinetics serves as a mechanism to regulate 
transcriptional output 
Traditionally, promoter occupancy of transcription factors has been linked to 
gene expression level. However, a recent report studying the transcription factor Rap1 
in budding yeast found that transcriptional output is correlated with a dynamic 
promoter turnover rate instead of the average occupancy of Rap1 at any given time 
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(Lickwar et al., 2012). The study demonstrated that a higher turnover rate leads to a 
lower transcriptional output. Therefore, the kinetics of the Rap1 transcription factor 
could serve as a mechanism of regulating transcription. Activation of genes is 
achieved by reducing protein dynamics and increasing DNA-binding stability, 
probably because an increase in promoter residence time extends the time of 
recruiting other components of the transcription machinery. This study highlights an 
important role for transcription factor dynamics. In my study, recycled SUMOylation 
and deSUMOylation is a likely mechanism for modulating TBP dynamics. This newly 
uncovered function of SUMO could be more widespread. Due to the general role of 
SUMO in transcription, it would be interesting to know whether there are other 
transcription factors whose promoter kinetics are also controlled by SUMO.  
In line with the notion that promoter kinetics of transcription factors is highly 
correlated with gene expression, another report comparing TBP turnover rates at 
promoters across the yeast genome obtained similar results (van Werven et al., 2009). 
In the study, the turnover rates of TBP at Pol I-regulated promoters, which are highly 
transcribed regions with continuous expression of rDNA gene, are generally the 
lowest. The highest turnover rate was detected at Pol II-mediated genes. This category 
of genes include most inducible promoters whose activation is relatively infrequent.  
 
 
9.6.  Potential explanation for TBP SUMO mutants effect in sporulation 
 
    A study linking TBP expression during the development of mammalian male 
germ cell has been undertaken. In rat and mouse cells, both TBP mRNA and protein 
levels are drastically overexpressed in testis compared to somatic cells during late 
spermatogenesis (Persengiev et al., 1996; Schmidt and Schibler, 1995). This reveals a 
need for TBP in this cellular stage. This might explain the sporulation defects in TBP 
SUMO mutants, where TBP protein stability is altered. 
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Alternatively, the defect could be explained by lack of flexibility during 
transcription reprogramming. Transcription plasticity includes a tightly temporal 
control of gene expression, which is largely decided by the efficiency of recruitment 
and promoter clearance of TBP. In my ChIP assays looking at the activation and 
shut-off of the inducible heat shock gene Hsp30, the release efficiency of TBP 6KR or 
TBP K47R was not different from WT, both were completely cleared off from 
promoters 5min after switching off the promoter. However, the recruitment efficiency 
of TBP 6KR was impaired, and TBP K47R also showed a minor effect. This implies 
that transcription plasticity, in particular the recruitment of TBP, might be affected by 
disrupting SUMOylation of TBP, which influences the transcription reprogramming 
during sporulation. 
 On the other hand, the sporulation defects could possibly come from abnormal 
transcriptional output of certain TBP-transcribed genes regulated for meiosis or 
sporulation due to a decrease in TBP kinetics. Apart from sporulation, the defect of 
TBP SUMO mutants might also be observed when precise expression levels of some 
TBP-transcribed genes need to be strictly controlled.  
 
 
9.7.  Relationship between SUMOylation of Mot1 and TBP dynamics 
 
Mot1, which has been identified as a SUMO substrate (Wang and Prelich, 2009), 
is a key TBP regulator which dissociates TBP from DNA in an ATP-dependent 
manner. It has both positive and negative roles in transcriptional regulation, and its 
ATPase activity is required for both activation and repression of Mot1-responsive 
genes (Dasgupta et al., 2002). Intriguingly, SUMOylation of mot1 mutant defective in 
binding to TBP is undetectable, and the mutant without ATPase activity, which is 
required for dissociating TBP from DNA, is highly SUMOylated (Wang and Prelich, 
2009). This suggests that binding or interacting with TBP is a prerequisite for Mot1 
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SUMOylation, and deSUMOylation of Mot1 occurs only when TBP is able to be 
released from DNA. In other words, recycled SUMOylation of Mot1 is closely related 
to the dynamic interaction between the two proteins. Given the function of Mot1 in 
destabilising TBP-DNA, as well as the effect of TBP SUMOylation in its promoter 
dynamics, it is interesting to speculate that SUMOylation of Mot1 takes part in the 
regulatory mechanism for TBP dynamics.  
 
 
9.8.  A proposed model for a regulatory mechanism of SUMO in 
transcription 
 
A novel role of SUMO in transcription is uncovered in my study, where SUMO 
controls the dynamics of TBP on promoters to regulate transcription. Figure 9-2 
proposes a model describing the functional significance of SUMOylation of TBP and 
the consequences of blocking its SUMOylation.  
In this model, DNA-bound TBP is not SUMOylated, whereas the exposure of the 
SUMO sites in the N-terminal domain increases the chance of SUMOylation. Once 
modified by SUMO, alteration of TBP configuration renders it unstable on DNA and 
thus it is released. TBP can rebind to promoters as soon as SUMO comes off. 
Recycling SUMOylation of TBP maintains normal promoter dynamics and thereby 
normal transcriptional output. DNA-bound TBP is prevented from degradation due to 
accumulation of de-ubiquitylating enzyme Ubp3 at promoters. However, since 
binding of TBP remains dynamic, every TBP molecule has an equivalent chance to 
stay in an unbound state and be degraded. By contrast, TBP 6KR is not SUMOylated, 
rendering DNA-bound TBP 6KR less mobile, and the generally lower promoter 
dynamics leads to higher transcriptional output. Moreover, lack of mobility represents 
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lack of exchange between the bound and unbound group, indicating the fact that the 
DNA-bound TBP is less likely to be degraded and has a longer protein half-life.  
 
 
 
Figure 9-2. The functional significance of TBP SUMOylation. The recycled SUMOylation (green 
oval) of TBP WT keeps the balance between two types of TBP which are able or unable to bind to 
DNA. This maintains normal promoter turnover of TBP WT and thereby a normal transcriptional 
output (bent arrow). The ubiquitylation (orange square) and degradation of the promoter-bound TBP is 
prevented by de-ubiquitylating enzyme Ubp3. Free TBP molecules are accessible to proteasome 
degradation and are degraded. Since TBP WT keeps itself dynamic on the promoters, the DNA-bound 
and unbound population are constantly exchanging. On the other hand, TBP 6KR, which is not 
SUMOylated, binds to DNA, but it cannot switch to a close configuration (due to lack of SUMOylation) 
and releases from the promoter. As a consequence, the binding is much more stable. The low promoter 
dynamics of TBP 6KR contributes to much higher expression level. Moreover, lack of exchange 
between the bound and unbound group makes the DNA-bound TBP 6KR proteins less likely to be 
degraded and therefore longer-lived. 
 
To provide more evidence for proposed model, future work should focus on 
examining whether gene expression levels are altered in TBP SUMO mutants.  
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In this study, I demonstrate that SUMOylation of TBP is crucial for maintaining 
its promoter dynamics. Given the central role of TBP in transcription and its highly 
conserved characteristic, this provides insight into a novel mechanism for 
transcription regulation which could be conserved among species. 
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ABBREVIATIONS 
 
AD Activation domain ATP Adenosine triphosphate 
BRE TFIIB recognition element cAMP Cyclic AMP 
CC Closed promoter complex ChIP Chromatin immunoprecipitation 
CLK Cross-linking kinetic CMV Cytomegalovirus 
cNLS Classical nuclear localization signal CTD C-terminal domain 
C-terminal Carboxy-terminal D Day(s) 
DBD DNA-binding domain DCE Downstream core element 
DMSO Dimethyl sulphoxide DNA Deoxyribonucleic acid 
Dnmt3a DNA methyltransferase 3a dNTP Deoxyribonucleotide triphosphate 
Dox Doxycycline DPE Downstream core promoter element 
EDTA Ethylenediaminetetraacetic acid ER Endoplasmic reticulum 
FRAP Fluorescence recovery after 
photobleaching 
GAE GA element 
GFP Green fluorescent protein GTF General transcription factor 
GTP Guanosine triphosphate H Hour 
HA Hemagglutinin HAC Histone acetylase 
HAT Histone acetyltransferase HDAC Histone deacetylase 
HeLa Henrietta Lacks HFD Histone fold domain 
HF-Smt3 6His-FLAG-Smt3 HMG High mobility group 
HSF1 Heat shock transcription factor 1 Ime1 Inducer of Meiosis I 
Inr Initiator Min Minute(s) 
MMS Methyl methanesulfonate MTE Motif ten element 
NC2 Negative cofactor 2 NHEJ Non-homologous end joining 
N-terminal Amino-terminal OC Open promoter complex 
OD Optical density ORF Open reading frame 
PBS Phosphate-buffered saline PCNA Proliferating Cell Nuclear Antigen 
PCR Polymerase chain reaction PDSM Phosphorylation-dependent SUMOylation 
motif 
PIC Preinitiation complex PML Promyelocytic leukaemia 
PMSF Phenylmethanesulphonylfluoride Pol Polymerase 
rDNA Ribosomal DNA RNA Ribonucleic acid 
ROI Region of interest ROS Reactive oxygen species 
Rpm Rotations per minute s/sec Seconds 
SAGA Spt-Ada-Gcn5 acetyltransferase SDS-PAGE SDS polyacrylamide gel electrophoresis 
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SDS Sodium dodecyl sulphate SIM SUMO-interacting motif 
Smc5/6 Structural maintenance of chromosomes 5 
and 6 
SPB Spindle pole body 
STUbL SUMO-targeted ubiquitin ligases SUMO Small ubiquitin-related modifier 
TAF TBP-associated factor TAND TAF N-terminal Domain 
TBP TATA-binding protein TBP 6KR TBP K8,11,15,35,47,55R 
TDG Thymine DNA glycosylase tetO Tetracycline operator boxes 
tetR Tetracycline-inducible repressor TSS Transcription start site 
Ubp3 Ubiquitin-specific protease 3 UIM Ubiquitin-interacting motif 
UV Ultraviolet V Volume 
V Volt W Weight 
WCE Whole cell extract WT/wt Wildtype 
YPD Yeast extract peptone dextrose   
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K8, K11, K15, K35, K47 and K55 of TBP are the only six lysine residues able to be SUMOylated. 
The intrinsic accessibility of individual lysine residue was examined by mutating all lysine residues on 
TBP to arginine except the one under investigation (KallR, RXK, X indicates where the only Lys 
localises). TBP KallR (all lysine residues are mutated to arginine) was used as a non-SUMOylatable 
negative control, while wild-type TBP served as a positive control. These TBP constructs with 
N-terminal 3HA tag were driven by GALS promoters. To induce their expression, galactose was added 
2h prior cell harvesting. Cellular SUMOylated proteins were subsequently purified by His pull-down, 
and TBP was detected by antibodies against HA. For comparison, whole cell extract without 
purification was also shown. Unmodified form of TBP is pointed by an arrow, and SUMOylated forms 
are marked with arrow heads. (A). SUMOylation of K11, K15, K35 and K47. Note that the lane 3 is an 
irrelevant lane. (B). SUMOylation of K8, K55, K83, K97, K110, and K120. (C). SUMOylation of 
K127, K133, K138, K145, K151 and K156. (D). SUMOylation of K167, K199, K201, K211, K218 and 
K239. 
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APPENDIX II 
 
 Yeast (S.cerevisiae) strains used 
Strain Description Genotype 
Plasmid/ 
Template 
Reference 
or Source 
Isogenic to BY4741: 
CCG7813 
(BY4741) 
WT (BY) 
MATa his3△1 leu2△0 
met15△0 ura3△0 
 Lab stock 
(Euroscarf) 
CCG4620 
(HZY1017) 
HF-Smt3 6HisFLAG-smt3::kanMX6 
 Lab stock 
(Zhou et al., 
2004) 
CCG9209 Hmo1-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Hmo1-9myc HYG 
pYM20 
This study 
CCG9210 Hmo1-9myc Hmo1-9myc HYG pYM20 This study 
CCG9211 Mtw1-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Mtw1-9myc HYG 
pYM20 
This study 
CCG9212 Mtw1-9myc Mtw1-9myc HYG pYM20 This study 
CCG9213 Scc2-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Scc2-9myc HYG 
pYM20 
This study 
CCG9214 Scc2-9myc Scc2-9myc HYG pYM20 This study 
CCG9215 Tfb2-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Tfb2-9myc HYG 
pYM20 
This study 
CCG9216 Tfb2-9myc Tfb2-9myc HYG pYM20 This study 
CCG9217 Rrm3-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Rrm3-9myc HYG 
pYM20 
This study 
CCG9218 Rrm3-9myc Rrm3-9myc HYG pYM20 This study 
CCG9315 TBP-3HA, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
TBP-3HA HYG 
 
Lab stock 
CCG9317 TBP-3HA TBP-3HA HYG  Lab stock 
CCG9353 Mcm5-3HA, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Mcm5-3HA HYG 
pYM24 
This study 
CCG9354 Mcm5-3HA Mcm5-3HA HYG pYM24 This study 
CCG8373 Pds5-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Pds5-9myc HYG 
 
Lab stock 
CCG8375 Pds5-9myc Pds5-9myc HYG  Lab stock 
CCG5597 Sir3-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX6; 
Sir3-9myc NAT 
 
Lab stock 
 v 
 
CCG5598 Sir4-9myc, HF-Smt3 
6HisFLAG-smt3::kanMX; 
Sir4-9myc NAT 
 
Lab stock 
CCG11155 CCG4620+TBP-6HA 
6HisFLAG-smt3::kanMX; 
TBP-6HA::HIS 
pYM15 
This study 
CCG11614 
CCG9315+3HA-TBP 
WT-6HA::HIS 
6HisFLAG-smt3::kanMX; 
3HA-TBP WT-6HA::HIS 
CCG11155 
Genomic DNA 
+ GeneCust 
243 
This study 
CCG11619 
CCG9317+3HA-TBP 
WT-6HA::HIS 
3HA-TBP WT-6HA::HIS 
CCG11155 
Genomic DNA 
+ GeneCust 
243 
This study 
CCG11645 
CCG9315+3HA-TBP 
6KR-6HA::HIS 
6HisFLAG-smt3::kanMX; 
3HA-TBP 
K8,11,15,35,47,55R-6HA::HIS 
CCG11155 
Genomic DNA 
+ GeneCust 
212 
This study 
     
 Isogenic to AS499: 
CCG5605 Sir3-9myc 
Mata leu2 ura3 his3 trp1 ade2 
lys2 bar1 pep4:HIS3; 
Sir3-9myc NAT 
 
Lab stock 
CCG5606 Sir4-9myc 
Mata leu2 ura3 his3 trp1 ade2 
lys2 bar1 pep4:HIS3; 
Sir4-9myc NAT 
 
Lab stock 
     
Isogenic to DF5a: 
CCG3144 WT (DF5a) 
MATa his3-∆200 leu2-3, 112 
lys2-801 trp1-1 (am) ura3-52 
 Lab stock 
(Finley et al., 
1987) 
CCG9603 CCG3144+ 6HisFLAG-smt3 6HisFLAG-smt3::kanMX6 
CCG4620 
Genomic DNA 
This study 
CCG9604 CCG9603 +TBP-3HA  
6HisFLAG-smt3::kanMX6; 
TBP-3HA HYG 
pYM24 
This study 
CCG9605 CCG3144 +TBP-3HA TBP-3HA HYG pYM24 This study 
CCG9606 
CCG9603+ pRS406- 
pGALS-3HA-TBP wt 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP wt 
GeneCust 100 
This study 
CCG9608 
CCG9603+ pRS406- 
pGALS-3HA-TBP K47R 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP K47R 
GeneCust 102 
This study 
 vi 
 
CCG9609 
CCG9603+ pRS406- 
pGALS-3HA-TBP 
K35-47-97-127R 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP 
K35-47-97-127R 
GeneCust 107 
This study 
CCG9610 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
GeneCust 110 
This study 
CCG9611 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R8K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R8K 
GeneCust 111 
This study 
CCG9612 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R11K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R11K 
GeneCust 112 
This study 
CCG9613 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R15K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R15K 
GeneCust 113 
This study 
CCG9614 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R35K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R35K 
GeneCust 114 
This study 
CCG9615 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R47K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R47K 
GeneCust 115 
This study 
CCG9616 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R55K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R55K 
GeneCust 116 
This study 
CCG9617 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R83K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R83K 
GeneCust 117 
This study 
CCG9618 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR R97K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R97K 
GeneCust 118 
This study 
CCG9619 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R110K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R110K 
GeneCust 119 
This study 
CCG9620 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R120K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R120K 
GeneCust 120 
This study 
CCG9621 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R127K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R127K 
GeneCust 121 
This study 
 vii 
 
CCG9644 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R133K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R133K 
GeneCust 122 
This study 
CCG9645 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R138K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R138K 
GeneCust 123 
This study 
CCG9646 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R145K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R145K 
GeneCust 124 
This study 
CCG9647 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R151K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R151K 
GeneCust 125 
This study 
CCG9648 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R156K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R156K 
GeneCust 126 
This study 
CCG9649 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R167K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R167K 
GeneCust 127 
This study 
CCG9650 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R199K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R199K 
GeneCust 128 
This study 
CCG9651 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R201K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R201K 
GeneCust 129 
This study 
CCG9652 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R211K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR  
GeneCust 130 
This study 
CCG9653 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R218K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R218K 
GeneCust 131 
This study 
CCG9654 
CCG9603+ pRS406- 
pGALS-3HA-TBP KallR 
R239K 
6HisFLAG-smt3::kanMX6; 
ura3::pGALS-3HA-TBP KallR 
R239K 
GeneCust 132 
This study 
CCG9845 
CCG9603+ 
pRS405-pGALS-3HA-TBP 
K8,11,15,35,47,55R 
6HisFLAG-smt3::kanMX6; 
leu2:: pGALS-3HA-TBP 
K8,11,15,35,47,55R 
GeneCust 215 
This study 
CCG9848 
CCG9603+ pRS405- 
pTbp1-3HA-TBP 
6HisFLAG-smt3::kanMX6; 
leu2:: pTbp1-3HA-TBP 
GeneCust 212 
This study 
 viii 
 
K8,11,15,35,47,55R K8,11,15,35,47,55R 
CCG10082 
CCG3144+ pRS405- 
pGALS-GFP-TBP wt 
leu2:: pGALS- GFP-TBP wt 
GeneCust 240 
This study 
CCG10084 
CCG3144+ pRS405- 
pGALS-GFP-TBP 
K8,11,15,35,47,55R 
leu2:: pGALS- GFP-TBP 
K8,11,15,35,47,55R 
GeneCust 241 
This study 
CCG10365 CCG3144+pRS405- 
pTbp1-3HA-TBP K47R 
leu2:: pTbp1-3HA-TBP K47R 
GeneCust 304 
This study 
CCG10547 CCG3144+ TBP-3myc TBP-3myc::trp pYM23 This study 
CCG10549 CCG10547+ endogenous TBP 
promoter is replaced with 
tetO7-tTA promoter 
TBP-3myc::trp; 
kanMX4::tetO7-tTA promoter 
pCM225 
This study 
CCG10550 CCG10547+ endogenous TBP 
promoter is replaced with 
tetO7-tTA promoter 
TBP-3myc::trp; 
kanMX4::tetO7-tTA promoter 
pCM225 
This study 
CCG10564 
CCG10550+ 
pRS405-pTbp1-3HA-TBP wt 
TBP-3myc::trp; 
kanMX4::tetO7-tTA promoter; 
leu2::pTbp1-3HA-TBP wt 
GeneCust 243 
This study 
CCG10566 
CCG10550+ 
pRS405-pTbp1-3HA-TBP 
K8,11,15,35,47,55R 
TBP-3myc::trp; 
kanMX4::tetO7-tTA promoter; 
leu2::pTbp1-3HA-TBP 
K8,11,15,35,47,55R 
GeneCust 212 
This study 
CCG11153 
CCG10550+ 
pRS405-pTbp-3HA-TBP K47R 
TBP-3myc::trp; 
kanMX4::tetO7-tTA promoter; 
leu2::pTbp1-3HA-TBP K47R 
GeneCust 304 
This study 
     
Isogenic to CCG4702: 
CCG4702  Matα, leu2∆0 lys2∆0 met15∆0 
 Lab stock 
(Euroscarf) 
     
Diploid strains 
CCG10665 10564 x 4702 
Mata/α; his3-∆200/HIS3; 
leu2::pTbp1-3HA-TBP 
wt/leu2∆0; lys2-801/lys2∆0; 
trp1-1 (am)/TRP1; 
ura3-52/URA3; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
 
This study 
 ix 
 
(endogenous)/pTbp1-TBP 
(endogenous); 
MET15/met15∆0 
CCG10667 10566 x 4702 
Mata/α; his3-∆200/HIS3; 
leu2::pTbp1-3HA-TBP 
K8,11,15,35,47,55R /leu2∆0; 
lys2-801/lys2∆0; trp1-1 
(am)/TRP1; ura3-52/URA3; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous)/pTbp1-TBP 
(endogenous); 
MET15/met15∆0 
 
This study 
CCG10720 10564 x 10674 
Mata/α; his3-∆200/HIS3; 
lys2-801/lys2-801(or lys2D0); 
trp1-1 (am)/trp1-1 (am)(or 
TRP1); ura3-52/ura3-52; 
MET15/met15∆0; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous) 
/KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP 
wt/leu2::pTbp1-3HA-TBP wt 
 
This study 
CCG10722 10566 x 10676 
Mata/α; his3-∆200/HIS3; 
lys2-801/lys2-801(or lys2D0); 
trp1-1 (am)/trp1-1 (am)(or 
TRP1); ura3-52/ura3-52; 
MET15/met15∆0; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous) 
/KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP 
 
This study 
 x 
 
K8,11,15,35,47,55R/ 
leu2::pTbp1-3HA-TBP 
K8,11,15,35,47,55R 
CCG11180 11153 x 4702 
Mata/α; his3-∆200/HIS3; 
leu2::pTbp1-3HA-TBP K47 R 
/leu2∆0; lys2-801/lys2∆0; 
trp1-1 (am)/TRP1; 
ura3-52/URA3; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous)/pTbp1-TBP 
(endogenous); 
MET15/met15∆0 
 
This study 
CCG11210 11153 x 11190 
Mata/α; his3-∆200/HIS3; 
lys2-801/lys2-801(or lys2D0); 
trp1-1 (am)/trp1-1 (am)(or 
TRP1); ura3-52/ura3-52; 
MET15/met15∆0; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous) 
/KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP K47R/ 
leu2::pTbp1-3HA-TBP K47R 
 
This study 
     
Haploid strains derived from diploids in this study 
CCG10674 Sporulation from 10665 
Matα;lys2-801(or lys2∆0); 
trp1-1 (am)(or TRP1); 
ura3-52; met15∆0; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP wt 
 
This study 
CCG10676 Sporulation from 10667 
Matα;lys2-801(or lys2∆0); 
trp1-1 (am)(or TRP1); 
ura3-52; met15∆0; 
 
This study 
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KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP 
K8,11,15,35,47,55R 
CCG11190 Sporulation from 11180 
Matα;lys2-801(or lys2∆0); 
trp1-1 (am)(or TRP1); 
ura3-52; met15∆0; 
KanMX4::tetO7-tTA 
promoter-TBP-3myc::trp 
(endogenous); 
leu2::pTbp1-3HA-TBP K47R 
 
This study 
 
 
 
 xii 
 
APPENDIX III 
 
Table. The list of plasmids used in this study 
Name Description Vector Reference 
From Euroscarf 
pYM15 C-terminal 3HA tag with marker HIS  (Janke et al., 2004) 
pYM20 C-terminal 9myc tag with marker hphNT1   (Janke et al., 2004) 
pYM23 C-terminal 3myc tag with marker klTRP1  (Janke et al., 2004) 
pYM24 C-terminal 3HA tag with marker hphNT1  (Janke et al., 2004) 
pCM225 promoter substitution cassette for tetracycline 
repressable expression under control of tetO7 with 
marker KanMX 
 (Belli et al., 1998) 
 
GeneCust 
100 TBP ORF pRS406  
102 TBP K47R ORF pRS406  
107 TBP K35-47-97-127R ORF pRS406  
110 GALS-3HA-TBP KallR ORF pRS406  
111 GALS-3HA-TBP KallR R8K pRS406  
112 GALS-3HA-TBP KallR R11K pRS406  
113 GALS-3HA-TBP KallR R15K pRS406  
114 GALS-3HA-TBP KallR R35K pRS406  
115 GALS-3HA-TBP KallR R47K pRS406  
116 GALS-3HA-TBP KallR R55K pRS406  
117 GALS-3HA-TBP KallR R83K pRS406  
118 GALS-3HA-TBP KallR R97K pRS406  
119 GALS-3HA-TBP KallR R110K pRS406  
120 GALS-3HA-TBP KallR R120K pRS406  
121 GALS-3HA-TBP KallR R127K pRS406  
122 GALS-3HA-TBP KallR R133K pRS406  
123 GALS-3HA-TBP KallR R138K pRS406  
124 GALS-3HA-TBP KallR R145K pRS406  
125 GALS-3HA-TBP KallR R151K pRS406  
126 GALS-3HA-TBP KallR R156K pRS406  
127 GALS-3HA-TBP KallR R167K pRS406  
128 GALS-3HA-TBP KallR R199K pRS406  
129 GALS-3HA-TBP KallR R201K pRS406  
 xiii 
 
130 GALS-3HA-TBP KallR R211K pRS406  
131 GALS-3HA-TBP KallR R218K pRS406  
132 GALS-3HA-TBP KallR R239K pRS406  
212 pTbp-TBP K8-11-15-35-47-55R pRS405  
215 GALS-3HA-TBP K8-11-15-35-47-55R ORF pRS405  
240 GALS-GFP-TBP pRS405  
241 GALS-GFP-TBP K8-11-15-35-47-55R pRS405  
243 pTbp-3HA-TBP pRS405  
244 pTbp-3HA-TBP KallR pRS405  
304 pTbp-3HA-TBP K47R pRS405  
 
 
 
